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requirements for the Degree of Doctor of Philosophy 
Abstract 
Molecular Genetics Underlying Ovine Growth and Carcass Traits 
in New Zealand Breeds 
by 
Ugonna Jane Ekegbu 
As a major source of protein in many nations, the global demand for meat is rising. The multi-
billion dollar New Zealand (NZ) export sheep meat industry is always searching for new ways 
to increase profitability, improve productivity and increase efficiency. Sheep growth and 
carcass traits are therefore considered to be of economic importance; with greater emphasis 
being placed on the use of genetic tools in breeding for leaner, faster-growing animals that 
yield more meat with good taste characteristics. 
This research examined four sheep genes: insulin-like growth factor 1 receptor (IGF1R), 
growth hormone (GH), POU class 1 homeobox 1 (POU1F1), and PROP paired-like 
homeobox 1 (PROP1). The biological function of the protein products of these genes, and 
their direct or indirect effect on traits associated with meat production, suggested they were 
good candidates for further study. This research investigated whether nucleotide sequence 
variation was present in these genes, and whether associations exist between variation in the 
genes and variation in selected sheep growth and carcass traits. 
To achieve this goal, firstly, ten different NZ sheep breeds were screened to ascertain whether 
nucleotide sequence variation was present in selected regions of the genes. This involved 
using a combination of polymerase chain reaction-single strand conformational polymorphism 
(PCR-SSCP) analysis, coupled with nucleotide sequencing. Next, with NZ Romney sheep that 
had well-recorded pedigree and growth and carcass traits, general linear mixed-effects models 
(GLMMs) were then used to ascertain whether or not any nucleotide sequence variation 
detected was associated with the growth and carcass traits. 
  iii 
The IGF1 receptor mediates key signalling processes that are crucial to cell growth, protein 
synthesis, proliferation, survival and metabolism. This study examined three fragments of 
ovine IGF1R, one of which spanned from exon 9 to intron 10. Five variants (A9 to E9) defined 
by ten nucleotide substitutions, including a deletion (c.2201+114_118delCGCAG), were 
detected in the exon 9 to intron 10 region. Lambs possessing the A9 variant grew faster by 
10.8 g/day (P = 0.001), had 9% less fat thickness (P = 0.038), weighed 3.2% more at slaughter 
(P < 0.001), and had 1.2% increase in total lean meat yield (P = 0.002). In contrast, the E9 
variant was associated with slower-growing lambs (P = 0.001), increased fat depth (P = 
0.022), and decreased muscularity (P = 0.009).  
Growth hormone is a key mediator of growth and other metabolic processes. Variation in GH 
has been reported in several species where it showed association with production traits. In this 
study, a fragment of ovine GH spanning the exon 2, intron 2 and exon 3 regions was found to 
have 11 nucleotide substitutions that were arranged in seven variants (named A3 to G3). Four 
of the substitutions were found in the coding region of GH, namely c.51C>T (p.Leu17Leu), 
c.59C>T (p.Pro20Leu), c.79G>A (p.Ala27Thr), and c.103G>C (p.Gly35Arg). The B3 variant 
was associated with an increase in average daily weight gain by 17.4 g/day (P < 0.001), lower 
fat depth at the 12th rib by 0.48 mm (P = 0.015), and increased total lean meat yield by 1.2% 
(P = 0.007). In contrast, the F3 variant was associated with decreased average daily weight 
gain (P < 0.001), lower weight at slaughter (P < 0.001), and decreased total lean meat yield (P 
< 0.001). Lambs possessing the A3B3 genotype grew the fastest (274.59 ± 10.56 g/day; P < 
0.001) and had the highest lean meat yield (53.47 ± 0.19%, P < 0.001). 
POU1F1 positively regulates the functions of three key hormones: GH, thyroid-stimulating 
hormone, and prolactin. Three fragments were explored in this study, but only the exon 1 
fragment revealed any sequence variation with two variants, A and B. Associations with 
growth and carcass traits were not tested. 
PROP1 controls prenatal muscle development and differentiation. Two fragments spanning 
the exon 1 and exon 2 regions of ovine PROP1 were examined. Three variant sequences were 
revealed in each region: exon 1 - A1, B1 and C1, and exon 2 - A2, B2 and C2. The more 
abundant A1 and A2 variants were associated with an increase in growth rate (P < 0.001) and 
higher total lean meat yield (P = 0.001). Variant B1 was associated with a decrease in birth 
weight by 0.14 kg (P = 0.025) and an increase in fat thickness by 0.45 mm (P = 0.013), while 
variant C2 was associated with lower growth rate of 22.3 g/day (P = < 0.001) and decreased 
total lean meat yield by 1% (P = 0.025).  
  iv 
The sequence variations found in this study could potentially be used in marker-assisted 
selection (MAS) for improving growth and carcass traits in sheep. 
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In some markets, the industry is being shaped by increasing consumer demands for better 
quality products, with juicier yet leaner meat being favoured in higher value markets. 
Consumer perception and increased awareness linking dietary fat to obesity, cardiovascular 
disease and mortality, has brought about this shift in consumer preference to lean meat 
(Bray and Popkin, 1998), such that only a minimal amount of intramuscular fat is 
considered acceptable for reasons of tenderness and taste. The meat industry is constantly 
seeking to strike a balance by ensuring the smallest fat content, whilst retaining 
palatability. 
Carcass quality is affected by the weight, muscularity and body composition (fat to bone 
and muscle ratio) of animals at slaughter (Stanford et al., 1998). In some markets, the 
weight of a carcass is of critical importance, while in others, the amount of saleable meat 
on a carcass governs its financial value. Accordingly, lambs that produce higher yields of 
lean meat can be of importance to farmers, processors and consumers. Previous research 
has suggested that about half of all NZ lamb carcasses do not meet industry standards 
(Gooch and Firth, 2007), and this along with declining sheep numbers, poses a huge threat 
to the NZ meat industry. There is therefore an on-going need to improve lamb growth and 
carcass traits.  
Short-term or transient improvement of carcass value can be achieved by using different 
management systems, including improving pre-slaughter handling of sheep, hormone 
administration, altering nutrition and feed quality/quantity, changing slaughter time and 
post-slaughter processing, and changing the on-farm environment (Freer, 2002). However, 
these strategies face limitations, such as the decreased efficiency of meat output per unit of 
land, as lamb slaughtered early has not attained its full growth potential (Lewis et al., 
1996). In addition, altering forage composition in extensive farming systems and the post-
slaughter trimming of fat can be both expensive and labour intensive. Results from these 
strategies are also not guaranteed, as they may vary across farms and processing plants. 
Long-term improvement of carcass quality would require the selection of superior animals 
with commercially desirable traits for breeding. Traditional livestock selection based on 
visible ancestral performance is, for some traits, being superseded by genetic selection 
approaches, largely because the physical measurement of meat quality traits using ex-vivo 
approaches can be expensive, unreliable and difficult to standardise (Dunner et al., 2013). 
As such, they are impractical for testing a large number of animals from across different 
breeds. While it is true that various factors contribute to growth and development in 
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animals, including genes, metabolism, nutrition and environment, the assessment of the 
genetic components of growth is a reliable method to predict improvement in these 
production traits. Vital production traits such as carcass weight, lean meat yield, and 
growth rate all exhibit moderate heritability (0.25 – 0.5) (Safari et al., 2005). Hence, 
genetic selection could potentially improve these traits; and in an NZ context, the large and 
diverse population of sheep makes it ideal for the exploration of genetic markers. 
Much of the diversity observed in species are governed by genetic loci, known as 
quantitative trait loci (QTL), exerting measurable effects on the phenotypic traits of an 
animal (Collard et al., 2005). Genes located in the QTL of established traits are known as 
candidate genes. Genetic improvement by means of molecular techniques relies on 
identifying, mapping and analysing genetic variations at important genetic loci. Hence, 
there is an exigent need to identify novel variations in candidate genes that are associated 
with key production traits. While some research has been completed in various ovine 
breeds, there is much work to be done with the NZ sheep breeds and in unexplored genes. 
Studies of diverse populations are then required to affirm the robustness of associations 
with key production traits reported for gene variations.  
The selective breeding of animals based on genotypic variation at targeted loci, as an 
approach to improve livestock performance, is gaining more popularity in the meat 
industry. Companies such as GeneSTAR® and Igenity® utilise genetic markers to 
commercially offer gene typing tests to livestock breeders (Igenity, 2012). 
Quantitative trait loci associated with liveweight, and growth and carcass traits in sheep, 
are found on chromosomes 1, 2, 3, 4, 5, 6, 11, 14, 18, 20, and 21 (Walling et al., 2004). Of 
the many genes housed in those regions, the ones selected for this study were: insulin-like 
growth factor 1 receptor (IGF1R), growth hormone (GH), POU class 1 homeobox 1 
(POU1F1), and PROP paired-like homeobox 1 (PROP1). These genes were chosen 
because the physiological functions of their products directly or indirectly link to growth 
and carcass traits in sheep. Hence, nucleotide variation found therein could serve as 
potential markers for selective breeding.  
This research thus aims to evaluate sequence variation in selected candidate genes and 
their association with growth and carcass traits in NZ sheep breeds. Genetic selection 
strategies utilising polymorphisms uncovered in this study have the potential to provide 
long-lasting approaches to boosting the profitability and sustainability of the NZ sheep 
industry, as well as promoting sheep production at higher market value.  
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amount of conjugated linolenic acid (CLA) than milk from cattle, goats and humans, which 
has been reported to have cancer-fighting properties (Park et al., 2007).  Milk obtained 
from sheep is commonly used in the production of cultured dairy products like cheese. The 
economic value of cheese is enhanced by its high solids content, greater than that of goats 
or cows (Raynal-Ljutovac et al., 2008).  A higher solid content means that a gallon of 
sheep milk would produce more cheese than a similar gallon of goat or cow milk, as well 
as contributing to its rich creamy texture. Popular cheese derived from sheep milk include 
feta (Greece), ricotta (Italy) and Roquefort (France). Another factor that makes sheep milk 
aesthetically pleasing is the presence of smaller fat globules compared to cattle, which 
makes it easier to digest (Giorgio et al., 2018). This is also a limitation, as the larger fat 
globules in cow’s milk aid the separation of cream, and subsequently the production of 
other products like butter.   
Although history asserts that the commodity first associated with sheep was wool, a 
paradigm shift in global demand has increasingly placed greater economic importance to 
meat relative to wool. Compared to its cattle or pig counterparts, sheep meat is in high 
demand globally, because it encounters fewer religious and dietary constraints to its 
consumption, especially in the Middle-Eastern and the Asian Sub-Continent States, where 
Islamic, Hindu and Jewish beliefs dictate the type of meat that can be eaten. In 2017 alone, 
over 14 million tonnes of sheep were produced worldwide (FAO, 2018). World sheep meat 
production and export over three years is summed up in Table 2.1. 
Table 2.1 Total sheep meat produced and exported in the world and selected 
countries 
 2015 2016 2017 
Total sheep meat production (x1000 tonnes) 
World 14607 14747 14839 
China 4410 4617 4691 
EU 908 877 893 
India 732 740 741 
Australia 755 715 1.8 
Total sheep meat export (x1000 tonnes) 
World 960 910 980 
Australia 442 428 454 
New Zealand 400 370 396 
EU 18 16 30 
India 22 21 23 
Sources: FAO (Food and Agriculture Organization of the United Nations) (FAO, 2018) 
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meat industry has enjoyed remarkable success with about 27 million sheep, with over 24 
million processed annually (Beef + Lamb NZ, 2018b; Stats NZ, 2018). In NZ, while some 
sheep are bred solely for meat or wool production, a good number of sheep are dual-
purpose. A brief history and detail of the ten sheep breeds investigated in this study is 
given below.  
Romney 
New Zealand Romney sheep originated from the wet marshes Kent in South England, and 
was brought to NZ by Messrs Bennett and Young, reaching Wellington in 1843 
(Stringleman and Peden, 2008). Romney was then established in the early 1900s. The 
Romney was initially bred for its long heavy fleece due to the necessity of wool in the 17th 
century for making carpets and furnishing, but a shift in the industry to meat production 
meant NZ Romney was bred for both meat and wool (Meadows, 1997). The emphasis on 
meat production has led to an increase in the weight, size and fertility of Romney breeds. 
These traits, along with their adaptability to rough terrains and areas of heavy rainfall 
makes the Romney a highly sought-after breed.  
About 50% of all the sheep in NZ are Romney breeds, making them a principal contributor 
to the economy (Dalton and Ackerley, 1974; Beef + Lamb NZ, 2018b). The Romney breed 
is also a favourite for use in crosses aimed at creating better sheep breeds. 
Perendale 
The Romney breeds experienced many difficulties in the steep landscapes of the North 
Island. The Perendale was formed from a cross between Romney and the Cheviot breeds to 
allow for adaptability on steep hill country (Stringleman and Peden, 2008). The Cheviot 
added its hardy constitution, easy shepherding and high lambing attributes to the mix. In 
addition to having a higher fertility rate than Romney, the Perendale has better foraging 
ability and hardiness (Dalton and Ackerley, 1974). 
Coopworth 
The Coopworth breed is the result of a Romney-Border Leicester cross in the 1960s. The 
Romney was added to the mix for its high-quality meat, while Border Leicester was 
selected primarily for its fertility, and also excellent maternal instinct. Coopworth ewes 
have a higher lambing percentage (30% triplets), and are best suited to low-land 
environments (Stringleman and Peden, 2008). 
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Poll Dorset 
The Poll Dorset is a critical breed in the NZ meat industry popular for its succulent and 
lean meat, good muscling and faster growth rates. Its high growth rate, leanness, ease of 
lambing and out-of-season lambing makes the Poll Dorset a popular choice as a terminal 
sire breed for crosses (NZ Sheep Breeders Association, 2019).  
Suffolk 
The Suffolk sheep are large-size sheep known for their characteristic dark faces and dark 
long legs with a lack of horns. Suffolks were created by a cross between Southdown and 
Norfolk Horned breeds (NZ Sheep Breeders Association, 2019). In the past, the Suffolk 
was the most common terminal meat sire, but is largely being supplanted by the Poll 
Dorset breed. Both breeds share similar traits such as early maturation, high muscularity 
and lean-carcass. 
White Dorper 
The Dorper, a popular breed in Africa and the Middle East, is a cross between a Dorset 
Horn and Blackhead Persian, and hence Dorpers can be either all white-head or black-head 
(NZ Sheep Breeders Association, 2019). The Dorper is bred purely for meat, with little or 
no wool, thus producing high quality carcass. They are used as sires in crosses favouring 
larger carcass sizes.  
Merino 
The NZ economy is renowned for its wool production and export. The Merino is a 
medium-sized sheep breed originating in Spain, and was introduced into NZ in the early 
1800s, making it one of the oldest NZ sheep breeds (NZ Sheep Breeders Association, 
2019).  On average, the NZ Merino sheep produces fine wool with a fibre diameter ranging 
from 13-25 microns (about one-third of the human hair diameter), weight of 3-6 kg, and a 
staple length of 65-100 mm (Wuliji et al., 2001). The Merino is bred for its highly prized 
ultra-fine and soft wool which is used in luxury garments like suits, insulation and 
upholstery.  
The resilience and high adaptability of Merinos to climates of different temperatures due to 
the nature of its wool, enables farming in NZ’s South Island where temperatures can climb 
to 35 ºC in summer, and drop to -10 ºC in winter. Merino breeds could hence stay cool in 
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summer and warm in winter. However, the stress brought upon the animal by harsh 
climates or neglect can be evident as weakened wool fibres (Wuliji et al., 2001). The The 
Merino breed was not ideal for meat production, as the carcass was very lean and produced 
tough meat. 
Some challenges associated with Merino farming includes their slower growth and 
maturation as compared to meat breeds, susceptibility to the footrot and flystrike diseases 
which requires costly management by drenching (Dalton and Ackerley, 1974). Footrot is a 
contagious infection of tissue inside the hoof, while flystrike is a parasitic infection caused 
by flies attracted to the sheep’s wool when it is contaminated with dirt, faeces and fluids. 
Corriedale 
In an attempt to improve wool production and inhibit footrot disease, a cross between long-
wool Lincoln and Merino took place in the Otago areas of NZ during the late 1800s to 
early 1900s (NZ Sheep Breeders Association, 2019). Initially known as the inbred half-
bred, the new breed was soon established as Corriedale, a dual-purpose breed reared for its 
wool and meat. Adapted for grazing on drier hilled areas, the Corriedale is farmed in both 
the North and South Island of NZ. Compared to the Merino breed, the Corriedale has 
higher fecundity and early maturation. The Corriedale lambs produce carcass with better 
muscling making them more profitable to rear (Stringleman and Peden, 2008).  The 
Corriedale produces medium-fine wool (28-33 microns) that is versatile for use in knitting 
yarns, blankets, and carpets.  
Texel 
Originating from the cold and harsh environment of Texel in Holland, the Texel breed has 
adapted to difficult conditions by developing useful traits such as hardiness, low 
maintenance, high feed-to-energy conversion ratio and good mothering ability (NZ Sheep 
Breeders Association, 2019).  
Dorset Down 
The Dorset Down breeds are known for their early maturing and very lean carcass. 
Initially, the breed did not adapt well to the NZ climate following import from Europe. The 
Dorset Down is now considered a valuable sire breed, bringing excellent growth rate, and 
low-fat carcass into the genetic mix (NZ Sheep Breeders Association, 2019).  
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2.1.2 Role of growth and carcass traits in sheep production 
Meat and meat products are an indisputable part of human diets which contain vital 
proteins, fatty acids, vitamins and minerals. A complex interplay of various factors 
including socio-economic status, price, religion, tradition, culture and geographical 
location influence dietary consumption. Consumers constitute the final step in the 
production chain, and meeting their expectations is of vital importance to the meat 
industry. The choice of the consumer is influenced by many factors including visual, 
sensory and marketing characteristics (Jopson et al., 2009). The consumer evaluation 
process can be broadly divided into two stages: before purchase and eating, and after 
purchase and eating. Prior to purchase, a key index of quality is the appearance of the 
meat, with colour being a major indicator of freshness (Pannier et al., 2018). Following 
consumption, the perception of taste in terms of tenderness, juiciness, and flavour of meat 
play important roles in the complete sensory experience.  
From the perspective of the efficiency of meat production, slower-growing animals have 
higher proportional maintenance in feeding (primarily a function of their live-weight), 
versus the additional feed needed to enable growth. As a function of its size, all animals 
exert a maintenance cost, in the form of energy required for normal body function and 
homeostasis, the left-over of which is used for growth (Dickerson, 1978; Dawson and 
Steen, 1998). Faster-growing animals are better in this regard as they require less 
maintenance cost. 
A carcass is composed of muscle, bone and fat, in varying proportions. Ideally, the animal 
carcass should have muscle in the highest proportion, sufficient fat, and very little bone. 
Although excessive fat is undesirable, a reasonable proportion enhances flavour (Pearce, 
2016). Visceral fat, subcutaneous fat, and intramuscular fat are the three major kinds of 
carcass fat. The fats serve as energy reserves and in visceral insulation, while bones 
provide a rigid support. The muscle of the carcass comprises mainly of water (over 70%), 
along with some proteins, minerals and lipids (Pannier et al., 2014).   
Animal growth is simply the deposition of protein, fat and bone in different quantities. As 
the animal approaches its mature body size plateau, protein deposition significantly 
decreases whilst fat deposition might continue (Irshad et al., 2013). Mature body size is 
thought to be the juncture at which muscle mass reaches its maximum. Typically, the 
protein mass increases proportionally to body weight. Consequently, increasing the mature 
body size through the use of genetic or nutritional techniques, such as the administration of 
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2.2.1 Skeletal muscle growth and development  
Dissecting the molecular processes governing skeletal muscle growth and development is 
of great importance to the livestock production industry, since muscle is the desired 
component of meat.  Growth is simply an accumulation of protein, fat and bone. Although 
protein accretion declines to a near halt as the animal approaches its mature body size, fat 
accumulation can continue through the end of the animal’s lifespan (Dickerson, 1978).  
Growth in animals entails an increase in tissue mass, and can be broadly classified into 
prenatal and postnatal growth. The major distinction between these two is the pattern of 
growth; with prenatal or embryonic growth characterised by hyperplasia, whilst 
hypertrophy is prevalent in postnatal growth (Rehfeldt et al., 2000).  
Skeletal muscle development is a multi-step process. Early embryonic skeletal muscle 
development can be broadly classified into three stages: (1) determination, (2) 
differentiation, and (3) maturation (Musumeci et al., 2015). In vertebrates, skeletal muscle 
primarily originates from somites. Somites are transient ball-like segments that bud off 
from the paraxial mesoderm on either side of the neural tube and notochord in the 
developing vertebral embryo (Buckingham et al., 2003).  
The immature somites are multipotent which means that any of its component cells could 
divide to yield more somites. During maturation, the somites form different compartments 
namely: (i) the sclerotome, which generates the cartilage of vertebrae and ribs, and (ii) the 
dermamyotome which forms the muscles and dermis (Goulding et al., 1994). In response 
to inductive cues from the neural tube and notochord, myogenesis commences in the 
somites. Determination begins with the assembly of multipotent mesodermal precursor 
cells present in the somites (Musumeci et al., 2015). These precursor cells proliferate to 
form myogenic progenitor cells, which further divide to yield proliferating myoblasts 
committed to the muscle-lineage (Figure 2.3). In the development process, myoblasts are 
thought to be the first group of cells identified as muscle cells (Chen and Goldhamer, 
2003). The ensuing differentiation of the myoblasts is a hallmark of skeletal muscle 
development. A major characteristic of myoblast differentiation is their withdrawal from 
the cell cycle, and the fine-tuning of their transcriptional circuitry towards the expression 
of muscle-specific genes allowing them to synthesise proteins that characterise a mature 
muscle cell (Walsh and Perlman, 1997). Differentiated myoblasts subsequently align and 
fuse to form elongated, multi-nucleated myotubes. While most undergo this process, a 
small population of myoblasts do not fuse; rather they dwell on the exterior of the 
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myotubes as a group of mesenchymal cells called satellite cells. Muscle injury or trauma 
actuates the division and proliferation of these cells to form new muscle fibres (Goulding 
et al., 1994; Chen and Goldhamer, 2003).  
 
Figure 2.3 Skeletal muscle growth and development 
In response to inductive cues, embryonic progenitors proliferate to form myoblasts, some 
of which transform into quiescent satellite cells, while others divide to form differentiating 
myoblasts. This group of myoblasts withdraw from the cell cycle and commit to the 
myogenic pathway. Differentiating myoblasts fuse to form a multinucleated myotube 
surrounded by satellite cells. These myotubes are bundled together to yield the mature 
muscle fibre. 
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Postnatal skeletal muscle growth and development occurs via hypertrophy. Although 
mature muscle fibres lose the ability to divide and proliferate, the presence of quiescent 
satellite cells allows a muscle fibre to retain a measure of its proliferative capacity (Figure 
2.3). Satellite cells have the ability to generate both muscle-progenitor cells that fuse with 
and repair muscle fibres, and stem cells that allow for the self-renewal of the satellite cell 
population (Goulding et al., 1994). Unlike skeletal muscle, adipose tissue retains the ability 
to undergo hyperplasia throughout the lifespan of the animal. 
Skeletal muscle mass is a delicate balance between two dynamic processes: muscle protein 
synthesis and muscle protein breakdown. While hypertrophy is the result of increased 
protein synthesis, atrophy is caused by protein degradation. The regulation of skeletal 
muscle size can occur via three major mechanisms, each yielding a different phenotypic 
outcome (Glass, 2005).  
Firstly, the activation of satellite cells into myoblasts, followed by differentiation and 
fusion to pre-existing muscle fibres (Figure 2.3), causing an expansion in the mass as new 
myonuclei are added (Frontera and Ochala, 2015). The extracellular milieu of a muscle 
fibre plays a crucial role in its development. The second way is increasing the protein 
content by inducing protein synthesis signalling pathways such as IGF1/IGF1R signalling 
(Glass, 2005). Finally, the inhibition of muscle atrophy pathways to retain current muscle 
mass. All three signalling branches intersect at several downstream messenger factors. A 
harmonised interplay between the three mechanisms allow muscles to adapt readily in 
response to environmental cues including mechanical load, nutrition, stress, injury and 
illness (Clemmons, 2009; Otto and Patel, 2010). Skeletal muscle bears some remarkable 
plasticity.    
2.2.2 Energy utilisation, partitioning and metabolism 
Feed cost and nutrition account for over half of the total production costs in many livestock 
production systems (Freer, 2002). It is, therefore, imperative that nutrients from the feed 
are utilised to the fullest.  
Feed efficiency is a measure of the weight gain of an animal over the dry matter of feed 
consumed. The feed utilisation of an animal is based upon a variety of factors such as age, 
length of time spent foraging, rumen constitution and type of feed (Rojas-Downing et al., 
2017). Partitioning of the energy obtained from feed occurs shortly after consumption. The 
total energy intake obtained from the feed is called gross energy (GE), some of which is 
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genetic evaluations schemes have been made available to NZ sheep breeders including the 
National Flock Recording Scheme in 1967, Sheeplan in 1976 and Animalplan in 1988 
(Newman et al., 2000). The existence of multiple competing software and reporting 
systems led to inconsistencies that obfuscated the analysis, presentation, and interpretation 
of industry data and information. Striving for uniformity, a national genetic evaluation 
scheme was established in 1995 called the Sheep Improvement Limited (SIL) (Newman et 
al., 2000). SIL was designed to serve as a transparent industry genetic database utilising a 
singular yet comprehensive evaluation system that takes into account multi-trait and 
repeated-measure analyses. The major traits of interest on the SIL database include growth, 
meat production, disease resilience and resistance, fertility, and fecundity (Newman et al., 
2002; Jopson et al., 2009). By providing insight into the genetic connection between 
flocks, the SIL database has enabled breeders to improve the genetic gain of their sheep 
and increase profitability. 
Animal breeding has undergone tremendous transformations in recent years. Early 
breeding strategies employed the estimation of breeding values to bring about genetic 
improvement. The estimated breeding value (EBV) assesses the level of performance of an 
animal for a given trait when compared to flock/population average, or base figures set by 
SIL (Jopson et al., 2009). The EBV entails the measurement of phenotypic traits on either 
the animal itself or its genetic relation, such as parents, progeny or siblings. The unit for an 
EBV is based on the trait being measured, for instance, grams/day for growth rate. When 
EBVs for multiple traits are considered, and weighting is applied to each trait, this is 
known as a breeding index (Hopkins et al., 2005). Expressed as a proportion, the weighting 
value signifies which traits are of greater interest to the breeder.  
A breeding index is beneficial for improving genetic gains on different traits. Depending 
on the production system, the SIL database has enabled the reliable determination of 
breeding indices for different traits which is reflective of an animal’s breeding worth (BW) 
when economic influence is accounted for (Dodds et al., 2013). The economic index of a 
trait is essentially the “dollar value per unit change in a trait, given that all other traits are 
constant”, and is an efficacious method of estimating a trait’s economic importance 
(Harris, 1970). The heritability of a trait can influence the EBV and BW (Van der Werf et 
al., 2010).  
Heritability refers to the proportion of total phenotypic variation in a trait that is explained 
by genetic variation (Smith and Simpson, 1986). A heritability value of 1 suggests that 
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genes alone control an animal’s phenotypic trait, while other factors such as nutrition, 
management and environment are inconsequential (Safari et al., 2005). For traits with high 
heritability, trait measurement of the animal itself would suffice. However selection 
accuracy is reduced with low heritable traits, thus necessitating a more accurate assessment 
– a progeny test. A progeny test evaluates traits of interest in the offspring of the animals 
(Van der Werf et al., 2010). Animals, especially males, found to possess higher genetic 
merit by virtue of their EBVs are selected to form a ‘superior breeding stock’. This 
superior stock is then applied intensively using reproductive technology to inseminate 
various females to yield improved offspring.  
By means of genetic selection techniques, a remarkable increase in the annual carcass gain 
in NZ lambs has been reported over the last decade (Beef + Lamb NZ, 2012; Brito et al., 
2017). Genome-wide or genomic selection (GS) is a type of marker-assisted selection that 
allows the estimation of marker effect across the genome of a reference population 
consisting of thousands of sheep (Desta and Ortiz, 2014) Genomic selection is capable of 
capturing genetic variation at any loci, irrespective of the size of the effect they may have 
on a phenotypic trait. This genetic tool allows for a more accurate prediction of the 
breeding value of a trait and genetic merit of an animal by assessing genomic relationship 
within the reference breeding population.  
The introduction of whole-genome sequencing was a break-through for genomic selection. 
It paved the way for the detection of thousands of DNA markers in the form of nucleotide 
variations that are present across the whole genome (Smith and Simpson, 1986). These 
markers are relatively stable, with low mutation rates. They are also easy to amplify with 
PCR, and have been used to develop chip-based DNA typing technologies that can be 
employed to detect genetic markers. Decisions regarding breeding and selection, especially 
for harder to measure traits, will be made easier with the use of these markers (Schaeffer, 
2006). The approach could potentially address a major challenge in breeding, by reducing 
reliance on visual assessment of the sheep prior to selecting for genetic merit, thus 
decreasing the time interval from testing to selection. Genomic selection has been reported 
to decreased the generation interval, and increase the rate of genetic gain in dairy cows and 
sheep by 60-120% (Schaeffer, 2006; Hayes et al., 2013). Such gain is beneficial to farmers 
and breeders. Intensive breeding for a given trait can, however, negatively impact animal 
welfare and other production traits (Rauw et al., 1998).  
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2.3.1 Quantitative trait loci (QTL) 
Understanding the genetic architecture governing complex traits is crucial to livestock 
farming. A quantitative trait locus (QTL) is a region of the DNA containing genes 
associated with a phenotypic trait. Over the past decades, advances in genomic research 
and QTL identification has invigorated its application in animal breeding (Collard et al., 
2005). Identification of genetic markers associated with phenotypic traits was a major 
scientific breakthrough that has led to the detection of QTL. Genetic markers are 
essentially ‘tags’ or ‘signs’ that are adjacent (that is tightly linked) to genes of interest 
(Vignal et al., 2002). The three major types of markers are: morphological, biochemical 
and DNA markers.  
Morphological traits represent visible phenotypic characteristics such as height, body 
length, chest size and tail length. Visual appraisal provided the basis upon which these 
traits were recorded, and hence was unsuitable for traits with low heritabilities, or ones that 
were costly or hard to measure (disease resistance) (Jopson et al., 2009). Many of the 
morphological traits can only be measured when the animal is of adult age (body weight 
and composition), or upon slaughter (carcass traits), which impedes utility. Additionally, 
visible features are influenced by environmental factors, diet and the developmental stage 
of the animal (Dickerson, 1978). On the other hand, biochemical markers employ isozymes 
which are different forms of an enzyme. Whilst biochemical markers have great use for the 
diagnosis of conditions, they are limited by the small number of different marker loci 
available.  
Molecular markers (DNA or genetic markers) are the ultimate and most widely used 
markers, as they provide a vast array of utility and application. The fundamental 
construction of genome-wide molecular maps is made possible by means of molecular 
markers (Gupta et al., 2005). A key distinction between DNA markers and biochemical or 
morphological markers is that DNA markers are abundant in number and are not affected 
by environmental and developmental factors. 
A linkage map is a map of the relative positions and distances of genes (as indicated by 
their genetic markers) along a chromosome (Montaldo and Meza-Herrera, 1998). These 
distances do not refer to physical distances, rather are determined linkage analysis as the 
recombination frequency of the two gene loci. Chromosomal recombination or crossing 
over of genes and markers during meiosis is the basis for constructing a linkage map 
(Ardlie et al., 2002).  
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Genes located on different chromosomes, or situated far apart assort independently, and 
thus are unlinked. In contrast, genes (or alleles) located in close proximity on the same 
chromosome are often inherited as a single unit, and hence are said to be linked. Therefore, 
the closer the genes, the more tightly linked they are, and the shorter their linkage distance 
(Ardlie et al., 2002). Linkage distance is measured in centiMorgans (cM). Major 
drawbacks hampering this traditional form of linkage analysis, also known as family 
linkage analysis, include the need for pedigree information, and limitations for use in 
larger population size (Liu, 1997). Although linkage mapping is the classical QTL 
mapping technique, advancements in mapping technology popularised the association 
mapping method.  
Linkage disequilibrium (LD) mapping, also known as association mapping, is a high-
resolution technique used in exploring the genetic undertone of production traits (McRae et 
al., 2002). Linkage disequilibrium is the non-random association of alleles at different loci 
within the population. By utilising information on the history of recombination and 
marker-trait associations within the population, linkage disequilibrium improves the power 
and accuracy of QTL mapping, compared to the conventional linkage analysis (Kruglyak, 
1999; Meuwissen and Goddard, 2004). The LD approach successfully integrates the effects 
of many past generational cross-overs between the gene locus and markers. Association 
analyses depend on the principle that common genetic variants underpin traits of interest 
such as susceptibility to diseases.  
Association studies have been applied extensively in human genetics in the mapping of 
alleles that influence common diseases. These include the association of Factor V Leiden 
with clotting disorders (Weiss and Clark, 2002), LDL receptors with heart disease (Reich 
and Lander, 2001), and ApoE-e4 with Alzheimer's (Corder et al., 1993). Genetic linkage 
mapping is an essential component in the study of plants and animals. Molecular markers 
facilitate the identification of QTL and candidate genes influencing variations in traits of 
interest (Collard et al., 2005). DNA markers are useful in constructing linkage maps.  
Marker-assisted selection (MAS) has received increased attention in the past few years, 
which has translated into intensified efforts towards QTL and marker identification. 
Remarkable success has been attained with the use of MAS in livestock evidenced by an 
increase in the annual genetic gain by up to 30% (Ge et al., 2001). Growth and body 
composition, meat yield, milk production, disease resistance, fertility and fecundity are 
some of the commonly investigated traits for QTL analyses.  
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witnessed. Muscle protein turnover or accretion is regulated by several genes including 
growth hormone (GH) and insulin-like growth factor receptor (IGF1R). Equally impacting 
growth, are genes involved in early prenatal development, such as POU class 1 homeobox 
1 (POU1F1) and PROP paired-like homeobox 1 (PROP1). The QTL associated with 
liveweight, and growth and carcass traits, are found on sheep chromosomes OAR 1, 2, 3, 4, 
5, 6, 11, 14, 18, 20, and 21 (Walling et al., 2004).  The aforementioned genes which will be 
examined in this thesis, are found within some of these QTL – IGF1R (OAR 18), GH 
(OAR 11), POU1F1 (OAR 1), and PROP1 (OAR 5). 
Dissecting the genetic makeup underpinning economically important traits is of great 
interest to researchers and farmers alike. Fundamental to this goal is the detection of 
marker-trait associations by means of QTL analyses (Hopkins et al., 2011). Nucleotide 
sequence variation found within the chosen genes that occur within QTL associated with 
animal productivity could serve as potential markers for selective breeding. They could 
also ensure that breeders and farmers have a better understanding, and can make more 
accurate decisions when selecting breeding stock.     
2.4.1 Insulin-like growth factor 1 receptor (IGF1R) 
Insulin-like growth factor 1 receptor (IGF1R) plays a vital role in cell growth, metabolism 
and survival in vertebrates. IGF1R is a tyrosine kinase receptor with an (αβ)2 structure, and 
comprises of an extracellular ligand-binding domain, a membrane-spanning region and an 
intracellular tyrosine kinase (TK) region (Adams et al., 2000). IGF1R also promotes the 
stable retention of muscle fibres and architecture by regulating protein accretion and 
breakdown, neuronal survival and plasticity. 
IGF1R signalling occurs upon binding to any of its ligands, IGF1, IGF2 or insulin. The 
ensuing dynamic structural transformation and signal transduction brings about the auto-
phosphorylation of the tyrosine kinase region, followed by a cascade of molecular events 
culminating in the activation of mitogenic genes and inhibition of apoptosis (Chitnis et al., 
2008; Girnita et al., 2014). Signalling by IGF1R inherently upregulates pathways leading 
to muscle hypertrophy, while simultaneously inhibiting pathways favouring muscle 
atrophy.  
The IGF1R disruption in mice is associated with a significant decrease in the size and 
number of muscle fibres, with null mice weighing only 40% of the normal, and in utero 
growth retardation in humans (Liu et al., 1993; Baker et al., 1996). Additionally, IGF1R 
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over-expression has been found to accelerate cell proliferation and differentiation, and IGF 
signalling can facilitate the attenuation of atrophy in skeletal muscles. Abnormal 
expression of IGF1R in humans has been reported to cause growth retardation, cancers, 
and impaired mental development (Kawashima et al., 2005; Yang et al., 2018).  
Nucleotide sequence variations in IGF1R have been reported to have an effect on the 
growth and performance traits of livestock including cattle (De la Rosa Reyna et al., 2010), 
buffalos (El-Magd et al., 2013), pigs (Wang et al., 2006) and chickens (Lei et al., 2008). 
Notwithstanding its predominant role in mammalian function, much remains to be learned 
about the role of IGF1R in livestock breeds. Given the ubiquitous presence of IGF1R in 
nearly all body cells, as well as its crucial function in growth and metabolic processes, 
sequence variation within its gene could likely have a multi-faceted effect on the resulting 
protein, and impact the phenotypic attributes of an animal. Therefore, further research 
examining the effect of sequence variation in IGF1R on sheep growth and carcass traits is 
required to provide more enlightenment. 
2.4.2 Growth hormone (GH) 
Growth is a principal characteristic of all living organisms. This biological process 
involves the coordinated networking of various genes, hormones and environmental 
factors.  
Growth hormone (GH) is a major regulator of growth and metabolism through direct 
signalling on target cells and indirect signalling via insulin-like growth factor 1 (IGF1) 
(Curi et al., 2006). GH binding to its receptor, GHR, brings about receptor dimerisation 
and activation. Cascading events due to this signal transduction lead to the activation of 
downstream effectors and secondary messengers, ultimately resulting in the GH-dependent 
regulation of gene expression, metabolism and somatic growth (Campbell, 1997; Brooks et 
al., 2014). The effects of GH signalling include protein synthesis, lipolysis and glycolysis, 
which translates to the longitudinal increase in muscle and bone mass. Therefore, GH is a 
suitable candidate gene for investigating growth and carcass traits in livestock. 
In sheep, GH is mapped to chromosome 11, a region harbouring the QTL for liveweight 
and growth and carcass traits (Carter-Su et al., 1996). The 1.8 kb long gene consists of five 
exons and four introns. Excessive GH secretion has been linked with acromegaly and 
gigantism in humans, while GH deficiency has been associated with dwarfism, congenital 
malformation and diabetes (Cogan et al., 1993; Giustina et al., 2008). Polymorphisms in 
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GH have been reported in various livestock such as cattle (Jia et al., 2014), goat (Malveiro 
et al., 2001), and sheep (Jia et al., 2014), and have been associated with key productive 
traits such as milk yield, and growth and carcass traits.  
Additional research is required to confirm already reported variations and associations in 
ovine GH, especially in unexplored NZ sheep breeds. This could also involve searching for 
new sequence variation that could impact sheep growth and carcass traits. 
2.4.3 POU class 1 homeobox 1 (POU1F1) 
The POU class 1 homeobox 1 (POU1F1) protein, also called pituitary-specific 
transcription factor 1 (PIT-1), plays a major role in the embryonic development of cells 
and tissues of the pituitary gland. It positively regulates the secretion of three major 
hormones: growth hormone (GH), the beta subunit of thyroid-stimulating hormone (TSH-
β) and prolactin (PRL) (Mangalam et al., 1989; Bastos et al., 2006b), by controlling the 
differentiation of the hormone-producing cells somatotropes, thyrotropes and lactotropes 
respectively. These hormones all have crucial roles in regulating growth, metabolism and 
homeostasis in mammals (Pierpaoli and Besedovsky, 1975; Wallis, 1988; Labad et al., 
2016).   
Being a part of the POU-domain family of transcription factors, POU1F1 has a common 
structure consisting of three domains: an N-terminal transactivation domain, which 
undertakes the transactivation of target genes such as GH, TSH and PRL, and a C-terminal 
POU-specific domain and the POU-homeodomain, both of which engage in high affinity 
DNA binding (Bastos et al., 2006a). 
Ovine POU1F1 is located on chromosome 1, is 17 kb long and comprises of six exons and 
five introns (Woollard et al., 2000). There exists close homology between ovine POU1F1 
and other species such as bovine (98.2%), human (91.2%) and murine (86.2%), thus 
indicating a high degree of evolutionary conservation. Nevertheless, variations have been 
reported for this gene in many breeds. Four sequence variations have been reported in 
Portuguese sheep breeds, including Gly89Asp and Ala105Thr in the exon 3 of ovine 
POU1F1, which were reported to affect sheep production traits (Bastos et al., 2006b). 
Other sequence variations in Sarda goat breed were found to impact milk yield and milk 
fatty acid content (Daga et al., 2013). 
Despite all the research done on ovine POU1F1, very little is known about its effect on 
growth and carcass composition traits, and nothing at all about NZ breeds. Due to its role 
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in prenatal growth and development, variation within this gene would likely have a multi-
faceted effect on the resulting protein and phenotypic attributes.  
2.4.4 PROP paired-like homeobox 1 (PROP1) 
Often referred to as the ‘master gland’, the pituitary gland serves a vital function in 
mammals. The PROP paired-like homeobox 1 (PROP1) gene encodes a paired-class 
homeodomain transcription factor essential in the early development of the pituitary. In 
response to intrinsic and extrinsic signals, the mammalian pituitary gland develops from a 
common primordium. The release of transcription factors and signalling molecules, such as 
PROP1 and HESX, in a spatiotemporal manner induces the differentiation and 
commitment of precursor cells into distinct hormone-producing cell populations (Deladoëy 
et al., 1999; Scully and Rosenfeld, 2002). The mature anterior lobe of the pituitary is 
inhabited by five distinct cell types: corticotropes (produce pro-opiomelanocortin which 
undergoes cleavage to adrenocorticotropin, ACTH), gonadotropes (produce luteinizing 
hormone, LH and follicle stimulating hormone, FSH), lactotropes (produce prolactin, 
PRL), somatotropes (produce GH) and thyrotropes (produce thyroid stimulating hormone, 
TSH).  
Ovine PROP1, which encodes 226 amino acids, is a 3.5 kb long gene and is organised into 
three exons interspersed by two introns. Contained within PROP1 are two major conserved 
domains: a central paired-like DNA-binding homeodomain which interacts with AT-rich 
promoter region on target DNA, and a transcription activation located at the carboxyl 
terminus (Sornson et al., 1996; Guy et al., 2004). The less conserved amino terminus of 
PROP1 possesses repressor activities.  
Prophet of POU1F1, another name for (PROP1), is derived from its upstream expression 
with respect to POU1F1, as it is necessary for POU1F1 expression. By virtue of its central 
function and the extensive reach of the hormone targets it governs, mutations in PROP1 
that result in dysfunction or hyperactivity of the anterior pituitary hormones would have 
sweeping effects on multiple organ systems. A total loss or impaired production of anterior 
pituitary hormones such as GH, PRL and TSH, commonly accompanies PROP1 mutations, 
which sometimes translates phenotypically as dwarfism, as seen in the Ames dwarf mouse 
(df/df) (Sornson et al., 1996; Flück et al., 1998). Combined pituitary hormone disorders 
(CPHD) is the term given to conditions displaying low circulating levels of anterior 
pituitary hormones such as GH, PRL, TSH, LH and FSH (Parks et al., 1999).  
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2YHUILIWHHQ3523PXWDWLRQVKDYHEHHQDVVRFLDWHGZLWK&3+'LQKXPDQV.HOEHUPDQHW
DOD$ERXWWZHOYH3523PXWDWLRQVKDYHEHHQXQFRYHUHGLQVKHHSPRVWQRWDEO\
RIZKLFKLVD&WR7WUDQVYHUVLRQDWSRVLWLRQLQLQWURQOLQNHGZLWKLQFUHDVHGOLWWHU
VL]HDQGD7KU$ODVXEVWLWXWLRQEURXJKWDERXWE\DJ$!*VXEVWLWXWLRQLQH[RQ
DVVRFLDWHGZLWKLQFUHDVHGZRROILEUHGLDPHWHULQ&KLQHVHVKHHS=HQJHWDO/LXHW
DO8QGRXEWHGO\PRUHUHPDLQVWREHOHDUQHGDERXW3523SDUWLFXODUO\LQ1=
VKHHSEUHHGV

 &KDOOHQJHV)DFHGE\WKH6KHHS,QGXVWU\
5LYDOOLQJWKHVKHHSLQGXVWU\WKHGDLU\LQGXVWU\LV1=¶VWRSH[SRUWHDUQHUZLWKLQ
DJULFXOWXUH7KHXQSDUDOOHOHGVXFFHVVRIWKHGDLU\LQGXVWU\KDVEHHQGHWULPHQWDOWRWKH
VKHHSLQGXVWU\DVPRUHODQGVDUHEHLQJFRQYHUWHGIRUGDLU\XVH7KHGDLU\H[SDQVLRQKDV
DOVRIRUFHGWKHUHORFDWLRQRIVKHHSIDUPLQJWROHVVSURGXFWLYHDUHDV7KLVKDVOHGWRD
VLJQLILFDQWGHFOLQHLQVKHHSQXPEHUVHVSHFLDOO\IRUWKHHZHEUHHGLQJIORFN0HDW,QGXVWU\
$VVRFLDWLRQ2YHUWKHODVWGHFDGHIURPWRZKLOHGDLU\FDWWOHQXPEHUV
KDYHLQFUHDVHGE\VKHHSQXPEHUVKDYHVXIIHUHGDGHFOLQHIURPPLOOLRQWR
PLOOLRQ6WDWV1=
6KHHSIDUPLQJLQ1=LVSDVWRUDODQGDVVXFKLVLQIOXHQFHGE\FOLPDWHDQGZHDWKHU
FRQGLWLRQVZKLFKFDQYDU\VLJQLILFDQWO\5LVLQJWHPSHUDWXUHVGXHWRJOREDOZDUPLQJFRXOG
KDYHDQDGYHUVHLPSDFWRQOLYHVWRFNSURGXFWLRQ5HGXFHGQXWULHQWDYDLODELOLW\LQIRUDJHV
GHFUHDVHGLQWDNHRIIHHGDQGFRQYHUVLRQHIILFLHQF\ORZHUOLYHVWRFNIHUWLOLW\UDWHVDQG
KLJKHUPRUWDOLW\UDWHVZRXOGEHVRPHRIWKHFKDOOHQJHVSUHVHQWHGE\ULVLQJWHPSHUDWXUH
5RMDV'RZQLQJHWDO)HHGTXDQWLW\DQGTXDOLW\ZRXOGDOVREHDIIHFWHGE\WKH
VXUJHLQFDUERQGLR[LGHOHYHOVDQGJUHHQKRXVHJDVHV3KHQRW\SLFYDULDELOLW\LVDOVR
REVHUYDEOHZLWKFDUFDVVPXVFOHDQGIDWWUDLWVLQGLFDWLQJDSRO\JHQLFLQKHULWDQFHRUVWURQJ
HQYLURQPHQWDOHIIHFW
&XUUHQWFRQVXPHUSUHIHUHQFHOHDQVWRZDUGVKLJKPHDWWRIDWUDWLR7KHLGHDOKLJKTXDOLW\
FDUFDVVZRXOGKDYHKLJKOHDQPHDW\LHOGORZOHYHOVRILQWHUPXVFXODUDQGVXEFXWDQHRXVIDW
DQGMXVWHQRXJKLQWUDPXVFXODUIDWWRLPSURYHSDODWDELOLW\WHQGHUQHVVDQGWDVWH
&RQVLGHULQJWKDWOHDQPHDWRQO\FRQVWLWXWHVDERXWRIWKHHQWLUHFDUFDVVPRUHHIIRUW
LVEHLQJSXWLQWREUHHGLQJIRUFDUFDVVHVZLWKKLJKHUOHDQPHDW\LHOG/HZLVHWDO
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Despite having enjoyed global success, conventional breeding methods are met with 
several limitations. Selection accuracy of estimated breeding values (EBV) is dependent on 
the abundance of data and its storage, which can be expensive and require certain 
infrastructure (Van der Werf et al., 2010).  Data could include pedigree, sire and dam data. 
Repetition of measurements is often required as this authenticates results and minimises 
the influence of random environmental conditions.  
Another quandary faced by traditional breeding strategies is the generation interval, which 
represents the average age of parents at which offspring are born. A shorter generation 
period allows for a quicker expression of genetic potential in the progeny, and subsequent 
comparison with parents to establish a trend (Hayes et al., 2013). Short generation intervals 
can be achieved with younger breeding animals. However, younger breeding animals 
usually have less information available such as fewer repeated records, absence of progeny 
test, and limited performance data, all of which decrease selection accuracy. Older 
breeding animals with higher selection accuracy, by virtue of copious data on their 
performance (repeated expression of traits) and possibly some progeny data, have higher 
generation intervals and are thus only available for fewer selection rounds during their 
lifetime, compared to their younger counterparts. 
The breeding sheep for increased lean meat yield can have an antagonistic effect on other 
traits such as decreased eating quality of meat and palatability (Brito et al., 2017). This 
“trade-off” phenomenon is seen across different breeding programmes where the intensive 
selection of one trait weakens the performance of other production traits. Inbreeding is also 
a possible consequence of the excessive usage of superior breeding stock (Vostry et al., 
2018). The resulting lack of genetic variation in the gene pool could put the animals at risk 
of being wiped out by a disease. Additionally, reproductive rates, which is the number of 
offspring born to an animal, and gestation periods are major determinants of the success of 
reproductive technology (Smith and Simpson, 1986). Animals with higher rates of 
reproduction are preferred since that reduces the number of breeding animals required. 
However, this is not always the case with available livestock.  
Intensive selection for particular traits might prove counterproductive as other valuable 
traits diminish. For instance, variation in the myostatin gene gives rise to double-muscled 
cattle that produce more meat with leaner quality (McPherron and Lee, 1997). These cattle, 
however, have been reported to suffer from poor fertility, and respiratory and skeletal 
problems (McPherron and Lee, 1997). In other cases, selection for particular traits has led 
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WRWKHORVVRIGLVHDVHUHVLVWDQFHJHQHVLQDQLPDOV6PLWKDQG6LPSVRQ&DWWOHDQG
VKHHSDOVRKDYHORQJJHVWDWLRQSHULRGVZKLFKPLJKWUHQGHUUHSURGXFWLYHWHFKQRORJ\
LQHIILFLHQW
$VXVWDLQDEOHVROXWLRQWRWKLVSUREOHPZRXOGEHWKHVLPXOWDQHRXVLPSURYHPHQWRIPHDW
TXDOLW\WUDLWVDORQJZLWKRWKHUSURGXFWLRQWUDLWVVXFKDVIHUWLOLW\DQGGLVHDVHUHVLVWDQFH

 2EMHFWLYHVRIWKLV6WXG\
,QDQHIIRUWWRLPSURYHVKHHSSURGXFWLRQDQGHQVXUHVXVWDLQDELOLW\DQGSURILWDELOLW\RIWKH
PHDWLQGXVWU\PRUHIRFXVLVEHLQJSODFHGRQVHOHFWLQJVKHHSZLWKIDVWHUJURZWKUDWH
KLJKHUOHDQPHDW\LHOGDQGLQFUHDVHGIHFXQGLW\7KLVVWUDWHJ\HIIHFWLYHO\GHFUHDVHVODERXU
LQSXWVFRVWRIKHDOWKFDUHDQGIUHHVXSODQGIRUVXEVHTXHQWXVH
,QWHQVLYHUHVHDUFKKDVHVWDEOLVKHGWKHLPSDFWRIJHQHWLFVRQWKHSHUIRUPDQFHWUDLWVRI
OLYHVWRFNDQLPDOV0DUNHUDVVLVWHGVHOHFWLRQZKLFKWDUJHWVJHQHVDVVRFLDWHGZLWKGHVLUHG
WUDLWVLVFRPLQJLQWRWKHOLPHOLJKWLQWKHPHDWLQGXVWU\*HQHWLFYDULDWLRQVLQFDQGLGDWH
JHQHVORFDWHGZLWKLQ47/DVVRFLDWHGZLWKHFRQRPLFDOO\LPSRUWDQWWUDLWVKDYHEHHQZHOO
GRFXPHQWHGLQFDWWOH6PDOOUXPLQDQWVVXFKDVVKHHSKRZHYHUDUH\HWWREH
FRPSUHKHQVLYHO\VWXGLHG:KLOHVRPHUHVHDUFKKDVEHHQFRPSOHWHGLQYDULRXVRYLQH
EUHHGVWKHUHLVPXFKZRUNWREHGRQHZLWKWKHXQH[SORUHG1=VKHHSEUHHGV
6NHOHWDOPXVFOH\LHOGDQGIXQFWLRQVRPDWLFJURZWKPHWDEROLVPDQGSURWHLQDFFUHWLRQDUH
UHJXODWHGE\WKHJHQHVFKRVHQIRUWKLVVWXG\QDPHO\JURZWKKRUPRQH*+LQVXOLQOLNH
JURZWKIDFWRUUHFHSWRU,*)5328KRPHRER[328)DQG3523SDLUHGOLNH
KRPHRER[35237KLVUHVHDUFKDLPVWRLGHQWLI\QRYHOYDULDWLRQVLQWKHVHIRXUJHQHV
RILQWHUHVWZLWKLQ1=VKHHSEUHHGVDQGHYDOXDWHWKHLUDVVRFLDWLRQZLWKJURZWKDQGFDUFDVV
WUDLWV7KHVHTXHQFHYDULDWLRQVXQFRYHUHGFRXOGWKHQEHDSSOLHGLQ0$6DQGWKHEUHHGLQJ
RIDQLPDOVZLWKGHVLUDEOHWUDLWVZLWKDYLHZWRFRQVLGHUDEOHHFRQRPLFJDLQ
7KLVSURMHFWZLOOSURYLGHPDMRUFRQWULEXWLRQVWRWKH1=PHDWDQGSDVWRUDOLQGXVWU\
LQFOXGLQJDSRVVLEOHPXOWLJHQHW\SLQJV\VWHP)XUQLVKHGZLWKWKHNQRZOHGJHSURYLGHGE\
WKLVUHVHDUFKIDUPHUVFRXOGPDNHPRUHLQIRUPHGDQGHIIHFWLYHEUHHGLQJGHFLVLRQVWKDW
PD[LPLVHVGHVLUDEOHWUDLWVVXFKDVLPSURYHGPHDW\LHOGIODYRXUDQGQXWULWLRQDOYDOXH
ZKLOHPLQLPLVLQJXQGHVLUHGWUDLWV


&KDSWHU
7KHUHODWLRQVKLSEHWZHHQJURZWKDQGFDUFDVVWUDLWVLQ1=VKHHS
EUHHGV
 ,QWURGXFWLRQ
*URZWKDQGFDUFDVVWUDLWVDUHVRPHRIWKHPRVWFUXFLDOWUDLWVRILQWHUHVWWRWKHPHDW
LQGXVWU\DVWKH\RIWHQGLFWDWHKRZPXFKFRQVXPHUVDUHZLOOLQJWRSD\IRUDSURGXFWDQG
WKHILQDQFLDOUHZDUGREWDLQDEOHE\VKHHSIDUPHUVDQGEUHHGHUV,QFUHDVLQJIRFXVRQ
SHUVRQDOILWQHVVDQGKHDOWKDZDUHQHVVKDVOHGWRDSDUDGLJPVKLIWLQFRQVXPHUWDVWHZLWK
KLJKIDWPHDWFRQVLGHUHGOHVVGHVLUDEOHZKLOHOHDQFXWVDUHVHHQDVSUHPLXPTXDOLW\
%LUWKZHLJKWZHDQLQJZHLJKWDQGJURZWKUDWHWRZHDQLQJDOVRFDOOHGDYHUDJHGDLO\JDLQ
DUHFRPPRQJURZWKLQGLFHVFUXFLDOWRWKHVKHHSLQGXVWU\,QDOLNHPDQQHUKRWFDUFDVV
ZHLJKWIDWGHSWKDURXQGWKHWKULEDQGOHDQPHDW\LHOGLQWKHOHJORLQDQGVKRXOGHURID
ODPEFDUFDVVDUHXVHIXOLQDSSUDLVLQJODPEPHDW\LHOG6DxXGRHWDO7KHHFRQRPLF
YDOXHRIODPEVDUHGHWHUPLQHGE\WKHVHSKHQRW\SLFWUDLWVDQGKHQFHWKH\ZLOOEHH[DPLQHG
LQWKLVVWXG\/DPESURGXFWLRQWUDLWVKDYHPRGHUDWHKHULWDELOLWLHVLQGLFDWLQJWKDWWKH\FDQ
EHLQIOXHQFHGE\ERWKJHQHWLFVDQGWKHHQYLURQPHQW+RSNLQVHWDO
1XWULWLRQERWKIURPPDWHUQDOPLONDQGODWHUIHHGW\SHRIIHHGSUHYDOHQFHRILQWHVWLQDO
SDUDVLWHVDQGRQVLWHIDUPPDQDJHPHQWV\VWHPVDUHHQYLURQPHQWDOIDFWRUVWKDWFDQLPSDFW
SURGXFWLRQWUDLWV7KHJHQHWLFFRPSRQHQWLVPRUHFRPSOH[EXWLWVLPSDFWLVH[WHQVLYH
*HQRW\SHVRIERWKWKHIRHWXVDQGPRWKHUKDYHEHHQIRXQGWRLQIOXHQFHLQXWHURJURZWK
2OGKDPHWDO*HQRPHZLGHDVVRFLDWLRQVWXGLHVKDYHOLQNHGFDQGLGDWHJHQHVRQ
VKHHSFKURPRVRPHV2$5DQGWRSURGXFWLRQWUDLWVVXFKDVSUHDQGSRVWZHDQLQJ
JDLQVZHDQLQJZHLJKWFKHVWJLUWKDQGVKLQFLUFXPIHUHQFH=KDQJHWDO
%LUWKZHLJKWLVRQHRIWKHPRVWLPSRUWDQWGHWHUPLQDQWVRIODPEVXUYLYDOGXULQJWKHILUVW
IHZGD\VRIOLIH2OGKDPHWDO6HYHUDOIDFWRUVFDQDIIHFWKRZPXFKDODPEIRHWXV
JURZVDQGLWVELUWKZHLJKWVXFKDVPDWHUQDODQGIRHWDOJHQRW\SHODPEJHQGHUPDWHUQDO
ERG\FRQGLWLRQOLWWHUVL]HDQGPDWHUQDOQXWULWLRQ)HHGDYDLODELOLW\HQHUJ\LQWDNHDQGWKH
PDWHUQDOERG\FRQGLWLRQIRUDSUHJQDQWHZHFDQKDYHDQLPPHQVHLPSDFWRQODPE
ELUWKZHLJKW,WLVYLWDOWKDWQXWULWLRQLVFRQWUROOHGGXULQJODPEJHVWDWLRQDVXQGHUIHHGLQJ
FRXOGUHVXOWLQORZHQHUJ\LQWDNHGHSOHWLRQLQHQHUJ\UHVHUYHVDQGUHGXFHGPDPPDU\
JURZWKDQGGHYHORSPHQWZKLOHRYHUIHHGLQJPD\OHDGWRELUWKLVVXHVDQGODPELQJ
&KDSWHU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GLIILFXOWLHV3URSHUQXWULWLRQLVHVSHFLDOO\FUXFLDOGXULQJWKHODWHVWDJHVRISUHJQDQF\DV
VWXGLHVKDYHVKRZQWKDWDNJJDLQLQHZHOLYHZHLJKWIURPGD\FDQLQFUHDVHODPE
ELUWKZHLJKWE\DERXWNJ2OGKDPHWDO
$VWKHODFWDWLRQSKDVHFRPPHQFHVJRRGQXWULWLRQDOSURYLVLRQLVUHTXLUHGWRHQVXUHWKH
PDLQWHQDQFHRIWKHPDPPDU\JODQGDQGHQVXULQJVWHDG\PLONSURGXFWLRQ3RVWQDWDO
QXWULWLRQDVGHWHUPLQHGE\WKHTXDOLW\RITXDQWLW\RIWKHHZH¶VPLONLVFUXFLDOWRWKH
GHYHORSPHQWRIQHZODPEV3HDUFH$UHVWULFWHGPLONDOORZDQFHLVH[SHULHQFHGE\
WZLQRUWULSOHWODPEVZKRKDYHWRFRPSHWHIRUVXFNOLQJWLPHDQGLVRIWHQUHIOHFWHGLQ
ZHDQLQJZHLJKWVDQGJURZWKJDLQV$GPLQLVWHULQJKLJKHQHUJ\GLHWVFRQVLVWLQJRI
FRQFHQWUDWHVWRODPEVIROORZLQJZHDQLQJKDVEHHQDVVRFLDWHGZLWKKLJKHUJURZWKUDWHVEXW
DOVRIDWWHUFDUFDVVHV6DxXGRHWDO
'HWHUPLQLQJWKHJHQHWLFUHODWLRQVKLSE\PHDQVRIFRUUHODWLRQDQDO\VHVEHWZHHQWKHVHWUDLWV
RIHFRQRPLFLPSRUWDQFHLVLPSHUDWLYHWRWKHHIIHFWLYHSODQQLQJRIDEUHHGLQJSURJUDPDQG
GHVLJQRIDQHIILFLHQWJHQHWLFHYDOXDWLRQVFKHPH

 0DWHULDOVDQG0HWKRGV
 'HWDLOVRIVKHHSWREHLQYHVWLJDWHG
$WRWDORI1=5RPQH\ODPEVZHUHLQYHVWLJDWHGLQWKLVVWXG\7KHODPEVH[DPLQHGLQ
WKLVVWXG\ZHUHREWDLQHGIURPXQUHODWHGVLUHOLQHVEHORQJLQJWRWKHWRSRIWKH6,/
GXDOSXUSRVHLQGH[UDQNLQJ
 6DPSOHFROOHFWLRQDQGSURFHVVLQJ
$OOUHVHDUFKLQWKLVWKHVLVLQYROYLQJDQLPDOVZDVSHUIRUPHGLQDFFRUGDQFHZLWKWKH
$QLPDO:HOIDUH$FW1=*RYHUQPHQWDQGWKHFROOHFWLRQRIVKHHSEORRGGURSVE\
WKHQLFNLQJRIWKHLUHDUVZDVFRYHUHGE\6HFWLRQ$QLPDO,GHQWLILFDWLRQLQ&RGHRI
:HOIDUH6KHHSDQG%HHI&DWWOHDFRGHRIZHOIDUHLVVXHGXQGHUWKDW$FW7KLV
SURFHVVLVFRQVLGHUHGWREHDUHJXODUSUDFWLFHLQIDUPPDQDJHPHQWV\VWHPDQGFDXVHVOLWWOH
RUQRKDUPWRWKHDQLPDOKHQFHWKLVVWXG\ZDVFRQVLGHUHGH[HPSWIURPIRUPDOHWKLFV
UHYLHZ
:LWKLQKRXUVRIELUWKODPEVZHUHWDJJHGZLWKSODVWLFHDUWDJVFRQWDLQLQJDXQLTXH
LGHQWLILFDWLRQQXPEHU7KHGDWHRIELUWKELUWKUDQNVLQJOHWZLQRUWULSOHWDVVLJQHGUDQNV
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2 and 3 respectively), birth weight (in kg), gender and sire details were documented 
concomitantly.  
To enable future analyses, blood samples were taken from a small nick the end of the 
animal’s ear using electric cutters (Appendix A), with several drops of whole blood 
collected on labelled FTA cards (Whatman, Middlesex, UK). The FTA card was then air-
dried and stored at room temperature in a dark room until required for further analyses.  
All the lambs were fed on pasture and placed together for three weeks until tailing was 
carried out using a rubber ring. The tailing date and weights were measured. Weaning 
occurred three months later, at which time weaning weights were recorded. The difference 
between the weaning weight and the birth weight divided by the age in days was used to 
calculate growth rate to weaning, expressed as grams/day. This parameter was calculated 
because it gives a useful indication of the lamb’s growth pattern during its lifetime. Both 
male and female lamb data where used in growth trait analyses. Separation of the lambs 
took place shortly after weaning, with only male lambs applied for further use in carcass 
yield and meat quality investigations, while female lambs were retained for use as ewe 
replacements for the flock.  
The target liveweight for male lambs in this study was 36 kg. Male lambs weighing 36 kg 
and over were immediately drafted for slaughter and transported to the meat processing 
plant. Underweight male lambs were kept of pasture for another four weeks, at which time 
a second draft took place for lambs hitting the target age. In the subsequent four-week 
period, a third and final draft occurred where all male lambs, regardless of liveweight, 
were taken to slaughter. The lamb weight and age at drafting were recorded. 
Hot carcass weight (HCW) in kg, which refers to the weight of carcass components 
without the head, pelt or gut, was measured at slaughter. Other post-slaughter carcass traits 
were evaluated using the VIASCAN® Video Image Analysis system (VIASCAN, Sastek, 
Hamilton, Queensland, Australia) developed by Meat and Livestock Australia and 
described by Hopkins et al. (2004). The leg yield, loin yield, shoulder yield, were 
calculated as a percentage of the lean meat tissue in proportion to HCW. The total yield is 
the sum of the leg, loin and shoulder yields. The carcass fat depth over the 12th rib (V-GR) 
was also recorded in millimetres. 
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A decrease in the mean birth weight was noticed with increasing birth rank, with triple-
birth lambs weighing about 1 kg less than single-birth lambs. A similar pattern was 
observed with weaning weights as lambs with ranking of 1 weighed nearly 4 kg more than 
their counterparts with a ranking of 3. Lambs born single were also faster growing by an 
average of 23 to 26 grams per day, when compared to lambs of double and triple births 
respectively.  
On the carcass side, single-born lambs had higher hot carcass weights in comparison to 
lambs born in a group (Table 3.1). These results may, however, be influenced by birth 
weight, as lambs with higher liveweight at birth and at weaning would very likely weigh 
more at slaughter too. A contrasting finding was observed for total yield, where lambs of 
single-birth produced lower lean meat than their multiple-birth counterparts. However, this 
finding along with those of fat depth were not statistically significant.        
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3.3.2 Relationship between growth and carcass traits 
           Table 3.2 Pearson correlation coefficient between different growth and carcass traits 
 
Tailing  
Wt1 (kg) 
Weaning 
Wt (kg) 
Growth rate 
(g/day) 
HCW2 
(kg) 
V-GR3 
(mm) 
Leg 
Yield4  
(%) 
Loin 
Yield4  
(%) 
Shoulder 
Yield4  
(%) 
Total 
Yield5  
(%) 
Birth Weight (kg) r 0.314** 0.343** 0.264** 0.130** 0.056 0.133** 0.146** 0.156** 0.165** 
Sig. 0.000 0.000 0.000 0.001 0.151 0.001 0.000 0.000 0.000 
Tailing Weight (kg) r  0.531** 0.392** 0.437** 0.072 -0.137** 0.062 0.111** -0.014 
Sig.   0.000 0.000 0.000 0.061 0.000 0.108 0.004 0.726 
Weaning Weight (kg) r   0.919** 0.574** 0.442** 0.195** 0.411** 0.362** 0.348** 
Sig.    0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Growth rate to weaning 
(g/day) 
r    0.526** 0.424** 0.218** 0.426** 0.349** 0.359** 
Sig.     0.000 0.000 0.000 0.000 0.000 0.000 
Hot Carcass Weight (kg) r     0.410** -0.106** 0.301** .269** 0.130** 
Sig.      0.000 0.006 0.000 0.000 0.001 
V-GR Fat Depth (mm) r      -0.017 0.192** 0.055 0.070 
Sig.       0.661 0.000 0.156 0.068 
Leg Yield (%) r       0.726** 0.548** 0.916** 
Sig.       0.000 0.000 0.000 
Loin Yield (%) r        0.590** 0.878** 
Sig.         0.000 0.000 
Shoulder Yield (%) r         0.790** 
Sig.          0.000 
** Correlation is significant at the 0.01 level (2-tailed),  r = Pearson correlation coefficient 
1 Wt = Weight;  2 HCW – Hot carcass weight;  3 V-GR – Viascan fat depth around the 12th rib   
4 Lean meat yield expressed as a percentage of hot carcass weight;  5 Total yield is the sum of the leg, shoulder and loin yields  
Chapter 3: The relationship between growth and carcass traits in NZ sheep breeds 
 
 36 
As illustrated in Table 3.2, most of the growth and carcass traits were linked as 
demonstrated by significant Pearson correlation coefficients. The strongest correlations 
were between weaning weight and growth rate-to-weaning (r = 0.919), and between total 
yield and leg yield (r = 0.916). This was expected because the growth rate calculation was 
derived from the weaning weight measurements, and loin yield represents a proportion of 
the total lean meat yield. Interestingly, unlike the loin and shoulder yields, leg yield had 
weak negative linear relationships with tailing weight (r = -0.137) and hot carcass weight (r 
= -0.106). 
 
 
 
A weak positive linear relationship between birth weight and total yield was observed (r = 
0.165, P < 0.001). However, regression analysis showed that weight at birth only accounts 
for about 3% (R2 = 0.027) of total lean meat yield (Figure 3.1). The results therefore, 
suggest that although higher birth weight animals tend to produce more lean meat, 
characteristics such as genetics may be better predictors of lean meat yield in NZ sheep 
breeds. 
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Figure 3.1 Scatterplot of total lean meat yield vs birth weight 
&KDSWHU7KHUHODWLRQVKLSEHWZHHQJURZWKDQGFDUFDVVWUDLWVLQ1=VKHHSEUHHGV

 37 
 'LVFXVVLRQ
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ZHLJKWIDWGHSWKDURXQGWKHWKULEDQGOHDQPHDW\LHOGVLQWKHOHJORLQDQGVKRXOGHU
DQGWRWDOOHDQPHDW\LHOG
7KHDYHUDJHELUWKZHLJKWUHFRUGHGIRUODPEVLQWKLVVWXG\ZDVNJZKLFKIDOOVZLWKLQ
WKHLGHDOUDQJHRINJWRNJ.QLJKWHWDO3UHYLRXVVWXGLHVKDYHGHPRQVWUDWHG
WKDWWKHUHODWLRQVKLSEHWZHHQELUWKZHLJKWDQGODPEVXUYLYDOIROORZVDEHOOVKDSHGFXUYH
ZLWKRSWLPXPVXUYLYDODWELUWKZHLJKWRINJDQGPLQLPDOVXUYLYDODWHLWKHU
H[WUHPHVRIYHU\KLJKRUYHU\ORZELUWKZHLJKWVQRWZLWKVWDQGLQJWKHVRXUFHRIYDULDWLRQ
.QLJKWHWDO'Z\HU/DPEVDWWKHORZHUH[WUHPHRIWKHELUWKZHLJKWVFDOH
DUHPRUHOLNHO\WRGLHGXHWRVWDUYDWLRQLQMXU\RUVXVFHSWLELOLW\WRH[SRVXUHZKLOHKLJK
ELUWKZHLJKWODPEVDUHPRUHOLNHO\WRGLHGXHWRG\VWRFLD7KLVUHLQIRUFHVWKHLQIOXHQFHRI
ELUWKZHLJKWLQODPEVXUYLYDODQGJURZWK
/LQHDUUHJUHVVLRQDQDO\VLVVKRZHGWKDWDQLQFUHDVHLQELUWKZHLJKWZDVZHDNO\FRUUHODWHG
ZLWKDQLQFUHDVHLQOHDQPHDW\LHOGVLQWKHSUHVHQWVWXG\7KLVREVHUYDWLRQPLJKWEH
H[SODLQHGE\WKHILQGLQJWKDWKHDYLHUERUQODPEVDUHDWDQDGYDQWDJHZLWKUHVSHFWWR
LQFUHDVHGODPEYLJRXUDQGLQGHSHQGHQFH'Z\HUDQG%QJHU'XHWRWKHLUDJLOLW\
YLJRXUDQGEHWWHUVXFNOLQJDELOLW\KHDYLHUERUQODPEVDUHOLNHO\WRUHFHLYHPRUHQXWULWLRQ
ZKHWKHULQWKHIRUPRIPLONRUSDVWXUHZKHQFRPSDUHGWRWKHLUOLJKWHUFRXQWHUSDUWVZKLFK
PLJKWWUDQVODWHWRLQFUHDVHGSRVWQDWDOJURZWKUDWHDQGVXEVHTXHQWPHDW\LHOG%LUWKZHLJKW
LVDXQLTXHSURGXFWLRQWUDLWUHTXLULQJDGHOLFDWHEDODQFHZKHQEHLQJVHOHFWHGIRUDVORZ
ELUWKZHLJKWKDVEHHQOLQNHGZLWKQHRQDWDOPRUWDOLW\ZKHUHDVKLJKELUWKZHLJKWKDVEHHQ
OLQNHGZLWKG\VWRFLDODERXUFRPSOLFDWLRQVDQGPDWHUQDOPRUWDOLW\*DUGQHUHWDO
5HJDUGLQJELUWKUDQNVLQJOHELUWKODPEVWHQGWRZHLJKPRUHWKDQWZLQODPEVZKRLQWXUQ
ZHLJKWPRUHWKDQWULSOHWODPEVDVGHPRQVWUDWHGLQWKLVVWXG\7KLVLVOLNHO\EHFDXVHWKH
DYDLODEOHQXWULHQWVSURYLGHGE\WKHHZHLQXWHURLVVKDUHGDFURVVODPEVLQPXOWLSOHODPE
SUHJQDQFLHVDVFRPSDUHGWRDVROHUHFLSLHQWLQDVLQJOHODPESUHJQDQF\7KLVSDWWHUQZDV
DOVRFRQVLVWHQWIRUZHDQLQJZHLJKWZLWKVLQJOHELUWKODPEVEHLQJKHDYLHUDWZHDQLQJWKDQ
ODPEVZLWKELUWKUDQNVRIRU&RPSHWLWLRQIRUPLONE\VLEOLQJODPEVLQPXOWLSOHELUWKV
LPSDFWWKHLUSHUIRUPDQFHDQGHQHUJ\LQWDNHKHQFHFDQOHDGWRGHFUHDVHGZHLJKW6RPH
VWXGLHVKDYHDOVRUHSRUWHGWKDWHZHVJLYLQJELUWKWRPXOWLSOHODPEVRIWHQGRQRWVXFNOHDOO
WKHLUODPEVGXHWRDIDUPPDQDJHPHQWGHFLVLRQLQIDYRXURIKDQGUHDULQJRUDVDUHVXOWRI
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premature lamb death (Notter and Brown, 2015). Hand-rearing is however, not a common 
practice in NZ Romney farming. 
An increase in growth rate-to-weaning was strongly correlated with an increase in both 
growth and carcass traits in the present study. The correlations with birth weight and 
weaning weight were expected as those parameters are directly applied in the calculation 
of growth rate. The findings are consistent with previous studies reporting a correlation 
between birth weight and weaning weight, as well as birth weight and average daily gain 
(Rashidi et al., 2008; Zhang et al., 2013). Worthy of note, however, was the positive 
correlation observed between growth rate and lean meat yields in the leg, loin and 
shoulders. This finding further confirms the notion that faster-growing lambs are more 
efficient in converting feed to usable energy that can be directed towards building up 
skeletal muscle, ultimately manifesting as higher lean meat yield. Therefore, a breeding 
program selecting for faster-growing lambs could produce a bi-faceted benefit by bringing 
about a simultaneous selection for higher lean meat yield in these lambs.  
Based on these preliminary findings, birth rank, gender and sire were corrected for in 
subsequent models analysing growth traits; while draft age, sire and birth weight were 
adjusted for in models examining carcass traits. By convention, ram lambs were sent to the 
slaughter rather than ewe lambs. While this is largely because ewes are retained for 
reproduction and as flock replacements, other reasons come into play.  
Gender has a huge influence on prenatal and postnatal lamb growth rate and performance. 
Previous studies have shown that male lambs tend to weigh more at birth and grow faster 
prior to weaning, when compared to than females lambs of the same age (Sañudo et al., 
1998; Lind et al., 2011). Ram carcasses are also heavier with a greater proportion of lean 
muscle, when compared to ewe carcasses slaughtered at the same age. From an early age, 
ewe lambs have a greater tendency to amass fat, which ultimately results in higher fat 
content in meat from ewe lambs when compared to ram lambs (Sañudo et al., 1998; Lind et 
al., 2011). In spite of the differences in carcass fatty acid composition, gender has not been 
shown to influence sensorial characteristics, taste and palatability of meat produced by 
both male and female lambs (Tejeda et al., 2008).  This indicates that the energy 
partitioning of a male lamb which yield the desirable lean-carcass is more suitable for meat 
production purposes. In this study, only male lambs were considered for the analyses of 
carcass traits.  
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4.1.1 IGF1R structure 
The structure of human IGF1R has been extensively studied and documented, with the first 
characterisation of the receptor undertaken using human placental tissue in the late 1800s 
(Bhaumick et al., 1981). The receptor is a transmembrane tyrosine kinase, and is initially 
synthesised as a 1367 amino acid precursor protein, with a signal peptide 30 residues long. 
This pro-receptor is processed into a mature peptide by the proteolytic cleavage of the 
signal peptide during its translocation into the endoplasmic reticulum, and the N-linked 
glycosylation of the remaining polypeptide (Sepp-Lorenzino, 1998). 
The mature and functional IGF1R is 1337 residues long and consists of an αβ-heterodimer 
held together by disulphide bonds in a β-α-α-β pattern. It is encoded by a 21-exon gene 
(Adams et al., 2000). A single disulphide bond links the α and β subunit, while multiple 
disulphide bonds between the α-chains of each αβ monomer hold the entire complex 
together. The α subunit contains about 710 residues (1 – 710), and they are strictly 
extracellular in locality; while the β subunits span the membrane and enter the cytoplasm 
(Figure 4.1) (Girnita et al., 2014). Unlike many receptors which dimerise upon ligand 
contact, the mature IGF1R receptor exists as a dimer, prior to activation.  
Each ectodomain α-monomer of IGF1R consists of two homologous leucine-rich domains 
called L1 and L2, connected by a cysteine-rich (CR) region (Cys148 to Cys298) (Lawrence et 
al., 2007). Findings from the development of peptide chimeras and the site-specific 
mutagenesis of the gene reveal a unique orientation that allows ligand-binding to occur at 
the centre of the IGF1R ectodomain, as well as contact with the surrounding L1, CR and 
L2 domains (Molina et al., 2000). The CR domain is the major participant in ligand 
contact. The L1, L2 and CR regions consist of approximately 150 residues each. Adjacent 
to the L2 domain is a linear arrangement of three fibronectin III domains (FnIII-1 to FnIII-
3) (Figure 4.1).  
FnIII-2 consists of an insert domain (ID) of about 120 residues, within which resides an α-
β furin-cleavage site that generates the distinct α and β subunits of IGF1R (Ward et al., 
2008). The α-α disulphide bonds in IGFR1 are located within two sites: one bond linking 
the C524 pair on each α chain FnIII-1 region, while the other three bonds are between 
residue pairs Cys682, Cys683 and Cys685 in the insert domain (Adams et al., 2000; Ward 
et al., 2008). The α-β disulphide bond occurs between C647 in the FnIII-2 domain and 
C860 in the FnIII-1 domain (Ward and Lawrence, 2009). This bond introduces some 
stability into the complex, and is crucial for signal transduction. The last 20 residues at the 
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The β subunit consists of 627 amino acid residues (residues 711 – 1337), and is subdivided 
into three regions: an extracellular region consisting of five N-linked glycosylation sites 
through which it binds to the α subunit, a hydrophobic transmembrane region (906 – 929), 
and an intracellular region (Sepp-Lorenzino, 1998) (Figure 4.1). The intracellular portion 
of the β-subunit consists of two regulatory domains, a membrane-proximal region (residues 
930 – 972) and a C-terminal tail (residues 1230 – 1337), interrupted by a catalytic tyrosine 
kinase (TK) domain (residues 973 – 1299) found in the middle (Ward et al., 2008).  
Three tyrosine residues are found at the positions 1131, 1135 and 1136 of the TK domain, 
and are essential for the auto-phosphorylation of the receptor during signalling. Also 
within the TK domain at residues 976 – 981, is a catalytic section consisting of an ATP-
binding motif (GXGXXG), and further downstream at position 1003 is a catalytic lysine 
residue that is crucial for Mg-ATP binding (Girnita et al., 2014). The membrane-proximal 
region plays a role in receptor internalisation, while the C-tail contains important 
regulatory elements of TK activity. In addition to the triple tyrosine cluster found in the TK 
domain, others residues necessary for receptor signal transduction include Y950, in the 
membrane-proximal region which serves as a docking site for Shc/IRS complex, and 
residues Y1250 and Y1251 in the C-terminal tail. 
4.1.2 IGF1R signalling and function 
Receptor signalling is a controlled process involving multiple factors including mitogen-
activated protein kinase (MAPK), mammalian target of rapamycin (mTOR), 
phosphatidylinositol-3-kinase (PI3K), and serine/threonine kinase or protein kinase B (Akt 
or PKB). Upon proteolysis of the bound IGFBP, the ligand is free to bind to membrane 
receptors.  
Ligand binding by IGF1, IGF2, or insulin to the extracellular domain of IGF1R brings 
about a conformational change, inducing the activation of its tyrosine kinase activity and 
the auto-phosphorylation of tyrosine residues 1131, 1135 and 1136 in the kinase domain 
(Chitnis et al., 2008). This action prompts the phosphorylation of juxtaposed tyrosine and 
serine residues outside the kinase domain, creating docking sites for downstream mediators 
such as insulin receptor substrates 1-4 (IRS-1-4), the Shc-adapter protein, and the Src 
kinase (Iams and Lovly, 2015).  Amongst the four IRS proteins, IRS-1 and IRS-2 
commonly mediate the physiological activities of IGFs in growth and development. 
Contained within the N-terminus of each IRS protein is a homologous phosphotyrosine 
binding (PTB) domain, through which they interact with membrane receptors (Girnita et 
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Following the phosphorylation of its tyrosines by IGF1R, IRS1/2 serves as the docking 
protein for p85, the regulatory subunit of P13K. The Src homology 2 (SH2) domain within 
p85 undergoes a high-affinity interaction with the phosphorylation-rich site in the C-
terminal region of IRS1/2, triggering the conversion of inner membrane bound-
phosphatidylinositol (4, 5)-bisphosphate (PIP2) to phosphatidylinositol (3, 4, 5)-
trisphosphate (PIP3) by the catalytic domain of PI3K (Girnita et al., 2014). This conversion 
is antagonised by the phosphatase and tensin homolog (PTEN), which dephosphorylates 
PIP3 to PIP2, thereby serving as a negative regulation mechanism for this pathway 
(Hemmings and Restuccia, 2012) (Figure 4.2). The PIP3 protein recruits other proteins 
possessing the pleckstrin homology (PH) domain, one of which is PI3K-dependent kinase 
1 (PDK1). This kinase phosphorylates Akt at the conserved threonine-308 residue, priming 
it for phosphorylation at serine-473 by the mTORC2 complex to bring about complete Akt 
activation (Adams et al., 2000; Hemmings and Restuccia, 2012).  
Phosphorylated Akt goes on to inhibit several atrophy-inducing factors including BAD (B-
cell lymphoma 2, BCL-2-associated agonist of cell death), FOXO (forkhead box), and 
GSK3β (glycogen synthase kinase 3 beta) (Stitt et al., 2004). The factors, BAD and BAX 
(BCL-2-associated X protein), both belong to the pro-apoptotic class of BCL2 factors, and 
their inhibition by Akt promotes cell survival. The phosphorylation of the FOXO1/3 
subfamily at multiple sites by Akt prevents nuclear entry. This consequently inhibits the 
expression of growth repressor genes encoding ubiquitin ligase proteins, including MuRF1 
(muscle RING finger 1), and muscle atrophy F box (MAFbx) or Atrogin-1 (Bodine et al., 
2001; Hribal et al., 2003). These ubiquitin ligases, if upregulated by FOXO, conjugate 
ubiquitin to protein targets and marks them for degradation by proteasomes. 
The fully active Akt subsequently stimulates the phosphorylation of cytosolic and nuclear 
substrates, including mTOR and p70 ribosomal S6 kinase (p70S6K). Phosphorylated 
mTOR downregulates the eukaryotic translation initiation factor 4E binding protein 1 
(4EBP1), which acts as a translational repressor (Figure 4.2). On the other hand, 
phosphorylated p70S6K brings about protein synthesis by activating ribosomal protein 
subunit S6 and other factors involved in translation initiation and elongation. The function 
of p70S6K is so important to muscle function that its deletion resulted in a reduction in the 
size of myoblasts and muscle fibres (Ohanna et al., 2005; Clemmons, 2009). The Akt 
signalling mechanism induces the expression of muscle-specific genes, resulting in the 
differentiation of myoblasts. These signalling events collectively promote growth, protein 
synthesis, cell survival, migration and increased metabolism.  
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The second parallel pathway involves Ras/Raf/MAPK signal transduction (Figure 4.2). 
Signal transduction from ligand-binding leads to the docking and phosphorylation of Shc 
proteins at the phosphorylated C-terminal tail of IGF1R. The activated phosphotyrosine 
residues of Shc binds to the SH2 domain of the adaptor protein, GRB2 (growth factor 
receptor-bound protein 2), which subsequently forms a complex with SOS (Son of 
Sevenless), a guanine nucleotide exchange factor (Duan et al., 2010). From the cytosol, the 
GRB2-SOS complex migrates to the plasma membrane, where the activated SOS elicits 
the conversion of GDP (guanosine diphosphate) to GTP on Ras. The protein Ras is one of 
a family of small GTPase proteins. The active GTP-bound Ras recruits and activates Raf, a 
serine/threonine kinase, which in turn activates MEK (MAPK kinase), that goes on to 
activate MAPK (also called ERK) (Girnita et al., 2014). MAPK activates downstream 
transcription factors, such as ELK1, c-Fos, c-Jun, c-Myc and cyclinD (Coolican et al., 
1997). This chain of events leads to growth and mitogenesis. 
Ultimately, both pathways converge in a concerted effort to promote cell growth, survival 
and protein synthesis. The organised phosphorylation and dephosphorylation in IGF1R 
signalling thereby enables regulation through an ON/OFF type of system. 
The IGF factors possess some uniqueness amongst other metabolic factors in that they can 
stimulate both proliferation and differentiation, two mutually exclusive processes within 
muscle fibres. Myoblast activation and proliferation occurs primarily via the MAPK 
pathway, while differentiation utilises the PI3K-Akt pathway (Coolican et al., 1997; 
Bodine et al., 2001; Rommel et al., 2001).  
4.1.3 IGF1R effects on skeletal muscle growth 
The size and strength of muscle fibres are often dependent on multiple factors including 
nutrient availability and gene expression. Despite sharing substantial similarity in their 
signalling pathways, insulin and IGFs diverge with respect to their physiological functions. 
While insulin primarily regulates fuel uptake, metabolism and homeostasis in cells, the 
IGFs stimulate cell survival, differentiation and growth.  
Insulin-like growth factor 1 can function in an autocrine, paracrine or endocrine fashion, 
depending on its site of synthesis. It is commonly accepted that IGF1 produced by the liver 
dominates the circulation, while IGF1 synthesised by extrahepatic tissue is secreted into 
the extracellular space, where it acts in an autocrine and paracrine manner (Clemmons, 
2016). 
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The signalling of IGF1 and IGF1R plays a vital role in skeletal myogenesis and 
maintenance, in both embryonic and postnatal stages. IGF1 expression has been found to 
induce the conservation of muscle architecture and satellite cell regeneration, while 
inhibiting atrophy. Studies undertaken with chicken embryos have shown IGF1 signalling 
to promote muscle hypertrophy, myoblast proliferation and differentiation, and an increase 
in the number of satellite cells, in a dose-dependent manner (Yu et al., 2015; Ma et al., 
2017).  
The IGF1 hormone is unique, in the sense that while most mitogenic growth factors 
promote myoblast proliferation and inhibit differentiation, IGF1-IGF1R signalling favours 
both myoblast proliferation and differentiation (Coolican et al., 1997; Hribal et al., 2003). 
Strong evidence demonstrating IGF1R participation in myogenesis include the observation 
that muscle hypoplasia and dwarfism result from the inactivation of IGF1R (Liu et al., 
1993), and that myofibre hypertrophy is brought about IGF1 transgene overexpression in 
the muscle (Coleman et al., 1995).  
Postnatal skeletal muscle fibres are post-mitotic, hence further growth or repair is made 
possible by the mitotically-capable satellite cells that surround the muscle fibres. Aging 
can bring about depletion in the number and function of satellite cells. IGF1 signalling has 
a beneficial effect on muscle fibres and can prolong the life of adult muscle. The repair and 
regeneration of muscle following damage are influenced by IGF1R signalling. 
4.1.4 Animal models of IGF1R inactivation and over-expression 
Transgenic and knock-out mice models have shed light on the role of IGF1 in muscle 
growth and development, and during both the embryonic and postnatal stages of 
development (Woods et al., 1996). Using a targeted mutagenesis approach, Liu et al. 
(1993) revealed that homozygous Igf1r(-/-) null mutants at birth exhibit growth retardation 
achieving at most 45% of the normal size. They have organ and muscle hypoplasia and 
typically die at birth due to respiratory failure caused by having insufficient muscle mass 
needed to inflate their lungs. When compared to Igf1r knock-out mice, Igf1(-/-) and Igf2(-/-
) null mutants experience less severe abnormalities, as some survive to adulthood and can 
grow up to 60% of the normal adult size (Liu et al., 1993; Baker et al., 1996; Woods et al., 
1996).  
Contrastingly, transgenic mice over-expressing a chimeric form of IGF1 manifested a 
130% increase in weight, a reflection of increased somatic growth (Mathews et al., 1988; 
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Coleman et al., 1995). Increased muscle fibre numbers, improved regeneration and 
enhanced muscle strength, are characteristic of mice that have over-expression of IGF1 
(Coleman et al., 1995; Barton-Davis et al., 1998; Barton et al., 2002).  
In diseases such as muscular dystrophies, muscle degeneration exceeds regeneration, often 
resulting in the permanent breakdown and loss of myofibres. In a study comparing mice 
expressing transgenic IGF1 against non-transgenic control, the transgenic expression of 
IGF1 was found to result in a 40% increase in muscle mass with higher contractile force 
compared to their non-transgenic counterparts (Barton et al., 2002). IGF1 was also found 
to protect against muscle disintegration and necrosis (Musarò et al., 2001; Barton et al., 
2002).  
Varying results were obtained, possibly as a consequence of muscle type, with transgenic 
mice expressing muscle-specific IGF1. A general increase in muscle size was noted, with 
the increase varying from 75% in the glycolytic triceps muscles, to 23% in oxidative soleus 
muscles, to a two-fold increase in some biceps muscles (Musarò et al., 2001; Otto and 
Patel, 2010). In addition, mIgf1 was confirmed to antagonise atrophy and maintain mass 
within senescent muscle fibres (Musarò et al., 2001; Barton et al., 2002; Stitt et al., 2004).  
The PI3K-Akt pathway has been demonstrated to be a critical driver of skeletal muscle 
hypertrophy activated by IGF1R signalling in transgenic mouse models. In these models, 
the conditional expression of Akt in transgenic mice possessing a constitutively active Akt 
mutant, brought about a rapid two-fold increase in the muscle fibre size (Lai et al., 2004; 
Stitt et al., 2004). Other studies, in vivo and in vitro, have demonstrated muscle 
hypertrophy following the expression of genes encoding active forms of the signalling 
mediators, PI3K or Akt (Bodine et al., 2001; Rommel et al., 2001; Lai et al., 2004).  
In addition to the muscle, the IGF system has effects on the nervous system (Woods et al., 
1996), bone (Zhao et al., 2000), and reproductive tissues (Baker et al., 1996).  Increased 
brain growth, synaptogenesis, improved myelination and neurogenesis, were observed with 
the over-expression of a mouse IGF1 transgene in transgenic mice (D'Ercole et al., 2002; 
Duan et al., 2010), whereas IGF1-null mice exhibited significant neuronal loss, hypo-
myelination, increased neuronal apoptosis, sensorineural deafness and a reduction in brain 
weight and size (Beck et al., 1995).  
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4.1.5 Human IGF1R mutations 
Human IGF1R is located on the long arm of chromosome 15 (15q26.3) (Klammt et al., 
2011; Janchevska et al., 2018). Pathological studies have implicated abnormalities in this 
region with syndromes such as ‘short for gestational age’ (SGA).  
Abuzzahab et al. (2003) reported the first three IGF1R mutations documented in humans. 
These were located in the exon 2 region of the gene, and included a C to T transition 
resulting in a premature stop codon at position 59, a C to A transversion leading to the 
substitution of the 108th arginine for glutamine, and an A to C transversion resulting in 
lysine residue being substituted for asparagine at position 115. Fibroblast culture studies 
revealed that patients with the nonsense p.Arg59stop mutation exhibited a decline in the 
number of cell surface IGF1R peptides, whereas patients with the missense mutations, 
p.Arg108Gln and p.Lys115Asn, had reduced IGF1R function (Abuzzahab et al., 2003). 
Exon 2 encodes the start of the mature IGF1R protein, hence the p.Arg59stop mutation 
allele would result in a truncated and non-functional receptor. As a result of their location 
in the ligand binding domain of IGF1R, the two amino acid substitutions would bring 
about a diminished affinity of IGF1 for its receptor (Abuzzahab et al., 2003).  
The cleavage site of IGF1R is conserved, and consists of the amino acids Arg-Lys-Arg-
Arg (R-K-R-R). A missense substitution of arginine for glutamine (p.Arg709Gln) at 
residue 709 due to a C to T transition in exon 11 of human IGF1R, altered the cleavage site 
to R-K-Q-R (Kawashima et al., 2005). This mutation halted the post-translational 
processing of the IGF1R precursor protein into the mature α and β subunits, ultimately 
resulting in short stature and intrauterine growth retardation (Kawashima et al., 2005).  
A c.3148G>A transition in the exon 16 of human IGF1R resulted in the substitution of 
glutamic acid for lysine at codon 1020 (Walenkamp et al., 2006). This p.Glu1020Lys 
substitution lies within the intracellular tyrosine kinase domain that is necessary for IGF1R 
signalling and function. Molecular and cell line studies revealed reduced auto-
phosphorylation and downstream signal transduction of IGF1R, although the binding of 
IGF1 to its receptor was unperturbed (Walenkamp et al., 2006). Reduced receptor auto-
phosphorylation and second messenger phosphorylation, as well as reduced cell 
proliferation were also reported for the following IGF1R mutations: an arginine 
substitution to leucine at position 431 (p.Arg431Leu) (Kawashima et al., 2012), an arginine 
481 substitution to glutamine (p.Arg481Gln) (Inagaki et al., 2007), and a valine 599 
substitution to glutamic acid (p.Val599Glu) (Wallborn et al., 2010).  
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Scanning microscopy and flow cytometric studies revealed that the p.Val599Glu 
substitution resulted in a misfolded IGF1R pro-receptor, which was withheld in the 
endoplasmic reticulum (ER), and for which cleavage to the mature form of the protein was 
abrogated (Wallborn et al., 2010). Intracellular retention in the ER, of the defective IGF1R 
pro-receptor was also postulated to occur with the p.Glu121Lys and p.Glu234Lys 
mutations described by Fang et al. (2012). 
In the distal end of the β-subunit, a glycine to alanine substitution at codon 1125 
(p.Gly1125Ala), caused by a G to C nucleotide transversion, disrupts a conserved region of 
the protein kinase activation loop motif in IGF1R (Kruis et al., 2010). Modelling analyses 
predict that the introduction of a methyl group by the arginine in this position would bring 
about a structural ‘clash’ with the other conserved motif residues, including the aspartate at 
position 1123, and the phenylalanine at position 1124, and this would culminate in 
abolished auto-phosphorylation (Kruis et al., 2010). 
Duplication mutations are quite rare in the coding regions of crucial house-keeping genes, 
nonetheless a 19 bp duplication (c.3348_3366dup19) in exon 18 of human IGF1R results 
in a frameshift and formation of a premature stop codon at position 1106 of IGF1R (Fang 
et al., 2009; Klammt et al., 2011). The tyrosine kinase domain is partially encoded by exon 
18, and thus this truncated IGF1R would be non-viable. The duplication resulted in mRNA 
degradation, indicated by the inability to detect mutant mRNA and subsequent IGF1R 
haplo-insufficiency (Fang et al., 2009).  
Humans possessing one or more of these mutations exhibit, to varying degrees, the 
following clinical phenotypes: intrauterine growth retardation (IUGR), postnatal growth 
failure and short stature, delayed mental development, microcephaly, craniofacial 
abnormalities, hindered bone growth, and IGF1 resistance (Abuzzahab et al., 2003; 
Kawashima et al., 2005; Walenkamp et al., 2006; Inagaki et al., 2007; Fang et al., 2012; 
Leal et al., 2013; Yang et al., 2018). 
Interestingly, one study revealed that humans possessing a p.Tyr387stop mutation, also had 
altered carbohydrate metabolism, including having reduced glucose tolerance and impaired 
insulin sensitivity (Mohn et al., 2011). In another rare condition, Cunningham et al. (2011) 
described five missense mutations (p.Pro190Ser, p.Arg406His, p.Met446Val, 
p.Arg595His, and p.Asn857Ser), that resulted in severe craniosynostosis and delayed 
neuronal development. 
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The ligand IGF1 has been identified as a risk factor in prostrate, lung, colon and breast 
cancers, with tumour cells expressing elevated levels of IGF1 (Duan et al., 2010). A 
homozygous partial deletion of IGF1 in humans has been associated with impaired foetal 
growth, mental and postnatal growth retardation, and sensorineural issues (Woods et al., 
1996). Research into IGF1R could, therefore, provide clinical benefit and therapeutic 
relevance for treating pathologies and muscle-related diseases including cachexia, sepsis 
and dystrophy. 
4.1.6 IGF1R variations in livestock 
Ovine IGF1R is located on chromosome 18, and consists of 21 exons and 20 introns that 
encode a 1367-amino acid polypeptide. Extensive effort has gone into studying IGF1R in 
humans, largely due to its role in pathological conditions, such as dwarfism and 
intrauterine growth retardation. However, compared to the human counterpart, very little 
knowledge is available on the effect of IGF1R sequence variation on animal production 
traits.   
In cattle, digestion of a 625 bp intronic fragment of bovine IGF1R by TaqI was found to 
yield two alleles, A and B, where the AA and AB genotypes were associated with increased 
milk production, while genotype BB was associated with a reduced interval for calving 
(Moody et al., 1996; Pereira et al., 2003; Curi et al., 2005). Another study in South 
Anatolian Red cattle reported a similar finding, with the A and B alleles presenting with 
frequencies of 82% and 18% respectively, although no association was observed with milk 
traits (Akis et al., 2010).  
Digestion of bovine IGF1R by MspI and TaqI enzymes, was reported to bring about two 
variations, a synonymous variation in exon 12, and a non-coding variation in the 3’ UTR, 
respectively. The GG genotype at the IGF1R/MspI locus showed association with 
increased weaning weight in Angus beef cattle, when compared to the AG genotype 
(Szewczuk et al., 2013).  
In a recent study in Polish Holstein-Friesian cows, increased milk protein, milk fat and 
milk yield were observed with IGF1R genotype combinations, TT/GG, TT/AG and CT/GG, 
when compared to the CC/AA genotype. The variations were reported to reside within exon 
2 of bovine IGF1R, which encodes the ligand binding domain that is crucial to IGF1R 
signalling (Szewczuk, 2017).  
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In sheep, the TT genotype of a C to T substitution in the intron 12 of ovine IGF1R showed 
significant association with higher body weight (at days 1, 30 and 90), and average daily 
weight gain in Pomeranian coarsewool ewes, when compared to the CC genotype 
(Proskura and Szewczuk, 2014). Three sequence variants (A, B, and C) were revealed in 
the intron 2-exon 3 region of ovine IGF1R, and a synonymous variation present in the C 
variant was associated with variation in the age and lifespan of NZ sheep breeds (Byun et 
al., 2008; Byun et al., 2012). When explored in Barki ewes, the same intron 2-exon 3 
region of IGF1R was found to yield three genotypes, AA, BB, and CC, where ewes 
possessing the AA genotype showed increased litter size and longevity, when compared to 
their counterparts.  
4.1.7 Rationale behind study 
The ovine IGF1R was selected for this study due to the central function of its protein 
product in animal growth, protein turnover and energy metabolism, as demonstrated by its 
high evolutionary conservation and ubiquitous distribution. IGF1R is a receptor for three 
important ligands – IGF1, IGF2 and insulin, and its signalling promotes the proliferation 
and differentiation of muscle cells, while inhibiting cell death. In response to growth 
hormone stimulation, IGF1R can also bring about lipolysis in the adipose tissue. This 
suggests that IGF1R may be an important regulator of growth, muscling and leanness in 
sheep. 
A region of ovine IGF1R spanning from exon 9 through to intron 10, which has not yet 
been explored in livestock, was selected for analysis. This region harbours the α-β cleavage 
site that results in the production of the two subunits of the mature protein. Also housed in 
this region is the fibronectin-III domain which enables the formation of disulphide bridges 
that maintain the structure and stability of the receptor.  
Two additional gene regions were chosen for this investigation: one spanning known 
regulatory regions in the 5’ UTR/promoter, and the other spanning exon 15 – a segment 
that encodes the transmembrane region of IGF1R.  
Given its broad functionality, nucleotide sequence variation in ovine IGF1R could not only 
alter its own signalling and physiological activity, but potentially exert effects on growth, 
homeostasis and metabolism.  
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Table 4.1 IGF1R primers and PCR-SSCP conditions 
Gene Region 
Forward/reverse primers 
Oligonucleotide (5’ to 3’) 
Amplicon 
size 
Annealing 
temp (ºC) 
SSCP 
conditions 
Promoter/5’ UTR 
F: CCTCGGGGAGTGGTGTCGC 
R: CGACGGCGGCAACTCGGGT 
319 bp 59 ºC 
14%, 300 V,  
30 ºC, 18 h 
Exon 9, Intron 9,  
Exon 10, Intron 10 
F: CTGAGCTACTACATCGTGCG 
R: CTCACTTCTGGGCTGTCAAC 
548 bp 58 ºC 
7%, 250 V, 
30 ºC, 12 h 
Exon 15 
F: CTCAGCTCCGGCCTCTTCC 
R: GCCCTGCACCACCTCTGG 
387 bp 59 ºC 
12%, 270 V,  
30 ºC, 19 h 
 
The PCR amplifications were performed in 15 µl reactions containing the purified genomic 
DNA on a 1.2 mm diameter disc of FTA, 0.25 µM of each primer, 150 µM of each dNTP 
(Eppendorf, Hamburg, Germany), 3.0 mM Mg2+, 0.5 U Taq DNA polymerase (Qiagen, 
Hilden, Germany), and 1 × the reaction buffer supplied with the enzyme. Amplifications 
were undertaken in Bio-Rad S1000 thermal cyclers (Bio-Rad, Hercules, CA, USA).  
The thermal profile entailed initial denaturation at 94 ºC for 2 mins, followed by 39 cycles 
of 94 ºC for 30 s, annealing at 58 ºC for 50 s, and extension at 72 ºC for 40 s, and a final 
extension step at 72 ºC for 5 min. The described profile is for the exon 9 – intron 10 
fragment; the specific annealing temperatures for the other amplified fragments are given 
in Table 4.1.   
Subsequent visualisation of the amplicons from the PCR reaction were carried out by 
means of agarose gel electrophoresis using 1% agarose (Quantum Scientific, Queensland, 
Australia) gels containing 1 × TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM 
Na2EDTA), 200 ng/mL ethidium bromide. 2 µL aliquots of the PCR products were mixed 
with 2 µL of loading dye (0.2% bromophenol blue, 0.2% xylene cyanol, 40% (w/v) 
sucrose), and loaded into the gels that were run at a constant 5 V/cm for 2 hours. After 
electrophoresis, the gels were visualised using ultraviolet transillumination at 254 nm. 
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4.2.3 Single-stranded conformational polymorphism (SSCP) analyses 
Optimisations for SSCP involved running amplicons at various conditions and using 
different gel compositions until consistently clear banding patterns were obtained. 
Following PCR, 0.7 µL of each PCR product was mixed with 7µL of loading dye (98% 
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol). The 
samples were denatured at 105 ºC for 5 min, snap-chilled on ice, and 10 µL of each sample 
was loaded into 16 x 18 cm, 7% acrylamide:bisacrylamide (37.5:1, Bio-Rad) gels in 
Protean II xi cells (Bio-Rad). The samples were run at a voltage of 250 V at 30 ºC for 18 
hours. The SSCP conditions stated above are for the exon 9 - intron 10 fragment, with the 
SSCP conditions for other amplified fragments are given in Table 4.1. 
Silver-staining of the gels was performed according to the method described by Byun et al. 
(2009). Briefly, the gels were silver-stained with silver nitrate, washed with distilled water 
and subsequently developed using a solution containing sodium hydroxide and 40% 
formaldehyde.  
In order to ensure the integrity of the experiments and to obtain reproducible banding 
patterns, freshly prepared PCR and SSCP products were always used. A negative control 
well containing no DNA was also run with each series of amplifications. 
4.2.4 Nucleotide sequencing and genotyping 
Following PCR-SSCP analysis, the banding patterns in the gels were observed. Amplicons 
deemed to be homozygous were sequenced in the forward and reverse directions using 
capillary sequencing at the Lincoln University DNA Sequencing Facility. For patterns that 
appeared to be heterozygous, single bands of non-homozygous samples were excised from 
the SSCP gel, washed repeatedly, and genomic DNA extracted. The resulting homozygous 
DNA was re-amplified, and then sequenced. Reactions were replicated to ensure accuracy 
and prevent PCR and sequencing errors. 
Sequence alignments, translations and comparisons were carried out using DNAMAN 
version 5.2.10 (Lynnon BioSoft, Vaudreuil, Canada). The BLAST algorithm 
(http://blast.ncbi.nlm.nih.gov/) was used to search the NCBI GenBank and Ensembl 
databases for homologous sequences in various species. 
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4.2.5 Statistical analyses 
IBM SPSS Statistics (Version 23, IBM, NY, USA) was used to perform all analyses. Trait 
data normality was tested using the Shapiro-Wilk test and Normal Q-Q plots. Variant and 
genotypic frequencies were calculated using the PopGene 3.2 software. The variant 
frequencies were then tested for deviation from Hardy-Weinberg equilibrium using a Chi-
square test available on the Online Encyclopedia for Genetic Epidemiology Studies 
(OEGE) (Rodriguez et al., 2009).  
The strength of relationships between the different traits was assessed using Pearson 
correlation coefficients. The growth traits investigated were birth weight, tailing weight, 
weaning weight, and growth rate-to-weaning. The carcass traits investigated were hot 
carcass weight (HCW), fat depth at the 12th rib (V-GR), hind-leg lean meat yield, loin lean 
meat yield, shoulder lean meat yield, and total carcass lean meat yield. 
Two sets of general linear mixed-effect models (GLMMs) were carried out. The first 
model was used to investigate the effect of the presence and absence (coded as 1 and 0 
respectively) of a specific variant on growth and carcass traits, while the second model 
assessed associations between the genotypes for each nucleotide substitution and growth 
and carcass traits. A Bonferroni correction was applied to the analyses. 
The statistical model used was:  
      Yijkl = µ + Si + Gj + Bk + Vl + eijkl     
where: 
Yijkl is the trait measured on each animal (birth, tailing and weaning weights,  
                 growth-rate, HCW, V-GR, and leg, loin, shoulder, and total lean meat yields) 
µ is the mean for the trait 
Si is the random effect of sire 
Gj is the fixed effect of gender 
Bj is the fixed effect of birth rank 
Vl  is the fixed effect of variant (presence or absence) or genotype 
eijkl is the random residual error 
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Gender was fitted as a fixed factor, and sire as a random factor in all growth trait models. 
For the growth trait models assessing the relationship between nucleotide genotype (or the 
presence/absence of a sequence variant) and tailing and weaning weights, the age at tailing 
and weaning were fitted as covariates respectively, as variation in age at measurement 
could potentially influence these traits.  
In order to account for the effect of prenatal growth and development, birth weight (which 
had a bigger effect than birth rank) was fitted as a covariate in models assessing the 
relationship between nucleotide variant genotype or the presence/absence of a sequence 
variant, and growth rate-to-weaning. Rearing rank, which is reflective of maternal 
influence was shown to have an effect, and hence was corrected for in growth rate models.  
For all carcass trait models, genotype was fitted as a fixed factor, and sire as a random 
factor, while birth weight and slaughter age in days were fitted as covariates, so as to 
correct for the effect of prenatal muscle development and the variation in the age of the 
lambs at slaughter respectively. Gender was not corrected for in any of the carcass trait 
models, as only ram lambs were sent for slaughter. 
The variant model was run in two phases. Firstly, a single variant model assessing the 
unilateral effect of variant presence/absence on individual traits was run. If a significant 
trend was observed (P < 0.2, the threshold for inclusion), then a subsequent multi-variant 
model investigating the effect of the presence/absence of a variant, within the context of 
the effect of the other variants, was performed. 
Values from the GLMM pairwise comparison was presented as estimated marginal means 
± standard error (mean ± SE). Unless otherwise specified, statistical significance was 
declared at P < 0.05, and trends were observed at P < 0.2. 
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4.3.2 Multiple sequence alignment of IGF1R sequences 
Alignments of the nucleotide sequences of the five IGF1R variants and other related 
species are presented in Figure 4.4. It can be seen from the alignment that the exon 9 - 
intron 10 region of IGF1R is conserved, with most species or breed-specific variations 
occurring in the non-coding regions. 
Variant_A   CTGGCAGCGCCAGCCCCAGGATAGCTACCTGTACCGGCACAACTACTGCT     50 
Variant_B   --------------------------------------------------     50 
Variant_C   --------------------------------------------------     50 
Variant_D   --------------------------------------------------     50 
Variant_E   --------------------------------------------------     50 
 Goat       ---------------------C----------------------------     50 
 Cattle     ---------------------C----------------------------     50 
 Yak        ---------------------C----------------------------     50 
 
Variant_A   CCAAAGgtgagggggcggccggg..cgcgcctgtgggcagtgagcggcag     98 
Variant_B   -----------------------..-------------------------     98 
Variant_C   -----------------------..-------------------------     98 
Variant_D   -----------------------..-------------------------     98 
Variant_E   -----------------------..-------------------------     98 
 Goat       -----------------------..---a-------------g-------     98 
 Cattle     ---------------a-------.cg---t-------g----g-------     99 
 Yak        ---------------a-------gcg---t-------g----ga------    100 
 
Variant_A   cggcggtcccgagcccgggggcgcgggctctcccctcccggcagcccgtg    148 
Variant_B   --------------------------------------------------    148 
Variant_C   ---------t----------------------------------------    148 
Variant_D   ---------------------t----------------------------    148 
Variant_E   --------------------------------------------------    148 
 Goat       gc------------------------------------------------    148 
 Cattle     ------g--t-----------------------at---------------    149 
 Yak        ------g--t-----------t-----------at---------------    150 
 
Variant_A   taacctggctcgcaccgggccactctgttccgagcagACAAAATCCCCAT    198 
Variant_B   --------------------------------------------------    198 
Variant_C   --------------------------------------------------    198 
Variant_D   --------------------------------------------------    198 
Variant_E   --------------------------------------------------    198 
 Goat       -------------g------------------------------------    198 
 Cattle     ----t----------g----------c-----------------------    199 
 Yak        ----t----------g----------c-----------------------    200 
 
Variant_A   CAGGAAGTACGCCGACGGCACCATCGACGTCGAGGAGGTGACGGAGAACC    248 
Variant_B   ---------T-----------------T----------------------    248 
Variant_C   ------------------------------------------A-------    248 
Variant_D   ---------T-----------------T----------------------    248 
Variant_E   --------------------------------------------------    248 
 Goat       ------------------------------------------------T-    248 
 Cattle     --------------------------------------------------    249 
 Yak        ---------------T----------------------------------    250 
 
Variant_A   CCAAGACCGAGGTGTGCGGCGGGGAGAAAGGGCCGTGCTGCGCTTGCCCC    298 
Variant_B   --------------------------------------------------    298 
Variant_C   --------------------------------------------------    298 
Variant_D   --------------------------------------------------    298 
Variant_E   --------------------------------------------------    298 
 Goat       --------------------------------------------------    298 
 Cattle     ----------------------------------------------T---    299 
 Yak        ----------------------------------------------T---    300 
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Variant_A   AAAACCGAAGCCGAGAAGCAGGCAGAGAAGGAGGAGGCCGAGTACCGCAA    348 
Variant_B   -----------------------G--------------------------    348 
Variant_C   -----------------------G--------------------------    348 
Variant_D   -----------------------G--------------------------    348 
Variant_E   -----------------------G--------------------------    348 
 Goat       -----------------------G--------------------------    348 
 Cattle     -----------T-----------G--------------------------    349 
 Yak        -----------T-----------G--------------------------    350 
 
Variant_A   GGTCTTCGAGAACTTCCTGCACAACGCCATCTTCGTGCCCAGgtactgct    398 
Variant_B   --------------------------------------------------    398 
Variant_C   --------------------------------------------------    398 
Variant_D   --------------------------------------------------    398 
Variant_E   --------------------------------------------------    398 
 Goat       --------------------------------------------------    398 
 Cattle     ----------------------------------------------c--c    399 
 Yak        ----------------------------------------------c--c    400 
 
Variant_A   atctttgtgcccaggtaccaccatcttggtgcccgggcaccaccatcttt    448 
Variant_B   ----------------------t---------------------------    448 
Variant_C   --------------------------------------------------    448 
Variant_D   --------------------------------------------------    448 
Variant_E   -------------------c------------------------------    448 
 Goat       --------------------------------------------------    448 
 Cattle     --t--c------g------g---------------------g--------    449 
 Yak        --t--c------g------g---------------------g--------    450 
 
Variant_A   gcacccaggccatatgtcctccgcggtgctggtgccccgaccccagccca    498 
Variant_B   -----------------------t--------------------------    498 
Variant_C   --------------------------------------------------    498 
Variant_D   -----------------------t--------------------------    498 
Variant_E   -----------------------t--------------------------    498 
 Goat       --------------------------------------------------    498 
 Cattle     -----------             460 
 Yak        -----------cc-c---t----------c-ccc----c---a-------    500 
 
Variant_A   ccatgcgcag                                            508 
Variant_B   -----.....                                            503 
Variant_C   ----------                                            508 
Variant_D   -----.....                                            503 
Variant_E   -----.....                                            503 
 Goat       ----------                                            508 
 Cattle                                                 460 
 Yak        --t-------                                            510 
 
Figure 4.4 Alignment of IGF1R sequences 
The sequences A – E represent the five different variants (A9 – E9) detected in this study 
(excluding the primer region). The alignment was carried out using the DNAMAN 
software. Dashes (-) denote nucleotides identical to the reference variant A9 sequence, 
while dots (.) denote missing nucleotides. The DNA sequences for the related species were 
extracted from GenBank with the following accession numbers: Goat, Capra hircus 
(NC_030828.1); Cattle, Bos taurus (JN204287); and Yak, Bos mutus (CP027089.1). 
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4.3.3 Variant diversities in ovine IGF1R 
The ten IGF1R sequence variations detected and their defining haplotypes are summarised 
in Table 4.2. 
Table 4.2 Variants and haplotypes detected in the intron 9, exon 10 and intron 10 
regions of ovine IGF1R 
                            Haplotype 
Variant 
 A9 B9 C9 D9 E9 
Region H1 H2 H3 H4 H5 
c.1996+52C>T Intron 9 c c t c c 
c.1996+64C>T Intron 9 c c c t c 
c.2019C>T  (p.Tyr673Tyr) Exon 10 C T C T C 
c.2037C>T  (p.Asp679Asp) Exon 10 C T C T C 
c.2052G>A  (p.Thr684Thr) Exon 10 G G A G G 
c.2133G>A  (p.Ala711Ala) Exon 10 A G G G G 
c.2201+28A>C Intron 10 a a a a c 
c.2201+31A>T Intron 10 a t a a a 
c.2201+82T>C Intron 10 c t c t t 
c.2201+114_118delCGCAG Intron 10 cgcag del cgcag del del 
 
All of the variation found in exon 10 was synonymous, meaning that there would not be 
changes in the putative amino acid sequence at positions 673, 679, 684 and 711. Intron 10 
had more variation than intron 9, with the most notable being a 5 bp deletion located 114 
bases upstream of the coding nucleotide at position 2201. This 
c.2201+114_118delCGCAG deletion was present in three of the five variants – B9, D9 and 
E9 (Table 4.2). 
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4.3.4 Variant and genotype frequencies of IGF1R 
The genotypic frequencies of IGF1R variants across ten NZ sheep breeds are given in 
Table 4.3.  
Table 4.3 Breed frequencies of ovine IGF1R 
  
IGF1R Variant Genotypes (%) 
Breed n A9A9 A9B9 A9C9 A9D9 A9E9 B9B9 B9C9 B9E9 E9E9 
Romney 743 20.0 41.0 _ _ 11.0 17.0 _ 8.0 3.0 
Coopworth 30 20.0 50.0 _ _ 13.3 10.0 _ 3.4 3.3 
Corriedale 31 9.7 38.7 _ _ 12.9 6.4 _ 32.3 _ 
Dorset Down 32 37.5 18.7 15.6 _ _ 15.6 6.3 6.3 _ 
Merino 51 13.7 43.1 _ _ 11.8 5.9 _ 25.5 _ 
Perendale 74 40.5 20.3 _ 4.1 13.5 _ 8.1 13.5 _ 
Poll Dorset 30 23.3 36.7 _ _ 16.7 16.7 _ 6.6 _ 
Suffolk 45 11.1 17.8 24.4 _ _ 13.4 33.3 _ _ 
Texel 31 22.6 22.6 _ _ 16.2 19.3 _ 19.3 _ 
White Dorper 68 11.8 60.3 2.9 _ 10.3 7.4 _ 2.9 4.4 
           
Total 1135                   
 
Genotypes A9A9 and A9B9 were detected in all breeds, while B9B9 was present in all but the 
Perendale breed. The Perendale was the only sheep breed with the A9D9 genotype (4.1%). 
Both the Suffolk and Dorset Down breeds possessed the limited A9C9 and B9C9 genotypes, 
with the highest frequencies found in the former. The B9D9, C9C9, C9D9, C9E9, D9D9 and 
D9E9 genotypes were not observed in any of the lambs. 
 
Figure 4.5 IGF1R variant genotype frequencies in NZ Romney breed 
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Only three variants (A9, B9 and E9) were observed for NZ Romney breed (Table 4.3). 
Genotype A9A9 was the most common (20%), followed by B9B9 (17%). Only 3% of the 
Romney lambs possessed the least common E9E9 genotype (Figure 4.5), which was also 
present in the Coopworth and Dorper breeds. The A9B9 genotype (41%) occurred twice as 
commonly as A9A9, while the A9E9 and B9E9 genotypes had frequencies of 11% and 8% 
respectively (Figure 4.5). 
Table 4.4 summarises the nucleotide and genotype frequencies of the detected variants, and 
their deviation from the Hardy-Weinberg Equilibrium. 
Table 4.4  IGF1R genotype frequencies at variant loci in NZ Romney sheep 
Variant Nucleotide 
Nucleotide 
frequency 
n Genotype 
Genotype 
frequency 
HWE1 
c.2019C>T  C 0.58 253 CC 0.34 χ
2 = 0.06  
T 0.42 364 CT 0.49 P = 0.970 
   126 TT 0.17  
       
c.2037C>T  C 0.58 253 CC 0.34 χ
2 = 0.06 
 T 0.42 364 CT 0.49 P = 0.970 
   126 TT 0.17  
       
c.2133G>A A 0.46 149 AA 0.20 χ
2 = 1.48  
G 0.54 387 AG 0.52 P = 0.477  
  207 GG 0.28   
    
 
 
c.2201+28A>C A 0.88 580 AA 0.78 χ
2 = 10.95  
C 0.12 141 AC 0.19 P = 0.004  
  22 CC 0.03   
    
 
 
c.2201+31A>T A 0.58 253 AA 0.34 χ
2 = 0.06  
T 0.42 364 AT 0.49 P = 0.970  
  126 TT 0.17  
       
c.2201+82T>C C 0.46 149 CC 0.20 χ
2 = 1.48 
 T 0.54 387 CT 0.52 P = 0.477 
   207 TT 0.28  
       
c.2201+114_118 CGCAG 0.46 149 CGCAG/CGCAG 0.20 χ
2 = 1.48 
delCGCAG del 0.54 387 CGCAG/del 0.52 P = 0.477 
      207 del/del 0.28  
1 HWE = Hardy-Weinberg Equilibrium 
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Within the NZ Romney sheep, the nucleotide substitutions were all in agreement with the 
Hardy-Weinberg Equilibrium (P > 0.05), except for c.2201+28A>C (P = 0.004). This was 
likely a consequence of adenine being the major nucleotide (88%) with a predominant AA 
genotype (78%), while cytosine was the minor nucleotide (12%) with the CC genotype 
being rare (3%).   
For the nucleotide substitutions c.2019C>T, c.2037C>T and c.2201+31A>T, the major and 
minor nucleotides had frequencies of 58% and 42% respectively (Table 4.4). For the 
nucleotide substitutions c.2133G>A, c.2201+82T>C and c.2201+114_118delCGCAG, the 
major and minor nucleotides had frequencies of 54% and 46% respectively. 
4.3.5 Association of IGF1R genetic variants with growth traits 
The presence or absence of each IGF1R variant was investigated for association with 
growth traits in NZ Romney lambs, and the results are given in Table 4.5.  
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Table 4.5 Association between variants in ovine IGF1R and variation in growth traits 
in NZ Romney sheep 
Trait 
(unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant 
absent (0) 
n 
Variant  
present (1) 
n P-value  
Birth  A9  5.03 ± 0.21 207 5.13 ± 0.20 536 0.150 
weight (kg) B9  5.13 ± 0.21 253 5.07 ± 0.20 490 0.368 
 E9  5.11 ± 0.20 580 5.00 ± 0.21 163 0.136 
 A9 E9 5.01 ± 0.21 207 5.09 ± 0.21 536 0.268 
  E9 A9 5.10 ± 0.20 580 5.00 ± 0.21 163 0.240 
Tailing  A9  11.75 ± 0.56 207 12.14 ± 0.56 536 0.029 
weight (kg) B9  12.20 ± 0.56 253 11.87 ± 0.55 490 0.055 
 E9  12.03 ± 0.55 580 11.61 ± 0.58 163 0.029 
 A9 B9, E9 11.80 ± 0.56 207 11.91 ± 0.56 536 0.609 
 B9 A9, E9 12.10 ± 0.56 253 11.61 ± 0.56 490 0.016 
  E9 A9, B9 12.15 ± 0.55 580 11.56 ± 0.57 163 0.008 
Weaning  A9  28.62 ± 0.97 207 29.76 ± 0.96 536 <0.001 
weight (kg) B9  29.93 ± 0.98 253 29.00 ± 0.96 490 0.002 
 E9  29.45 ± 0.95 580 28.27 ± 0.99 163 0.001 
 A9 B9, E9 28.79 ± 0.96 207 29.13 ± 0.96 536 0.327 
 B9 A9, E9 29.63 ± 0.96 253 28.29 ± 0.96 490 <0.001 
  E9 A9, B9 29.78 ± 0.95 580 28.14 ± 0.98 163 <0.001 
Growth rate 
to weaning  
A9  249.59 ± 10.57 207 260.35 ± 10.35 536 0.001 
B9  264.91 ± 10.56 253 254.78 ± 10.34 490 0.001 
(g/day) E9  259.40 ± 10.36 580 249.61 ± 10.71 163 0.006 
 A9 B9, E9 254.20 ± 10.55 207 257.43 ± 10.30 536 0.374 
 B9 A9, E9 262.70 ± 10.54 253 248.93 ± 10.30 490 <0.001 
  E9 A9, B9 263.13 ± 10.38 580 248.50 ± 10.55 163 <0.001 
 
The presence of A9 was associated with a 3.3% increase in tailing weight and a 4.0% 
increase in weaning weight. A 0.42 kg decrease in tailing weight was associated with E9 
being present. Weaning weight was 1.18 kg lower when E9 was present, and 0.93 kg lower 
when B9 was present.  
Animals possessing the A9 variant grew 4.3% faster by 10.76 g/day when compared to their 
counterparts that did not possess A9. In contrast, animals possessing the B9 and E9 variants 
grew more slowly by 10.13 g/day and 9.79 g/day respectively (Table 4.5). All the 
associations and trends observed for B9 and E9 remained when the other variants that may 
have had an effect were factored into the models. 
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Table 4.6 summarises results from association studies assessing the effect of individual 
variant loci on ovine growth traits. 
 
Table 4.6 Association of genotypes at variant loci in ovine IGF1R with growth traits 
in NZ Romney sheep 
Variant Loci Genotypes n 
Birth 
weight (kg) 
Tailing 
weight (kg) 
Weaning 
weight (kg) 
Growth rate-to-
weaning (g/day) 
c.2019C>T  CC 253 5.14 ± 0.21 12.19 ± 0.57 29.90 ± 0.98a 265.01 ± 10.56a 
(p.Tyr673Tyr) CT 364 5.09 ± 0.21 11.85 ± 0.56 28.92 ± 0.97ab 254.22 ± 10.37a 
 TT 126 5.04 ± 0.21 11.91 ± 0.57 29.10 ± 0.98
b 256.80 ± 10.81b 
 P-value 
 0.557 0.153 0.007 0.004 
  
 
    
c.2037C>T  CC 253 5.14 ± 0.21 12.19 ± 0.57 29.90 ± 0.98a 265.01 ± 10.56a 
(p.Asp679Asp) CT 364 5.09 ± 0.21 11.85 ± 0.56 28.92 ± 0.97
ab 254.22 ± 10.37a 
 TT 126 5.04 ± 0.21 11.91 ± 0.57 29.10 ± 0.98
b 256.80 ± 10.81b 
 P-value 
 0.557 0.153 0.007 0.004 
  
 
    
c.2133G>A AA 149 5.24 ± 0.21
a 12.51 ± 0.57a 31.01 ± 0.98 274.22 ± 10.65a 
(p.Ala711Ala) AG 387 5.08 ± 0.21
b 11.97 ± 0.56b 29.18 ± 0.95 256.51 ± 10.24b 
 GG 207 5.02 ± 0.21
b 11.72 ± 0.56b 28.52 ± 0.95 250.23 ± 10.42b 
 P-value  0.036 0.004 <0.001 <0.001 
  
 
    
c.2201+28A>C AA 580 5.10 ± 0.20 12.03 ± 0.55 29.44 ± 0.95 259.35 ± 10.28
a 
 AC 141 5.02 ± 0.21 11.65 ± 0.58 28.62 ± 0.99 253.34 ± 10.68
a 
 CC 22 4.83 ± 0.27 11.33 ± 0.73 25.65 ± 1.25 222.57 ± 13.27
b 
 P-value 
 0.197 0.075 <0.001 <0.001 
  
 
    
c.2201+31A>T AA 253 5.14 ± 0.21 12.19 ± 0.57 29.90 ± 0.98a 265.01 ± 10.56a 
 AT 364 5.09 ± 0.21 11.85 ± 0.56 28.92 ± 0.97
ab 254.22 ± 10.37a 
 TT 126 5.04 ± 0.21 11.91 ± 0.57 29.10 ± 0.98
b 256.80 ± 10.81b 
 P-value 
 0.557 0.153 0.007 0.004 
  
 
    
c.2201+82T>C CC 149 5.24 ± 0.21a 12.51 ± 0.57a 31.01 ± 0.98 274.22 ± 10.65a 
 CT 387 5.08 ± 0.21
b 11.97 ± 0.56b 29.18 ± 0.95 256.51 ± 10.24b 
 TT 207 5.02 ± 0.21
b 11.72 ± 0.56b 28.52 ± 0.95 250.23 ± 10.42b 
 P-value  0.036 0.004 <0.001 <0.001 
       
c.2201+114_118 CGCAG/CGCAG 149 5.24 ± 0.21a 12.51 ± 0.57a 31.01 ± 0.98 274.22 ± 10.65a 
delCGCAG CGCAG/del 387 5.08 ± 0.21b 11.97 ± 0.56b 29.18 ± 0.95 256.51 ± 10.24b 
 del/del 207 5.02 ± 0.21
b 11.72 ± 0.56b 28.52 ± 0.95 250.23 ± 10.42b 
  P-value   0.036 0.004 <0.001 <0.001 
a, b Mean values within the same column group with different superscripts differ at P < 0.05 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
Chapter 4: Investigation of variation in ovine IGF1R and its association with growth and carcass traits 
 
 67 
Nucleotide substitutions with similar genotype frequencies exhibited similar associations 
with growth traits, reflecting their linkage in the variants. The common homozygous 
genotypes CC, CC, and AA for c.2019C>T, c.2037C>T and c.2201+31A>T respectively, 
were associated with a 2.7% increase in weaning weight and a 3.1% increase in growth 
rate by 8.2 g/day, when compared to the less abundant TT genotypes (Table 4.6). No 
associations were found with birth weight and tailing weight, although a decreasing trend 
of association with TT was noted for the latter.  
At loci c.2201+114_118delCGCAG, the more abundant del/del homozygous genotype was 
associated with a 6.3% decrease in tailing weight, an 8% decrease in weaning weight, and 
an 8.7% decrease in growth rate of 24.0 g/day, when compared to the less abundant 
CGCAG/CGCAG genotype that lacked the deletion. Individuals possessing the del/del 
genotype were also 4.2% lighter at birth. The same pattern was noted for major and minor 
genotypes of c.2133G>A and c.2201+82T>C (Table 4.6).  
The CC genotype of c.2201+28A>C was associated with lower weight at weaning by 3.79 
kg and lower growth rate by 36.8 g/day, when compared to its more predominant AA 
counterpart. Similar decreasing trends were seen with birth weights and tailing weight at 
this loci. 
 
4.3.6 Association of IGF1R genetic variants with carcass traits 
The presence and absence of each variant was investigated for association with carcass 
traits in NZ Romney lambs, and the results are presented in Table 4.7. 
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Table 4.7 Association of variants in ovine IGF1R with carcass traits in NZ Romney 
sheep 
Trait (unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant 
absent (0) 
n 
Variant  
present (1) 
n P-value  
HCW1 (kg) A9  16.74 ± 0.11 192 17.27 ± 0.08 491 <0.001  
B9  17.39 ± 0.11 231 17.00 ± 0.08 452 0.002  
E9  17.20 ± 0.08 533 16.85 ± 0.13 150 0.009  
A9 B9, E9 16.88 ± 0.12 192 17.15 ± 0.09 491 0.056  
B9 A9, E9 17.24 ± 0.12 231 16.78 ± 0.10 452 0.001 
  E9 A9, B9 17.25 ± 0.10 533 16.77 ± 0.13 150 0.003 
V-GR2 Fat  A9  4.44 ± 0.17 192 4.04 ± 0.12 491 0.038 
Depth (mm) B9  3.97 ± 0.16 231 4.24 ± 0.12 452 0.138  
E9  4.05 ± 0.11 533 4.52 ± 0.19 150 0.022  
A9 B9, E9 4.34 ± 0.19 192 4.22 ± 0.14 491 0.574  
B9 A9, E9 4.07 ± 0.18 231 4.49 ± 0.15 452 0.046 
  E9 A9, B9 3.97 ± 0.15 533 4.59 ± 0.19 150 0.010 
Leg  A9  21.35 ± 0.09 192 21.56 ± 0.06 491 0.025 
Yield (kg) B9  21.48 ± 0.08 231 21.51 ± 0.06 452 0.707  
E9  21.55 ± 0.06 533 21.32 ± 0.10 150 0.032  
A9 E9 21.33 ± 0.09 192 21.50 ± 0.07 491 0.075 
  E9 A9 21.50 ± 0.06 533 21.32 ± 0.10 150 0.100 
Loin  A9  14.45 ± 0.06 192 14.62 ± 0.04 491 0.011 
Yield (%) B9  14.57 ± 0.06 231 14.58 ± 0.04 452 0.921  
E9  14.60 ± 0.04 533 14.48 ± 0.07 150 0.097  
A9 E9 14.44 ± 0.06 192 14.59 ± 0.05 491 0.028 
  E9 A9 14.56 ± 0.04 533 14.48 ± 0.07 150 0.282 
Shoulder  A9  16.66 ± 0.06 192 16.92 ± 0.04 491 <0.001 
Yield (%) B9  16.85 ± 0.06 231 16.85 ± 0.04 452 0.981  
E9  16.90 ± 0.04 533 16.69 ± 0.07 150 0.005  
A9 E9 16.64 ± 0.06 192 16.87 ± 0.05 491 0.001 
  E9 A9 16.83 ± 0.05 533 16.68 ± 0.07 150 0.055 
Total   A9  52.46 ± 0.18 192 53.11 ± 0.12 491 0.002 
Yield (%) B9  52.90 ± 0.17 231 52.94 ± 0.12 452 0.817  
E9  53.05 ± 0.12 533 52.50 ± 0.20 150 0.009  
A9 E9 52.41 ± 0.18 192 52.96 ± 0.14 491 0.005 
  E9 A9 52.89 ± 0.13 533 52.48 ± 0.197 150 0.061 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
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The presence of the A9 variant was associated with a 3.2% increase in hot carcass weight of 
0.53 kg; whereas B9 and E9 were associated with decreases in hot carcass weight of 0.39 kg 
and 0.35 kg respectively. Variant A9 was associated with an increase in lean meat yield in 
the leg (1%), loin (1.2%) and shoulder (1.6%) regions, and total yield (1.2%); while E9 was 
associated with a decrease in leg (1.1%), loin (0.8%), shoulder (1.2%) and total (1%) yield. 
A 9% (0.4 mm) decrease in fat depth around the 12th rib was associated with the presence 
of A9, while E9 was associated with an increase in fat depth by 0.47 mm (Table 4.7). 
Variant B9 showed a trend of association with increased fat depth in the single-variant 
model, which became significant in the subsequent multi-variant model.  
This is an interesting observation as it appears that the associations of the B9 and E9 
variants were strengthened in multi-variant models where both variants were factored in 
(i.e. HCW and V-GR), as opposed to the multi-variant models where only E9 was factored 
in (i.e. leg, loin, shoulder and total yields). In the multi-variant model, B9 and E9 were 
associated with a decrease in hot carcass weight of 0.46 kg (P = 0.001) and 0.48 kg (P = 
0.003) respectively, compared to the single-variant model where the difference was 0.39 
kg (P = 0.002) and 0.35 kg (P = 0.009) respectively (Table 4.7).  
Table 4.8 summarises results from association studies assessing the effect of individual 
nucleotide substitutions on ovine growth traits in the Romney sheep breed. 
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                             Table 4.8 Association of genotypes at variant loci of IGF1R with carcass traits in NZ Romney sheep 
Variant Loci Genotypes n HCW1 (kg) V-GR2 (mm) Leg yield (%) Loin yield (%) 
Shoulder yield 
(%) 
Total yield 
(%) 
c.2019C>T  CC 231 17.39 ± 0.12a 3.97 ± 0.16 21.48 ± 0.08 14.57 ± 0.06 16.85 ± 0.06a 52.90 ± 0.16a 
(p.Tyr673Tyr) CT 335 17.01 ± 0.09ab 4.16 ± 0.13 21.57 ± 0.07 14.62 ± 0.05 16.92 ± 0.05ab 53.11 ± 0.14b 
 TT 117 16.96 ± 0.14
b 4.47 ± 0.21 21.35 ± 0.11 14.46 ± 0.07 16.65 ± 0.08b 52.46 ± 0.22b 
 P-value 
 0.004 0.145 0.178 0.154 0.006 0.026 
         
c.2037C>T  CC 231 17.39 ± 0.12a 3.97 ± 0.16 21.48 ± 0.08 14.57 ± 0.06 16.85 ± 0.06a 52.90 ± 0.16a 
(p.Asp679Asp) CT 335 17.01 ± 0.09ab 4.16 ± 0.13 21.57 ± 0.07 14.62 ± 0.05 16.92 ± 0.05ab 53.11 ± 0.14b 
 TT 117 16.96 ± 0.14
b 4.47 ± 0.21 21.35 ± 0.11 14.46 ± 0.07 16.65 ± 0.08b 52.46 ± 0.22b 
 P-value 
 0.004 0.145 0.178 0.154 0.006 0.026 
         
c.2133G>A AA 136 17.69 ± 0.14 3.18 ± 0.20a 21.73 ± 0.10a 14.72 ± 0.07a 17.06 ± 0.07 53.51 ± 0.21 
(p.Ala711Ala) AG 355 17.12 ± 0.08 4.34 ± 0.13b 21.50 ± 0.06ab 14.59 ± 0.04ab 16.88 ± 0.05 52.97 ± 0.13 
 GG 192 16.74 ± 0.11 4.44 ± 0.17
b 21.35 ± 0.09b 14.45 ± 0.06b 16.66 ± 0.06 52.46 ± 0.18 
 P-value 
 <0.001 <0.001 0.012 0.011 <0.001 <0.001 
         
c.2201+28A>C AA 533 17.20 ± 0.07a 4.05 ± 0.11a 21.55 ± 0.06a 14.60 ± 0.04a 16.89 ± 0.04a 53.05 ± 0.11a 
 AC 130 16.97 ± 0.13
ab 4.28 ± 0.20a 21.44 ± 0.10a 14.57 ± 0.07a 16.77 ± 0.07ab 52.78 ± 0.20a 
 CC 20 15.98 ± 0.33
b 6.32 ± 0.50b 20.51 ± 0.25b 13.85 ± 0.17b 16.10 ± 0.18b 50.45 ± 0.51b 
 P-value  0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
         
c.2201+31A>T AA 231 17.39 ± 0.12a 3.97 ± 0.16 21.48 ± 0.08 14.57 ± 0.06 16.85 ± 0.06a 52.90 ± 0.16a 
 AT 335 17.01 ± 0.09
ab 4.16 ± 0.13 21.57 ± 0.07 14.62 ± 0.05 16.92 ± 0.05ab 53.11 ± 0.14b 
 TT 117 16.96 ± 0.14
b 4.47 ± 0.21 21.35 ± 0.11 14.46 ± 0.07 16.65 ± 0.08b 52.46 ± 0.22b 
 P-value 
 0.004 0.145 0.178 0.154 0.006 0.026 
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a, b Mean values within the same column group with different superscripts differ at P < 0.05 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
         
c.2201+82T>C CC 136 17.69 ± 0.14 3.18 ± 0.20a 21.73 ± 0.10a 14.72 ± 0.07a 17.06 ± 0.07 53.51 ± 0.21 
 CT 355 17.12 ± 0.08 4.34 ± 0.13
b 21.50 ± 0.06ab 14.59 ± 0.04ab 16.88 ± 0.05 52.97 ± 0.13 
 TT 192 16.74 ± 0.11 4.44 ± 0.17
b 21.35 ± 0.09b 14.45 ± 0.06b 16.66 ± 0.06 52.46 ± 0.18 
 P-value 
 <0.001 <0.001 0.012 0.011 <0.001 <0.001 
         
c.2201+114_118 CGCAG/CGCAG 136 17.69 ± 0.14 3.18 ± 0.20a 21.73 ± 0.10a 14.72 ± 0.07a 17.06 ± 0.07 53.51 ± 0.21 
delCGCAG CGCAG/del 355 17.12 ± 0.08 4.34 ± 0.13b 21.50 ± 0.06ab 14.59 ± 0.04ab 16.88 ± 0.05 52.97 ± 0.13 
 del/del 192 16.74 ± 0.11 4.44 ± 0.17
b 21.35 ± 0.09b 14.45 ± 0.06b 16.66 ± 0.06 52.46 ± 0.18 
  P-value   <0.001 <0.001 0.012 0.011 <0.001 <0.001 
&KDSWHU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$WWKHOHYHORIQXFOHRWLGHVXEVWLWXWLRQVYDULDQWVZLWKVLPLODUJHQRW\SHIUHTXHQFLHV
XQVXUSULVLQJO\H[KLELWHGVLPLODUDVVRFLDWLRQVZLWKFDUFDVVWUDLWVDVWKHQXFOHRWLGHVZHUH
OLQNHGLQWKHFRQWLJXRXVYDULDQWVHTXHQFH7KHFRPPRQ&&&&DQG$$KRPR]\JRXV
JHQRW\SHVRIF&!7F&!7DQGF$!7UHVSHFWLYHO\ZHUHDVVRFLDWHG
ZLWKDNJLQFUHDVHLQKRWFDUFDVVZHLJKWDVZHOODVDQLQFUHDVHLQVKRXOGHUDQG
WRWDOOHDQPHDW\LHOGVZKHQFRPSDUHGWRWKHOHVVDEXQGDQW77JHQRW\SH7DEOH
1RRWKHUVLJQLILFDQWDVVRFLDWLRQVZHUHREVHUYHGIRUWKHUHPDLQLQJFDUFDVVWUDLWV
DOWKRXJKDWUHQGRIDVVRFLDWLRQZLWKLQFUHDVHGIDWGHSWKDQGGHFUHDVHGOHJDQGORLQ\LHOGV
ZHUHREVHUYHGIRUWKH77JHQRW\SH
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
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,QFUHDVLQJFRQVXPHUGHPDQGIRUTXDOLW\SURGXFWVSURPSWVWUDQVIRUPDWLRQLQWKHPHDW
LQGXVWU\,QWHUHVWLVWKHUHIRUHEHLQJGLUHFWHGWRZDUGVWKHLGHQWLILFDWLRQRIJHQHWLFPDUNHUV
WKDWFRXOGLPSURYHDQLPDOEUHHGLQJDQGPHDWSURGXFWLRQ,*)5LVDSULQFLSDOSDUWLFLSDQW
LQFUXFLDOSK\VLRORJLFDOSURFHVVHVVXFKDVJURZWKDQGPHWDEROLVPLQVKHHS
7KLVLVWKHILUVWUHSRUWRIDVVRFLDWLRQVEHWZHHQYDULDWLRQLQVKHHSJURZWKDQGFDUFDVVWUDLWV
DQGVHTXHQFHYDULDWLRQLQRYLQH,*)5IRUDIUDJPHQWVSDQQLQJSDUWRIH[RQDOORI
LQWURQDOORIH[RQDQGSDUWRIWKHLQWURQUHJLRQV1XFOHRWLGHVHTXHQFLQJUHYHDOHG
ILYHYDULDQWVDQGWHQQRYHOVHTXHQFHYDULDWLRQVLQWKLVUHJLRQ7KH$%JHQRW\SHZDVWKH
PRVWIUHTXHQWO\RFFXUULQJDFURVVWKH1=VKHHSEUHHGVH[DPLQHG,QWHUHVWLQJO\WKHKLJKHVW
IUHTXHQFLHVRIWKH%(JHQRW\SHZHUHIRXQGLQWKH&RUULHGDOHDQG0HULQREUHHGVWKXV
VXJJHVWLQJDSRVVLEOHEHQHILWWRZRROSURGXFWLRQ2EVHUYHGRQO\LQWKH3HUHQGDOHEUHHG
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the A9D9 genotype could be advantageous toward other desired traits of the breed, such as 
better foraging abilities and adaptability for hilly landscapes. 
The presence of the A9 variant was associated with faster-growing lambs that weighed 
more at tailing, weaning and slaughter; while lambs possessing the B9 and E9 variants had 
lower tailing and weaning weights, and also grew slower than their counterparts that did 
not have these variants. This is perhaps unsurprising, given that regulating growth is the 
primary function of IGF1R (Clemmons, 2009).  
The evolutionary conservation of mammalian IGF1R has been established in many studies. 
This notion is supported by findings from this study, as only four of the ten nucleotide 
variations detected were located within the coding region (exon 10 specifically), none of 
which resulted in amino acid changes. In addition, there were no nucleotide variations 
detected in the promoter and exon 15 regions of ovine IGF1R. This is consistent with the 
findings of Byun et al. (2012), who reported two nucleotide substitutions within an intron 
2/exon 3 fragment of ovine IGF1R, both of which did not result in amino acid changes.  
Through ligand binding (of IGF1, IGF2 or insulin), IGF1R signalling promotes cell 
proliferation and differentiation, inhibits apoptosis and ensures skeletal muscle 
maintenance (Florini et al., 1996; Girnita et al., 2014). In this context, IGF1R has been 
presumed to be a ‘house-keeping’ gene, and given the near-ubiquitous presence of the 
protein in cells and tissues, it would seem logical that the receptor would be subject of 
functional constraint. Changes in the primary amino acid sequence may lead to 
dysfunctionality, and hence any gene variation underpinning this would be selected 
against. Several reports in humans have demonstrated the grave clinical consequences of 
non-synonymous mutations within IGF1R, including growth retardation, poor brain and 
neuronal development, and metabolic disorders (Kawashima et al., 2005; Klammt et al., 
2011).  
The long-standing misconception that intronic and synonymous genetic variations that do 
not alter the amino acid sequence or reading frame of a protein are inconsequential or 
silent, has been debunked by various studies. The functional importance of introns is 
underscored by compelling evidence that genes containing introns are transcribed 10-100 
fold more efficiently than their intronless counterparts (Brinster et al., 1988; Le Hir et al., 
2003). Both synonymous and intronic variations can impact the rate and efficiency of 
transcription and translation, which in turn can affect protein folding, functionality and 
quantity (Barrett et al., 2012). The creation of rare codons by synonymous variations, for 
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which there are less available tRNAs, can also slow down translation (Sauna and Kimchi-
Sarfaty, 2011). Synonymous and non-coding variations may also have an impact by being 
linked to other potent variations elsewhere within the coding sequence or regulatory 
regions of a gene.  
Four synonymous substitutions, located in the exon 10 of ovine IGF1R, were reported in 
this study: c.2019C>T (p.Tyr673Tyr), c.2037C>T (p.Asp679Asp), c.2052G>A 
(p.Thr684Thr), and c.2133G>A (p.Ala711Ala), and they all showed significant association 
with growth and carcass traits in sheep. The AA genotype of c.2052G>A (p.Thr684Thr) 
was associated with lower fat thickness, and increased carcass weight and lean meat yield. 
The CC genotypes of c.2019C>T (p.Tyr673Tyr) and c.2037C>T (p.Asp679Asp) showed 
association with higher weaning weight and average daily weight gain. This is consistent 
with findings by (Szewczuk et al., 2013), where the GG genotype of a synonymous 
variation in the exon 12 of bovine IGF1R was associated with higher weaning weight in 
Angus beef cattle.  
In order for translation to occur, the transcribed mRNA must fold into a stable secondary 
structure – a process that can be hindered by non-coding nucleotide sequence variations. 
Irregular pre-mRNA splicing and relocation of the splice site may lead to the formation of 
a dysfunctional protein (Cartegni et al., 2002). Non-coding variations can also impair the 
cytosolic export and degradation of mRNA (Sauna and Kimchi-Sarfaty, 2011). Overall, it 
appears that because introns play such a crucial role in gene regulation, then the more 
complex an organism is, the higher the presence of non-coding DNA regions that can 
produce RNAs, as opposed to protein-coding regions (Barrett et al., 2012). 
The functional importance of introns was suggested by results of this study, as all four 
intron sequence variants were found to show association with growth and carcass traits in 
sheep. Most notably were the c.2201+28A>C and c.2201+114_118delCGCAG variants 
found in the intron 10 of IGF1R. The c.2201+114_118delCGCAG variant may account for 
the observed decrease in weaning and slaughter weights and growth rate with the B9 and E9 
variants, as both variants have the deletion. A9, on the other hand, possessed the CGCAG 
sequence. The presence of the homozygous ‘deletion’ genotype was found to be associated 
with an 8.7% decrease in the average daily gain of lambs. The presence of the del/del 
genotype in 28% of Romney lambs suggests that although this genotype is not ideal for 
lamb growth, it might be useful for other commercially desirable traits such as increased 
fertility, cold tolerance or immunity. 
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The C nucleotide of c.2201+28A>C was unique to variant E9, and thus it might account for 
the decrease in the leg, loin and total lean meat yields. Lambs possessing the CC genotype 
(in the form of E9E9), had the lowest total lean meat yield, and an increase in intermuscular 
fat when compared to other genotypes. This might explain the rarity of the E9E9 genotype, 
with it only being observed in three sheep breeds, and in no more than 5% of the 
population. In contrast, lambs possessing the A9 variant had leaner high-yielding carcasses, 
with less intermuscular fat. They also had a higher average daily gain. The finding that the 
A9 variant was the most common, suggests that it confers some advantage to the lambs.  
These findings are consistent with those of Proskura and Szewczuk (2014), where a 
g.195C>T transition in the intron 12 of IGF1R was found to be associated with body 
weight variation and average daily gain in Pomeranian coarse wool sheep. Similar studies 
confirming the effect of IGF1R variations on growth and performance traits of livestock 
have also been reported in cattle (Pereira et al., 2003; Szewczuk et al., 2013), buffalos (El-
Magd et al., 2013), pigs (Wang et al., 2006) and chickens (Lei et al., 2008). 
The conserved cleavage site that yields the α and β subunits of the mature IGF1R protein is 
encoded by exons 9 and 10 (Adams et al., 2000), where the nucleotide sequence variations 
reported in this study were located. Also encoded by exons 9 and 10 of IGF1R is the third 
repeat of the fibronectin type III (FnIII) domain – the largest and most common fibronectin 
subdomain. In IGF1R, the FnIII domain plays a crucial role in dimerisation, as cysteine 
residues within the domain form the disulphide bonds that connect the α and β subunits 
(Molina et al., 2000; Girnita et al., 2014). In addition to dimer cross-linking, the FnIII 
domain facilitates protein-protein interactions and ligand binding, and act as spacers that 
ensure the correct positioning and orientation of functionally important regions of IGF1R 
(Campbell and Spitzfaden, 1994; Ward et al., 2001). Therefore, alterations to this domain 
might not only impact the FnIII structure and function, but also engender flow-on effects to 
other regions of IGF1R. Potential changes to the α-β cleavage site and the linking 
disulphide bridges by the variations reported in this study, could result in either enhanced 
or impaired IGF-IGF1R signalling, thus ultimately promoting or inhibiting growth. This 
might explain why some of the detected nucleotide variants improved growth and muscle 
development, while others were inhibitory.  
The myostatin gene (MSTN), a negative regulator of muscle growth, is a notable example 
of how non-coding gene sequence variations can have significant effects on livestock 
production traits. In sheep, a c.*1232 G>A substitution in the 3’untranslated region of 
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In spite of the progress being made, research into GH was challenged by the disparity 
observed between its in vitro and in vivo effects. The accelerated somatic growth, bone 
formation and myogenesis observed with the in vivo administration of GH to GH-null 
mice, were not replicated in vitro in muscle and cartilage cell cultures, where the effects 
seemed to be more subtle and inconsistent (Isaksson et al., 1985; Waters, 2016). This 
finding led to the discovery of other circulating GH-dependent peptides in the mid-1900s; 
these being termed the somatomedins, or insulin-like growth factors (IGFs). They are 
known to mediate the biological effects of GH in vivo. Subsequent experiments, in which a 
combination of GH and somatomedins were administered in vitro, led to an increase in 
growth-associated parameters as might be expected in vivo, indicating that the 
somatomedins were crucial to GH function (Fryklund et al., 1974; Holder et al., 1981). It is 
now accepted that the two major plasma factors secreted by the liver upon GH stimulation 
are IGF1 and IGF2.  
As seen in Figure 5.1, GH is pleiotropic in nature, exerting multiple effects while being 
regulated by two other hormones: growth hormone releasing hormone (GHRH), the 
positive regulator, and somatostatin (SST), the negative regulator. 
Growth hormone is unique in that it is one of the few hormones capable of inducing 
somatic growth in a dose-dependent manner, as well as promoting both insulin-like and 
insulin-antagonistic actions, two diametrically opposed phenomena (Barta et al., 1981; 
Isaksson et al., 1985) (Figure 5.1). Various scientific experiments have established the 
stimulatory effects of GH on cells and tissues, including connective, lymphocyte, adipose 
and muscle tissues (Lesniak et al., 1974; Isaksson et al., 1985). Growth hormone secretion 
from the anterior pituitary gland is also pulsatile, and dependent upon biological maturity, 
exercise, nutrition, health status, gender, stress, and the stage of growth of the organism. 
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insulinaemia (Kopchick and Andry, 2000) (Figure 5.1). This insulin-counteracting effect of 
GH is thought to increase blood glucose levels in the event of hypoglycaemia, and occurs 
after the insulin-like effects are elicited.  
The GH-IGF signalling pathway or axis, plays a crucial part in the regulation of growth 
and the differentiation of the skeletal muscle. It reportedly mediates 50-70% of the effects 
of GH, as compared to the 30-50% brought about by direct stimulation via GHR 
(Rosenfeld, 2003; Rosenfeld, 2006). IGF1 stimulates the proliferation and differentiation 
of myoblasts and chondrocytes. It also promotes cell survival and inhibits apoptosis.  
In addition to somatic growth, GH regulates the metabolism of lipids, nitrogen, minerals, 
carbohydrates and proteins, liver detoxification via cytochrome P450 enzymes, cognitive 
and neuronal development, and synaptogenesis (Nyberg and Hallberg, 2013; Waters, 
2016). Cell-line studies have also demonstrated that GH can stimulate the differentiation of 
pre-adipose 3T3 cells into mature adipocytes, and chondrocyte proliferation without the 
help of an intermediator (Morikawa et al., 1982; Kopchick and Andry, 2000). Growth 
hormone is also critical for prenatal and postnatal immune system development, 
modulation and maintenance, including the development of the thymus and T-cell selection 
(Chen et al., 1998). The B-cells, T-cells and other lymphoid cells, have been shown to 
express a high-affinity GHR.  
Within cells of the immune system, GH is also reported to regulate the expression of 
cytokines and proto-oncogenes that are crucial for the proliferation and expansion of cells, 
such as c-fos and c-jun (Piechaczyk and Blanchard, 1994; Chen et al., 1998). This is 
possibly explained by the marked similarity between GHR, a type 1 cytokine receptor, and 
other cytokine receptors in the lymphopoietic system. Stress responses, neuropeptide 
activity, behaviour and emotion are some of the neuroendocrine actions modulated by GH 
effects in the amygdaloid and hypothalamic regions of the brain (Yoshizato et al., 1998; 
Kopchick and Andry, 2000).   
Given its importance in so many biological systems, it is unsurprising that multiple 
mechanisms exist to modulate GH activity. The synthesis and secretion of GH by pituitary 
somatotropes is positively regulated by the hypothalamic hormone, GH releasing hormone 
(GHRH), and the enteric hormone, ghrelin; while GH release is inhibited by somatostatin. 
GHRH binding to its receptor on the surface of somatotropes causes a surge in cAMP 
(cyclic adenosine monophosphate) levels, triggering the transcription factor, POU1F1, 
which in turn stimulates GH expression and release (Kopchick and Andry, 2000).  
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As with IGF1 and the IGFBPs, the bioavailability of GH and binding to its receptor is 
modulated by GH binding proteins (GHBPs). More than half of the plasma GH has been 
revealed to be bound to GHBP (Baumann, 1991). Considering the pulsatile nature of GH 
secretion, GHBPs are effective at storing GH during secretion spikes, and releasing them 
into the circulation when the levels are low, thus ensuring constant availability of 
circulating GH. The GHBPs form a complex with circulating GH preventing degradation 
by plasma proteases and prolonging the half-life of GH. The inhibitory actions of GHBPs 
can involve the sequestration of GH, preventing GH binding to its receptor, and the 
competitive binding of GHBP to GHR (Baumann, 1991; Kopchick and Andry, 2000). 
GHBPs are found in many tissues, including adipose, hepatic and muscle tissues.  
5.1.2 Growth hormone signalling 
The GHR is a transmembrane cytokine receptor induced by ligand-dependent dimerisation. 
Upon binding to two molecules of GHR, GH brings about dimerisation and the subsequent 
activation of the tyrosine kinase called Janus Kinase 2 (JAK2) (Argetsinger et al., 1993; 
Carter-Su et al., 1996) (Figure 5.2). The activated JAK2 in turn phosphorylates tyrosine 
residues within itself, and those present in the cytoplasmic domain of the associated GHR 
(Carter-Su et al., 2000). These phosphorylated tyrosine residues form high-affinity docking 
sites for a variety of signalling molecules, such as signal transducers and activators of 
transcription (STAT), and the adapter protein, SH2-containing collagen-related proteins 
(SHC), and the insulin substrates (IRS) 1 and 2 (Campbell, 1997).  
The STAT family of transcription factors (STAT 1, 3, 5a and 5b) are translocated to the 
nucleus where they stimulate the expression of the GH-dependent genes. Of particular 
significance is the stimulation of STAT-5b, which binds to specific recognition sequences 
to bring about the transcription of IGF1 (Chia, 2014). While IGF1 expression and secretion 
occur in various tissues, the liver is the major site of IGF1 synthesis.    
The SHC proteins activate the Ras-Raf-MEK-MAPK and ERK pathways, while IRS 
initiates the phosphatidyl inositol 3-kinase (PI3K)-Akt pathways (Argetsinger and Carter-
Su, 1996). These events initiate a downstream signalling cascade that leads to the release 
of various secondary messengers, and the ultimate regulation of cellular functions such as 
gene transcription, enzymatic action and metabolite transport (Campbell, 1997) (Figure 
5.2). These effectively mediate the function of GH in the regulation of body growth and 
cell metabolism. This type of signalling is observed in adipocytes, where direct binding of 
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Conventional views have long held that the GH-GHR signalling, which mediates the direct 
effects of GH, is confined solely to the plasma membrane. However, emerging evidence 
suggests that the GH-GHR complex is capable of nuclear translocation, where it can exert 
other biological functions. For example, Hainan et al. (2018) demonstrated the nuclear 
translocation of GH-GHR complexes in porcine liver cells. After GH ligand-binding and 
receptor activation is completed, the GH-GHR complex is internalised via either of two 
major pathways: clathrin-mediated endocytosis or caveolin-mediated endocytosis (Lobie et 
al., 1994a; van Kerkhof et al., 2001). The conventional view is that the internalised 
complex is marked for one of two fates: proteolytic degradation within the lysosomes, or 
targeted recycling back to the cell membrane to await subsequent signalling cycles. Recent 
studies have however led to an understanding that the internalised GH-GHR complex can 
still transmit signals from within whatever organelle that localisation has occurred, 
including the mitochondria, Golgi apparatus, endoplasmic reticulum, and even the 
cytoplasm (Lobie et al., 1994b; van Kerkhof et al., 2001; Hai-nan et al., 2019).  
The localisation of GH-GHR complexes in the nucleus has been described. Endosomal 
vesicles carrying the ligand-receptor complex are believed to dock on and fuse with the 
nuclear membrane, where they empty their contents into the nucleoplasm. In vivo and in 
vitro studies with rat liver models, have demonstrated that the localisation of GHR within 
the nucleus, can result in accelerated cell proliferation via the STAT and P13K/Akt 
pathways, and that this may ultimately progress to cancer formation (Conway-Campbell et 
al., 2007; Hainan et al., 2018). The intracellular nuclear signalling of the GH-GHR 
complex is also reported to result in growth promoting effects, including increased gene 
expression, protein synthesis and carbohydrate metabolism (Lobie et al., 1994b; Hainan et 
al., 2018) 
The ubiquitous distribution of GHR in many peripheral tissues including muscle, 
lymphopoietic tissues, liver, adipose tissue and bone, is testament to the diverse functions 
of growth hormone (Waters, 2016).  
5.1.3 Growth hormone structure 
Growth hormone is made up of 191 amino acids, encoded by a gene with five exons and 
four introns (Marques et al., 2006). The resulting GH polypeptide is arranged into four 
helices aligned in an up-up-down-down pattern that make up approximately half of the GH 
secondary structure. These helices are connected by non-helical loop regions (Kopchick 
and Andry, 2000). Hydrophobic residues within the GH core are responsible for 
Chapter 5: Variation in ovine GH and its association with growth and carcass traits in NZ sheep 
 
 84 
maintaining the stability of the four helices and for maintaining the secondary structure 
(Kopchick and Andry, 2000).   
Located around the 5’ UTR or promoter regions of the gene, there are regulatory sequences 
including TATAAA, at the -30 position, CATAAAT at -84, and a 41 bp sequence at -142, 
which is conserved in mammals (Byrne et al., 1987). The polyadenylation signal 
AATAAA is located at nucleotide 2734, along with a second polyadenylation site present 
at nucleotide 2758  (Byrne et al., 1987). The regions after the 5’ UTR encoding the GH N-
terminal (residues 1-44) have been associated with the modulation of carbohydrate 
metabolism. 
The anti-insulin-like or diabetogenic function of GH appears to be encoded by exon 3. 
Experiments with human GH variants, have demonstrated that variants where part of exon 
3 (amino acids 32-46) are deleted, do not exert insulin antagonistic actions, but are growth-
enhancing; while variants possessing exon 3 amino acids (32-70) are anti-insulin-like in 
action, and do not promote growth (Lewis et al., 1980; Barta et al., 1981). Disulphide 
bridges between Cys53 and Cys164 in exon 3 and exon 5 respectively, and Cys181 and 
Cys189 (both in exon 5) of GH are crucial to the structure of the mature peptide and its 
growth-enhancing function (Lewis et al., 1980; Barta et al., 1981; Kopchick and Andry, 
2000). These four cysteine residues, although in slightly different locations, are conserved 
across many species (Kopchick and Andry, 2000).  
Human GH exists in multiple protein isoforms, the two most common of which are 22 kDa 
and 20 kDa in size that are brought about by the alternative splicing of a common mRNA. 
The 22 kDa isoform is more abundant in circulation and is 191 residues in length. Removal 
of amino acids 32-46 yields the 20 kDa isoform of length 176 residues (Baumann, 1991; 
Hai-nan et al., 2019). Potency-wise, both isoforms are mostly equivalent in how they exert 
biological functions such as growth-promoting effects, and both bind with similar affinities 
to GHR (Wada et al., 1998). However, studies in rats revealed that they differ in their 
effects on water retention and diabetogenic properties, with the 22 kDa having greater 
diabetogenic effects (Satozawa et al., 2000; Takahashi et al., 2001). This comes as no 
surprise, since the 20 kDa isoform lacks a significant portion of the exon 3 region that 
encodes amino acids creating the anti-insulin-like properties. 
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5.1.4 Growth hormone gene duplication 
Growth hormone is considered to be part of a family of proteins (Kannian and Ryan, 
2019). The family consists of three related proteins, namely GH, prolactin (PRL), and a 
placental hormone called placental lactogen (PL) (Barta et al., 1981; De Vos et al., 1992). 
All three are endocrine hormones, and they share several common features including 
having analogous protein structures and sizes (190-199 amino acids), being produced by 
genes that contain four introns, with exon-intron boundaries that occur in similar locations. 
The hormones can affect growth and lactogenesis, and each has an important tryptophan 
residue between amino acids 85-95 (Barta et al., 1981; Miller and Eberhardt, 1983). This 
similarity has led to the belief that the hormones in the GH family share a common 
ancestral precursor gene, which may have evolved to produce the observed genetic 
diversity by means of gene duplication, potentially as a consequence of unequal crossing-
over events (Barta et al., 1981; Miller and Eberhardt, 1983).  
The discovery of a repetitive DNA element within the nucleotide sequence of GH supports 
this theory. This pattern of genetic evolution is by no means uncommon for mammalian 
genes, and it has been suggested as the origin of human β-globin and human insulin gene 
families (Bell et al., 1980; Efstratiadis et al., 1980).  
Duplication of entire genes and even genomes are not unheard of, and can arise by 
molecular interactions such as unequal crossing over, retroposition, and recombination 
(Ohta, 1987; Ohno, 1999; Gu et al., 2004). As long as a single gene locus controls a 
particular function in an organism and natural selection limits the accumulation of 
nucleotide variation (or mutation), functionality is maintained. The duplication of a gene 
could therefore, produce a ‘redundant’ gene locus with more freedom to accumulate 
sequence variation and possibly bring about phenotypic novelty. The accumulation of 
sequence variation could either be a deleterious mutation resulting in the failure to produce 
a protein, or bring about the emergence of a new and different function, or a different 
regulatory mechanism (Wapinski et al., 2007).  
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Despite their similarities, GH2-N and GH2-Z have been reported to exhibit certain 
differences, and are predominantly expressed in different organs; the pituitary gland for 
GH2-N and the placenta for the GH2-Z (Gootwine et al., 1996; Lacroix et al., 1996). The 
different ovine GH have sequence differences with some variations present in one and 
absent in the others, as well as having different receptor-binding affinities for their 
polypeptide products. It has been suggested that sequence divergence in duplicated genes 
impacts regulatory control, rather than biological function (Wapinski et al., 2007). 
The occurrence of these GH structures in sheep and goats, but not cattle, suggests their 
creation must have occurred in the Caprinae family after separation from the bovine 
species, but prior to the divergence of sheep and goats (Ofir and Gootwine, 1997). 
5.1.6 Growth hormone gene variation 
Growth hormone deficiency (GHD) is a broad term referring to conditions characterised by 
a low level of circulating GH. It can be an isolated event called isolated GH deficiency 
(IGHD), or part of a series of growth-related syndromes called combined pituitary 
hormone deficiencies (CPHD) (Cogan et al., 1993).  
In humans, nucleotide sequence variations resulting in GH deficiency have been associated 
with dwarfism, congenital malformation and diabetes; while sequence variations causing 
excessive GH production have been linked to acromegaly and gigantism (Giustina et al., 
2008; Renehan and Brennan, 2008). For example, in one study, Egyptians that presented 
with short stature and isolated growth hormone deficiency were found to have an A to T 
nucleotide substitution in intron 4 of GH (Esmaiel et al., 2019). 
The functional consequences of GH sequence variation have been documented in livestock 
(Ge et al., 2003). Marques et al. (2006) detected 24 single nucleotide variations in 
GH1/GH2-N, and 13 single nucleotide variations (12 coding and one non-coding) in GH2-
Z, in the Serra da Estrela sheep breed. The variations observed in GH2-Z were unique to 
that gene, whereas similar nucleotide sequence variations were reported to be present in 
when comparing the GH1 and GH2-N genes (Marques et al., 2006). This suggest that GH1 
and GH2-N likely constitute a paired loci. 
Vacca et al. (2013) reported five nucleotide sequence variations located in the 5’ UTR and 
promoter regions of GH2-Z, and a nucleotide insertion in the 3’ UTR region. These 
variations brought about putative changes in binding site conformation and the sequence of 
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enhancers and transcription factor-binding elements, which may influence the regulation of 
gene expression (Vacca et al., 2013).  
Five variations found to be associated with body length, height and weight were reported 
in Chinese Tibetan sheep, including a single T nucleotide insertion in the 3’ UTR  (Jia et 
al., 2014). Similar associations with growth traits such as birth weight and body weight at 
six months and nine months of age, were reported with two ovine GH genotypes, G1 and 
G2, in Iranian Baluchi sheep (Tahmoorespur et al., 2011). 
The GH genes have also been found to have nucleotide sequence variability in other 
livestock breeds, such as goats and cattle. Gupta et al. (2007) found several variations in 
exon 4 of GH in Black Bengal goats, including an arginine to histidine substitution, an 
aspartic acid to valine substitution, an arginine to tryptophan substitution, and an arginine 
to proline substitution.  
In the exon 3 of caprine GH, amino acid substitutions of glycine to serine, and arginine to 
tryptophan, caused by C to T nucleotide transition; and in exon 5, a proline to histidine 
substitution caused by a C to A nucleotide transversion, were thought to affect the structure 
and function of caprine GH, and revealed to be associated with growth traits in Chinese 
goat breeds (An et al., 2010). Variants FF and AA in exon 4 and exon 5 of caprine GH, 
were found to be associated with increased milk yield, and milk protein and fat content in 
goats (Malveiro et al., 2001). 
In cattle, an A to C transversion in the exon 5 of bovine GH, and a T to C transition in 
intron 3 in Holstein-Friesian bulls were found to be associated with milk production traits 
(Yao et al., 1996). Variations in the promoter region of bovine GH were found to be 
associated with carcass weight, rib thickness and milk fat content in Japanese Black cattle 
(Sugita et al., 2014), and associations with milk production have also been reported in 
Simmental cattle, where the BB genotype of bovine GH was linked with higher milk yield 
and milk protein when compared to the AA and AB genotypes (Falaki et al., 1997). 
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The genomic DNA from the FTA blood samples was purified using a two-step procedure. 
This involved a cell and protein denaturation with 20 mM NaOH at 60 ºC heat for 30 min, 
and subsequent washing with 1 × TE buffer for 5 min, as outlined by Zhou et al. (2006).  
5.2.2 Primer design and PCR analysis 
A 560 bp fragment (primer inclusive) of ovine GH spanning part of exon 2, all of intron 2 
and part of exon 3, was amplified using a pair of primers: forward primer was 5’-
GCCCTCCTGGTCTCTCCC-3’ and the reverse primer was 5’-
GTCCCCTGCTCCTCGGTC-3’. Due to the unique nature of ovine GH, the primers 
designed were based on ovine GH nucleotide sequences obtained from the NCBI database, 
with accession numbers: DQ450147.1 (GH1), KU341778.1 (GH2), AH005493.2 (GH2-N) 
and DQ461615.1 (GH2-Z). BLAST comparisons between these database sequences 
revealed high homology across the different GH loci. The primers used in this study were 
then designed using the DNAMAN software version 5.2.10 (Lynnon BioSoft, Vaudreuil, 
Canada).  
The ideal PCR and SSCP conditions for each primer set were established empirically 
following multiple optimisation experiments. For a start, PCR optimisations entailed low 
stringency PCR with standard temperatures and reagent concentrations. The annealing 
temperature was subsequently raised in stepwise increments of 1 ºC until a single band was 
observed on agarose gel electrophoresis. This was done to curb non-specific amplification. 
Similar increments in a stepwise fashion were employed to the reagents used until the best 
results were obtained. 
PCR amplifications were performed in 15-µL reactions containing the purified genomic 
DNA on a 1.2 mm diameter disc of FTA, 0.25 µM of each primer, 150 µM of each dNTP 
(Eppendorf, Hamburg, Germany), 1.5 mM Mg2+, 0.5 U Taq DNA polymerase (Qiagen, 
Hilden, Germany), and 1 × the reaction buffer supplied with the enzyme. Amplifications 
were undertaken in Bio-Rad S1000 thermal cyclers (Bio-Rad, Hercules, CA, USA). The 
thermal profile entailed an initial denaturation at 94 ºC for 2 mins, followed by 39 cycles of 
94 ºC for 30 s, annealing at 62 ºC for 50 s, and extension at 72 ºC for 40 S, and a final 
extension step at 72 ºC for 5 min.   
Subsequent visualisation of the amplicons from the PCR reaction were carried out by 
means of agarose gel electrophoresis using 1% agarose (Quantum Scientific, Queensland, 
Australia) gels containing 1 × TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM 
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Na2EDTA), 200 ng/mL ethidium bromide. 2 µL aliquots of the PCR products were mixed 
with 2 µL of loading dye (0.2% bromophenol blue, 0.2% xylene cyanol, 40% (w/v) 
sucrose), and loaded into the gels that were run at a constant 5 V/cm for 2 hours. After 
electrophoresis, the gels were visualised using ultraviolet transillumination at 254 nm. 
5.2.3 Single-stranded conformational polymorphism (SSCP) analyses 
Optimisations for SSCP involved running amplicons at various conditions and using 
different gel compositions until consistently clear banding patterns were obtained. 
Following PCR, 0.7 µL of each PCR product was mixed with 7 µL of loading dye (98% 
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol). The 
samples were denatured at 105 ºC for 5 min, snap-chilled on ice, and 8 µL of each sample 
was loaded into 16 x 18 cm, 10% acrylamide:bisacrylamide (37.5:1, Bio-Rad) gels in 
Protean II xi cells (Bio-Rad). The samples were run at a voltage of 320 V at 20 ºC for 18 
hours. Silver-staining of the gels was performed according to the method described by 
Byun et al. (2009). Briefly, the gels were silver-stained with silver nitrate, washed with 
distilled water, and subsequently developed using a solution containing sodium hydroxide 
and 40% formaldehyde. 
In order to ensure the integrity of the experiments and to obtain reproducible banding 
patterns, freshly prepared PCR and SSCP products were always used. A negative control 
well containing no DNA was also run with each series of amplifications. 
5.2.4 Nucleotide sequencing and genotyping 
Following PCR-SSCP analysis, the banding patterns in the gels were observed. Amplicons 
deemed to be homozygous were sequenced in the forward and reverse directions using 
capillary sequencing at the Lincoln University DNA Sequencing Facility. For patterns that 
appeared to be heterozygous, single bands of non-homozygous samples were excised from 
the SSCP gel, washed repeatedly, and genomic DNA extracted. The resulting homozygous 
DNA was re-amplified, and then sequenced. Reactions were replicated to ensure accuracy 
and prevent PCR and sequencing errors. 
Sequence alignments, translations and comparisons were carried out using DNAMAN 
version 5.2.10 (Lynnon BioSoft, Vaudreuil, Canada). The BLAST algorithm 
(http://blast.ncbi.nlm.nih.gov/) was used to search the NCBI GenBank and Ensembl 
databases for homologous sequences in various species. 
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5.2.5 Statistical analyses 
IBM SPSS Statistics (Version 23, IBM, NY, USA) was used to perform all analyses. Trait 
data normality was tested using the Shapiro-Wilk test and Normal Q-Q plots. Variant and 
genotypic frequencies were calculated using the PopGene 3.2 software. The variant 
frequencies were then tested for deviation from Hardy-Weinberg equilibrium using a Chi-
square test available on the Online Encyclopedia for Genetic Epidemiology Studies 
(OEGE) (Rodriguez et al., 2009).  
Prediction of the effect of nucleotide variations on protein stability and function was 
performed using a variety of online software to ensure reliability, including SIFT (Ng and 
Henikoff, 2003), PROVEAN (Choi et al., 2012), HOPE (Venselaar et al., 2010), MuPro 
(Cheng et al., 2006), and iMutant 2.0 (Capriotti et al., 2005). Changes in protein stability 
were predicted using delta delta G (ΔΔG) in Kcal/mol, which refers to a change in the 
Gibbs free energy between folded and unfolded states of the wild-type and variant protein 
sequences. The analyses were carried out on the assumptions that temperature was 25 °C 
and pH was 7.0. 
The strength of relationships between the different traits was assessed using Pearson 
correlation coefficients. A Bonferroni correction was applied to the analyses. The growth 
traits investigated were birth weight, tailing weight, weaning weight, and growth rate-to-
weaning. The carcass traits investigated were hot carcass weight (HCW), fat depth at the 
12th rib (V-GR), hind-leg lean meat yield, loin lean meat yield, shoulder lean meat yield, 
and total carcass lean meat yield. 
Two sets of general linear mixed-effect models (GLMMs) were carried out. The first 
model was used to investigate the effect of the presence and absence (coded as 1 and 0 
respectively) of a specific variant on growth and carcass traits, while the second model 
assessed associations between the genotypes for each nucleotide substitution and growth 
and carcass traits.  
The statistical model used was:  
      Yijkl = µ + Si + Gj + Bk + Vl + eijkl     
where: 
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Yijkl is the trait measured on each animal (birth, tailing and weaning weights,  
                 growth-rate, HCW, V-GR, and leg, loin, shoulder, and total lean meat yields) 
µ is the mean for the trait 
Si is the random effect of sire 
Gj is the fixed effect of gender 
Bj is the fixed effect of birth rank 
Vl  is the fixed effect of variant (presence or absence) or genotype 
eijkl is the random residual error 
 
Gender was fitted as a fixed factor, and sire as a random factor in all growth trait models. 
For the growth trait models assessing the relationship between nucleotide genotype (or the 
presence/absence of a sequence variant) and tailing and weaning weights, the age at tailing 
and weaning were fitted as covariates respectively, as variation in age at measurement 
could potentially influence these traits.  
In order to account for the effect of prenatal growth and development, birth weight (which 
had a bigger effect than birth rank) was fitted as a covariate in models assessing the 
relationship between nucleotide variant genotype or the presence/absence of a sequence 
variant, and growth rate-to-weaning. Rearing rank, which is reflective of maternal 
influence was shown to have an effect, and hence was corrected for in growth rate models.  
For all carcass trait models, genotype was fitted as a fixed factor, and sire as a random 
factor, while birth weight and slaughter age in days were fitted as covariates, so as to 
correct for the effect of prenatal muscle development and the variation in the age of the 
lambs at slaughter respectively. Gender was not corrected for in any of the carcass trait 
models, as only ram lambs were sent for slaughter. 
The variant model was run in two phases. Firstly, a single variant model assessing the 
unilateral effect of variant presence/absence on individual traits was run. If a significant 
trend was observed (P < 0.2, the threshold for inclusion), then a subsequent multi-variant 
model investigating the effect of the presence/absence of a variant, within the context of 
the effect of the other variants, was performed. 
Values from the GLMM pairwise comparison was presented as estimated marginal means 
± standard error (mean ± SE). Unless otherwise specified, statistical significance was 
declared at P < 0.05, and trends were observed at P < 0.2. 
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)LJXUH+RPR]\JRXVDQGKHWHUR]\JRXV3&566&3SDWWHUQVGHWHFWHGIRURYLQH*+
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RIWKHIROORZLQJJHQHWLFFRPELQDWLRQV*+*+RU*+*+1RU*+1*+1
6SHFLILFGHWHUPLQDWLRQRIZKHWKHU*+RU*+1ZDVEHLQJDPSOLILHGFRXOGRQO\EH
DFKLHYHGE\WKHDPSOLILFDWLRQRIDIUDJPHQWVSDQQLQJDPXFKODUJHUUHJLRQRIWKHJHQH
SRWHQWLDOO\!NE±WZLFHWKHGLVWDQFHEHWZHHQ*+1DQG*+=ZKLFKZDVQRW
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 6HTXHQFHDOLJQPHQWRI*+'1$DQGSURWHLQVHTXHQFHV
6HTXHQFHDOLJQPHQWVRIWKHQXFOHRWLGHVHTXHQFHVRIWKHVHYHQ*+YDULDQWVDUHSUHVHQWHGLQ
)LJXUH
Template    tagGCCCCCGGACCTCCCTGCTCCTGGCTTTCACCCTGCTCTGCCTGCTC     50 
Variant_A3  --------------------------------------------------     50 
Variant_B3  ------------------------------------------------C-     50 
Variant_C3 ------------------------------------------------C- 50
Variant_D3  ------------------------------------------------C-     50 
Variant_E3  ------------------------------------------------C-     50 
Variant_F3  ----------------------------------------T---------     50 
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Variant_G3  ------------------------------------------------C-     50 
 
Template    TGGACTCAGGTGGTGGGCGCCTTCCCAGCCATGTCCTTGTCCCGCCTGTT    100 
Variant_A3  ------------------------------------------G-------    100 
Variant_B3  ------------------------------------------G-------    100 
Variant_C3  ------------------------------------------G-------    100 
Variant_D3  ------------------------------------------G-------    100 
Variant_E3  --------------------------------------------------    100 
Variant_F3  ------------------A-------------------------------    100 
Variant_G3  ------------------------------------------G-------    100 
 
Template    TGCCAACGCTGTGCTCCGGGCTCAGCACCTGCATCAACTGGCTGCTGACA    150 
Variant_A3  --------------------------------------------------    150 
Variant_B3  --------------------------------------------------    150 
Variant_C3  --------------------------------------------------    150 
Variant_D3  --------------------------------------------------    150 
Variant_E3  --------------------------------------------------    150 
Variant_F3  --------------------------------------------------    150 
Variant_G3  --------------------------------------------------    150 
 
Template    CCTTCAAAGAGTTTgtaagctccccagagatgtgtcctagaggtggggag    200 
Variant_A3  --------------------------------------------------    200 
Variant_B3  --------------------------------------------------    200 
Variant_C3  --------------------------------------------------    200 
Variant_D3  --------------------------------------------------    200 
Variant_E3  --------------------------------------------------    200 
Variant_F3  --------------------------------------------------    200 
Variant_G3  --------------------------------------------------    200 
 
Template    gcaggaagggatgaatccgcaaccc.tccacacaatgggagggaactgag    249 
Variant_A3  ----------g----------c---c------------------------    250 
Variant_B3  ----------g----------c---c------------------------    250 
Variant_C3  ----------g------t---c---c---------c--------------    250 
Variant_D3  ----------g----------c---c------------------------    250 
Variant_E3  ----------g----------c---c------------------------    250 
Variant_F3  ----------g----------c---c------------------------    250 
Variant_G3  ----------g----------c---c------------------------    250 
 
Template    gacctcagtggtattttatccaagtaaggatgtggtcaggggagtagaaa    299 
Variant_A3  --------------------------------------------------    300 
Variant_B3  --------------------------------------------------    300 
Variant_C3  ----------------------------a---------------------    300 
Variant_D3  --------------------------------------------------    300 
Variant_E3  --------------------------------------------------    300 
Variant_F3  ---------------------------------------------g----    300 
Variant_G3  --------------------------------------------------    300 
 
Template    tgggggtgtgtggggtggggagggttccgaataaggcagtgaggggaacc    349 
Variant_A3  --------------------------------------------------    350 
Variant_B3  --------------------------------------------------    350 
Variant_C3  --------------------------------------------------    350 
Variant_D3  --------------------------------------------------    350 
Variant_E3  --------------------------------------------------    350 
Variant_F3  --------------------------------------------------    350 
Variant_G3  --------------------------------------------------    350 
 
Template    ccgcaccagctgagacctgggtgggtgtgttctccccccagGAGCGCACC    399 
Variant_A3  --------------------------------------------------    400 
Variant_B3  --------------------------------------------------    400 
Variant_C3  a-------------------------------------------------    400 
Variant_D3  ---------------------------------------------A----    400 
Variant_E3  --------------------------------------------------    400 
Variant_F3  --------------------------------------------------    400 
Variant_G3  -----------t--------------------------------------    400 
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Template    TACATCCCGGAGGGACAGAGATACTCCATCCAGAACACCCAGGTTGCCTT    449 
Variant_A3  --------------------------------------------------    450 
Variant_B3  --------------------------------------------------    450 
Variant_C3  --------------------------------------------------    450 
Variant_D3  --------------------------------------------------    450 
Variant_E3  --------------------------------------------------    450 
Variant_F3  --------------------------------------------------    450 
Variant_G3  --------------------------------------------------    450 
 
Template    CTGCTTCTCTGAAACCATCCCAGCCCCCACGAGCAAGAATGAGGCCCAGC    499 
Variant_A3  ---------C-----------G---------G------------------    500 
Variant_B3  ---------C-----------G---------G------------------    500 
Variant_C3  ---------C-----------G---------G------------------    500 
Variant_D3  ---------C---------------------G------------------    500 
Variant_E3  ---------C---------------------G------------------    500 
Variant_F3  ---------C-----------G---------G------------------    500 
Variant_G3  ---------C---------------------G------------------    500 
 
Template    AGAAATCAGTGAgtggccacctag                              523 
Variant_A3  ------------------------                              524 
Variant_B3  ------------------------                              524 
Variant_C3  ------------------------                              524 
Variant_D3  ------------------------                              524 
Variant_E3  ------------------------                              524 
Variant_F3  ------------------------                              524 
Variant_G3  ------------------------                              524 
 
Figure 5.6 Sequence alignment of the GH variants  
An alignment of the seven GH variants was undertaken using the DNAMAN software. 
Bars (-) denote nucleotides identical to the ovine GH sequence, while dots (.) denote 
missing nucleotides. The 524 bp region presented does not include the primer sequences. 
The ovine template sequence was obtained from GenBank (accession number DQ461615). 
 
The nucleotide sequence alignment revealed coding and non-coding sequence variation in 
the GH variants (Figure 5.6). Subsequent alignment of the putative protein sequences of 
the GH variants, including a comparison with other mammalian species, revealed several 
non-synonymous amino acid changes (Figure 5.7). 
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A3       GPRTSLLLAFTLLCLLWTQVVGAFPAMSLSGLFANAVLRAQHLHQLAADTFKEFERT   5-61 
B3       ---------------p-----------------------------------------   5-61 
C3       ---------------p-----------------------------------------   5-61 
D3       ---------------p---------------------------------------h-   5-61 
E3       ---------------p--------------r--------------------------   5-61 
F3       ----------------------t-------r--------------------------   5-61 
G3       ---------------p-----------------------------------------   5-61 
SHEEP    GPRTSLLLAFTLLCLLWTQVVGAFPAMSLSRLFANAVLRAQHLHQLAADTFKEFERT   5-61 
HUMAN    -s--------g----s-l-egs---tip-----d--m---rr-y---y--yq---ea   5-61 
GOAT     ---------------p--------------g--------------------------   5-61 
COW      ----------a----p--------------g--------------------------   5-61 
PIG      -----v----a----p---e-------p--s-------------------y-----a   5-61 
DOG      s--n-v----a----p-p-e-------p--s-------------------y-----a   5-61 
RAT      dsq-pw--t-s------p-ea--l---p--s-------------------y-----a   5-61 
MOUSE    ds---w--tvs------p-eas-----p--s--s----------------y-----a   5-61 
 
 
A3       YIPEGQRYS.IQNTQVAFCFSETIPAPTGKNEAQQKS            62-97 
B3       ---------.---------------------------            62-97 
C3       ---------.---------------------------            62-97 
D3       ---------.---------------------------            62-97 
E3       ---------.---------------------------            62-97 
F3       ---------.---------------------------            62-97 
G3       ---------.---------------------------            62-97 
SHEEP    YIPEGQRYS.IQNTQVAFCFSETIPAPTSKNEAQQKS          62-97 
HUMAN    --lke-k--fl--p-tsl----s--t-snrvkt----            62-98 
GOAT     ---------.------------------g--------            62-97 
COW      ---------.------------------g--------            62-97 
PIG      ---------.---a-a------------g-d----r-            62-97 
DOG      ---------.---a-a------------g-d----r-            62-97 
RAT      ---------.---a-a------------g-e----rt            62-97 
MOUSE    ---------.---a-a------------g-e----rt            62-97 
  
Figure 5.7 Alignment of the putative protein sequences of ovine GH with other 
related species 
Alignment was performed using the DNAMAN software across (a) the seven variants of 
ovine GH, starting from amino acid p.5 and ending at p.97, as well as (b) across different 
mammalian species. Bars (-) denote amino acids identical to the sheep GH protein 
sequence, while dots (.) denote missing amino acids. The amino acid sequences were 
derived from GenBank DNA sequences with the following accession numbers: Human, 
Homo sapiens (AY890602); Sheep, Ovis aries (DQ461615); Goat, Capra hircus 
(GU355687); Cow, Bos taurus (KP221576); Pig, Sus scrofa (AY536527); Dog, Canis 
familiaris (AF069071); Rat, Rattus norvegicus (U62779) and Mouse, Mus musculus 
(NM_008117.3). A3, B3, C3, D3, E3, F3 and G3 depict amino acid sequences obtained from 
the putative translation of the variant DNA sequences reported in this study. 
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5.3.3 Diversity in ovine GH 
The arrangement of the nucleotide substitutions across the seven haplotypes is summarised 
in Table 5.1.  
Table 5.1 Nucleotide substitutions and haplotypes detected in a fragment spanning 
exon 2, intron 2 and intron 3 of ovine GH 
                                Haplotype 
          Variant 
 A3 B3 C3 D3 E3 F3 G3 
Region H1 H2 H3 H4 H5 H6 H7 
1 c.51C>T (p.Leu17Leu) Exon 2 C C C C C T C 
2 c.59C>T (p.Pro20Leu) Exon 2 T C C C C T C 
3 c.79G>A (p.Ala27Thr) Exon 2 G G G G G A G 
4 c.103G>C (p.Gly35Arg) Exon 2 G G G G C C G 
5 c.174+58A>C Intron 2 c c t c c c c 
6 c.174+72T>C Intron 2 t t c t t t t 
7 c.174+115G>A Intron 2 g g a g g g g 
8 c.174+132A>G Intron 2 a a a a a g a 
9 c.174+187C>A Intron 2 c c a c c c c 
10 c.174+198G>T Intron 2 g g g g g g t 
11 c.179G>A (p.Arg60His) Exon 3 G G G A G G G 
 
Four amino acid substitutions were predicted based on the nucleotide variations found in 
the exon 2 of ovine GH: c.51C>T (p.Leu17Leu), c.59C>T (p.Pro20Leu), c.79G>A 
(p.Ala27Thr), and c.103G>C (p.Gly35Arg). All of these were non-synonymous, except for 
c.51C>T (p.Leu17Leu). The variation c.179G>A (p.Arg60His) was the only amino acid 
variation revealed in exon 3 (Table 5.1). Predictions of the effects of putative amino acid 
substitutions on GH protein stability are summarized in Table 5.2. 
Table 5.2 Protein stability prediction for missense variations in ovine GH 
 
  
GH missense variant Region 
iMutant ΔΔG 
(Kcal/mol) 
muPRO ΔΔG 
(Kcal/mol) 
Effect on protein 
stability 
c.59C>T (p.Pro20Leu) Exon 2 -1.19 -2.19 Decrease 
c.79G>A (p.Ala27Thr) Exon 2 -1.33 -0.89 Decrease 
c.103G>C (p.Gly35Arg) Exon 2 -0.84 -0.37 Decrease 
c.179G>A (p.Arg60His) Exon 3 -1.00 -1.11 Decrease 
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In all four detected non-synonymous GH variations, the ΔΔG value was negative. This 
means that the resulting putative amino acid change was predicted to bring about decreased 
GH protein stability (Table 5.2). These results were consistent across all other protein 
prediction software used.  
The variant genotype frequencies for ovine GH across the ten NZ breeds examined are 
given in Table 5.3. 
 
Table 5.3 Frequencies of ovine GH variant genotypes in different sheep breeds 
  GH variant genotype frequencies 
Breed n A3A3 A3B3 A3C3 A3D3 A3E3 A3F3 A3G3 B3B3 B3D3 B3E3 C3C3 C3E3 
Romney 766 62.9 22.1 3.9 _ _ 11.1 _ _ _ _ _ _ 
Coopworth 32 68.7 6.3 25.0 _ _ _ _ _ _ _ _ _ 
Corriedale 30 70.0 26.7 _ _ _ 3.3 _ _ _ _ _ _ 
Dorset Down 30 43.3 13.4 43.3 _ _ _ _ _ _ _ _ _ 
Merino 58 15.5 5.2 19.0 _ _ 55.2 _ 1.7 1.7 _ 1.7 _ 
Perendale 62 22.6 32.3 37.1 1.6 3.2 _ _ _ _ 1.6 _ 1.6 
Poll Dorset 31 51.6 35.5 _ _ _ 12.9 _ _ _ _ _ _ 
Suffolk 30 63.3 _ 26.7 _ _ 10.0 _ _ _ _ _ _ 
Texel 32 75.0 _ 9.4 _ _ 15.6 _ _ _ _ _ _ 
White 
Dorper 
72 13.9 52.7 29.2 _ 1.4 _ 1.4 _ _ 1.4 _ _ 
              
Total 1143             
 
 
Different GH genotype combinations were present in varying proportions across the ten 
examined NZ sheep breeds. Some rare genotypes were peculiar only to certain breeds: 
A3D3 (Perendale), A3G3 (White Dorper), B3B3 (Merino), B3D3 (Merino), C3C3 (Merino) and 
C3E3 (Perendale). The A3A3 was the most predominant GH genotype across NZ sheep 
breeds, with the highest frequency (75%) observed for the Texel breed, and the lowest 
frequencies observed for the White Dorper (13.9%) and Merino (15.5%) breeds 
respectively (Table 5.3).  
5.3.4 Variant and nucleotide substitution frequencies 
The A3 variant was observed in every Romney lamb investigated, and hence it had a 
frequency of 100%, while B3, C3 and F3 variants occurred at frequencies of 22%, 4% and 
11% respectively. In the NZ Romney breed, A3 was the only variant observed in a 
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ZKLOHWKHRWKHUYDULDQWVDOZD\VH[LVWHGLQDKHWHUR]\JRXV
FRPELQDWLRQZLWK$QDPHO\$%$&DQG$)
 
)LJXUH3LHFKDUWRI*+JHQRW\SHIUHTXHQFLHVLQWKH1=5RPQH\VKHHS

7KHYDULDQWJHQRW\SH$$ZDVWKHPRVWFRPPRQEHLQJREVHUYHGLQPRUHWKDQKDOI
RI1=5RPQH\ODPEVIROORZHGE\$%DQG$))LJXUH7KH$&
JHQRW\SHKDGWKHORZHVWIUHTXHQF\LQ5RPQH\ODPEVDQGKHQFHLWZDVQRWLQFOXGHG
LQIXUWKHUDQDO\VHVDVLWZDVORZHUWKDQWKHVWDWLVWLFDOFXWRIIIRUDQDO\VLV$FFRUGLQJO\
WKHORFLFRQVLGHUHGLQQXFOHRWLGHVXEVWLWXWLRQJHQRW\SHDQDO\VHVZKHUHRQO\WKRVHWKDW
GLIIHUHGEHWZHHQWKH$%DQG)YDULDQWVQDPHO\F&!7F&!7F*!$
F*!&DQGF$!*7DEOH
$VVKRZQLQ7DEOHDOOWKHDIRUHPHQWLRQHGYDULDQWVH[FHSWIRUF&!7KDYHDVLPLODU
JHQRW\SHIUHTXHQF\SDWWHUQZKHUHWKHPDMRUQXFOHRWLGHZDVSUHVHQWLQRIWKH
SRSXODWLRQZKLOHRQO\RISRSXODWLRQSRVVHVVHGWKHPLQRUQXFOHRWLGH7KHPDMRU
KRPR]\JRXVJHQRW\SHZDVUHSRUWHGLQRIDOOODPEVZKLOHWKHKHWHUR]\JRXVIRUPZDV
IRXQGLQDQGWKHPLQRUKRPR]\JRXVQXFOHRWLGHZDVQRWUHSRUWHGDWDOO
7KHJHQRW\SHDQGQXFOHRWLGHIUHTXHQFLHVIRUWKH*+VXEVWLWXWLRQVDUHJLYHQLQ7DEOH
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Table 5.4 Nucleotide and genotype frequencies for ovine GH variations 
 
1 HWE = Hardy-Weinberg Equilibrium 
 
 
Notably, at all variant loci, the minor homozygous genotypes had frequencies of 0% as 
they were not detected in any lamb; as a result, these minor genotypes were excluded from 
further analyses. For the c.59C>T, C was the minor nucleotide occurring in about 13% of 
the lambs, while the more abundant T nucleotide occurred in 87% of lambs, and its 
homozygous form TT occurred in 74% of the lambs investigated (Table 5.4). The c.59C>T 
variation was the only one found to deviate from Hardy-Weinberg Equilibrium.  
 
 
 
  
Variant Nucleotide 
Nucleotide 
frequency 
n Genotype 
Genotype 
frequency 
HWE1 
c.51C>T C 0.94 681 CC 0.89 χ2 =  2.41 
(p.Leu17Leu) T 0.06 85 CT 0.11 P = 0.300 
   0 TT 0.00  
       
c.59C>T C 0.13 0 CC 0.00 χ2 = 15.65 
(p.Pro20Leu) T 0.87 199 CT 0.26 P = <0.001 
   567 TT 0.74  
       
c.79G>A A 0.06 0 AA 0.00 χ2 =  2.41 
(p.Ala27Thr) G 0.94 85 AG 0.11 P = 0.300 
   681 GG 0.89  
       
c.103G>C C 0.06 0 CC 0.00 χ2 =  2.41 
(p.Gly35Arg) G 0.94 85 CG 0.11 P = 0.300 
   681 GG 0.89  
       
c.174+132A>G A 0.94 681 AA 0.89 χ2 =  2.41 
 G 0.06 85 AG 0.11 P = 0.300 
   0 GG 0.00  
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5.3.5 Association of GH genetic variants with growth traits 
 
The presence and absence of each variant were investigated for association with growth 
traits in the NZ Romney lambs, and the results are summarised in Table 5.5. Due to the 
presence of the A3 variant in all Romney lambs studied, it was excluded from the present-
absent models. 
 
Table 5.5 Association of variants in ovine GH with growth traits in NZ Romney sheep 
Trait (unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE 
Variant 
absent (0) 
n 
Variant  
present (1) 
n P-value 
Birth  B3  5.05 ± 0.20 597 5.20 ± 0.21 169 0.037 
weight (kg) F3  5.09 ± 0.20 681 4.97 ± 0.22 85 0.160 
 B3 F3 5.02 ± 0.21 597 5.15 ± 0.21 169 0.063 
 F3 B3 5.13± 0.20 681 5.04 ± 0.22 85 0.298 
Tailing  B3  11.86 ± 0.55 597 12.35 ± 0.57 169 0.008 
weight (kg) F3  11.99 ± 0.55 681 11.37 ± 0.59 85 0.012 
 B3 F3 11.64 ± 0.56 597 12.06 ± 0.58 169 0.027 
 F3 B3 12.11 ± 0.55 681 11.59 ± 0.60 85 0.038 
Weaning  B3  28.91 ± 0.95 597 30.68 ± 0.98 169 <0.001 
weight (kg) F3  29.42 ± 0.95 681 27.13 ± 1.03 85 <0.001 
 B3 F3 28.13 ± 0.95 597 29.62 ± 1.00 169 <0.001 
 F3 B3 29.84 ± 0.94 681 27.92 ± 1.03 85 <0.001 
Growth rate to B3  253.59 ± 10.31 597 270.97 ± 10.63 169 <0.001 
weaning  F3  264.06 ± 10.41 681 242.99 ± 10.76 85 <0.001 
(g/day) B3 F3 250.91 ± 10.24 597 265.90 ± 10.61 169 <0.001 
 F3 B3 267.16 ± 10.31 681 249.65 ± 10.74 85 <0.001 
 
The presence of the B3 variant of ovine GH was associated with increased weight at birth 
(0.15 kg), tailing (0.49 kg) and weaning (1.77 kg). Lambs possessing the B3 variant also 
grew faster by 17.4 g/day (Table 5.5). In contrast, lambs possessing the F3 variant had 
lower tailing (0.62 kg) and weaning (2.29 kg) weights, as well as slower growth rates (by 
21.07 g/day). F3 showed a decreasing trend of association with birth weight.  
Table 5.6 summarises association studies assessing the effects of individual nucleotide 
variants on growth traits in the NZ Romney lambs.  
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Table 5.6 Association of nucleotide substitution genotypes in ovine GH with growth 
traits in the NZ Romney lambs 
 
 
Since the minor homozygous nucleotide genotypes were not observed for any lambs, these 
were excluded from further analyses. Hence for nucleotide substitution analyses, only the 
major homozygous and heterozygous variants were investigated. The four variants 
(c.51C>T, c.79G>A, c.103G>C and c.174+132A>G) exhibiting the same genotypic 
frequencies were unsurprisingly found to exert similar effects on growth traits (Table 5.6). 
Lambs possessing the major homozygous genotypes were found to have a 0.62 kg increase 
in tailing weight, a 2.29 kg increase in weaning weight, and grew faster by 21.1 g/day, 
when compared to their heterozygous counterparts. The variants showed no association 
with birth weight. 
On the other hand, compared to the heterozygous CC genotype, the homozygous TT 
genotype of c.59C>T was associated with decreased birth (0.13 kg), tailing (0.48 kg) and 
weaning (16.85 kg) weights, and a diminished growth rate (16.8 g/day).   
  
Variant Loci 
Geno 
types 
n 
Birth 
weight (kg) 
Tailing 
weight (kg) 
Weaning 
weight (kg) 
Growth rate-to-
weaning (g/day) 
c.51C>T CC 681 5.10 ± 0.20 11.99 ± 0.55 29.42 ± 0.95 264.06 ± 10.41 
(p.L17L) CT 85 4.97 ± 0.22 11.37 ± 0.59 27.13 ± 1.03 242.99 ± 10.76  
P value  0.160 0.012 <0.001 <0.001  
      
c.59C>T CT 199 5.24 ± 0.21 12.34 ± 0.56 30.66 ± 0.97 269.97 ± 10.56 
(p.P20L) TT 567 5.04 ± 0.20 11.86 ± 0.55 28.87 ± 0.95 253.12 ± 10.31  
P value  0.002 0.006 <0.001 <0.001  
       
c.79G>A GG 681 5.10 ± 0.20 11.99 ± 0.55 29.42 ± 0.95 264.06 ± 10.41 
(p.A27T) AG 85 4.97 ± 0.22 11.37 ± 0.59 27.13 ± 1.03 242.99 ± 10.76  
P value  0.160 0.012 <0.001 <0.001  
      
c.103G>C GG 681 5.10 ± 0.20 11.99 ± 0.55 29.42 ± 0.95 264.06 ± 10.41 
(p.G35R) CG 85 4.97 ± 0.22 11.37 ± 0.59 27.13 ± 1.03 242.99 ± 10.76  
P value  0.160 0.012 <0.001 <0.001  
  
    
c.174+132A>G AA 681 5.10 ± 0.20 11.99 ± 0.55 29.42 ± 0.95 264.06 ± 10.41  
AG 85 4.97 ± 0.22 11.37 ± 0.59 27.13 ± 1.03 242.99 ± 10.76 
 P value  0.160 0.012 <0.001 <0.001 
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5.3.6 Association of genetic variants with carcass traits 
 
The presence and absence of each variant were investigated for association with carcass 
traits in NZ Romney lambs, and the results are summarised in Table 5.7. The presence of 
the B3 variant was associated with an increase in hot carcass weight (0.41 kg), and an 
increase in the leg (1.4%), loin (1.2%), shoulder (1.1%), and total lean meat yield (1.2%) 
(Table 5.7). Conversely, when present, the F3 variant showed associations with decreased 
hot carcass weight (0.63 kg), leg yield (1.8%), loin yield (1.8%), shoulder yield (1.8%) and 
total yield (1.8%). Fat depth around the 12th rib was also lower by 0.48 mm with B3, whilst 
being higher by 0.84 mm when F3 was present. 
Table 5.7 Association of variants in ovine GH with carcass traits in NZ Romney sheep 
Trait (unit) Variant assessed 
Other 
variants 
Mean ±  SE  
Variant 
absent (0) 
n 
Variant  
present (1) 
n P-value  
HCW1 (kg) B3  17.03 ± 0.08 551 17.44 ± 0.13 155 0.002 
 F3 
 17.19 ± 0.07 628 16.56 ± 0.17 78 <0.001 
 B3 F3 16.83 ± 0.10 551 17.17 ± 0.15 155 0.011 
  F3 B3 17.28 ± 0.08 628 16.72 ± 0.18 78 0.002 
V-GR2 Fat  B3  4.24 ± 0.11 551 3.76 ± 0.19 155 0.015 
Depth (mm) F3  4.05 ± 0.11 628 4.89 ± 0.26 78 0.001 
 B3 F3 4.52 ± 0.15 551 4.13 ± 0.23 155 0.049 
  F3 B3 3.95 ± 0.12 628 4.70 ± 0.27 78 0.004 
Leg  B3  21.45 ± 0.06 551 21.75 ± 0.09 155 0.003 
Yield (%) F3  21.56 ± 0.05 628 21.16 ± 0.13 78 0.003 
 B3 F3 21.33 ± 0.07 551 21.58 ± 0.11 155 0.011 
  F3 B3 21.62 ± 0.06 628 21.28 ± 0.14 78 0.010 
Loin  B3  14.54 ± 0.04 551 14.72 ± 0.06 155 0.012 
Yield (%) F3  14.61 ± 0.04 628 14.35 ± 0.09 78 0.005 
 B3 F3 14.46 ± 0.05 551 14.61 ± 0.08 155 0.036 
  F3 B3 14.64 ± 0.04 628 14.41 ± 0.10 78 0.015 
Shoulder  B3  16.81 ± 0.04 551 17.00 ± 0.07 155 0.010 
Yield (%) F3  16.88 ± 0.04 628 16.57 ± 0.09 78 0.001 
 B3 F3 16.71 ± 0.05 551 16.86 ± 0.08 155 0.037 
  F3 B3 16.92 ± 0.04 628 16.64 ± 0.10 78 0.004 
Total  B3  52.80 ± 0.12 551 53.47 ± 0.19 155 0.001 
Yield (%)   F3  53.05 ± 0.11 628 52.07 ± 0.26 78 <0.001 
 B3 F3 52.49 ± 0.15 551 53.05 ± 0.23 155 0.007 
  F3 B3 53.20 ± 0.12 628 52.34 ± 0.28 78 0.002 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
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Association studies assessing the effect of individual nucleotide substitutions on variation in carcass traits were carried out for the NZ Romney lambs, 
and the results are presented in Table 5.8. 
 
Table 5.8 Association of nucleotide genotypes at the different loci in ovine GH with carcass traits in the NZ Romney lambs 
 
 
 
 
 
 
 
 
 
                                                                
                                        1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib
Variant Loci Genotype n HCW1 (kg) V-GR2 (mm) Leg yield (%) Loin yield (%) Shoulder yield (%) Total yield (%) 
c.51C>T CC 628 17.19 ± 0.07 4.05 ± 0.11 21.56 ± 0.05 14.61 ± 0.04 16.88 ± 0.04 53.05 ± 0.11 
(p.L17L) CT 78 16.56 ± 0.17 4.89 ± 0.26 21.16 ± 0.13 14.35 ± 0.09 16.57 ± 0.09 52.07 ± 0.26 
 P value  <0.001 0.001 0.003 0.005 0.001 <0.001 
         
c.59C>T CT 183 17.45 ± 0.12 3.65 ± 0.17 21.78 ± 0.09 14.74 ± 0.06 17.00 ± 0.06 53.53 ± 0.18 
(p.P20L) TT 523 17.01 ± 0.08 4.31 ± 0.11 21.42 ± 0.06 14.52 ± 0.04 16.80 ± 0.04 52.75 ± 0.12 
 P value  0.001 <0.001 <0.001 0.001 0.004 <0.001 
         
c.79G>A GG 628 17.19 ± 0.07 4.05 ± 0.11 21.56 ± 0.05 14.61 ± 0.04 16.88 ± 0.04 53.05 ± 0.11 
(p.A27T) AG 78 16.56 ± 0.17 4.89 ± 0.26 21.16 ± 0.13 14.35 ± 0.09 16.57 ± 0.09 52.07 ± 0.26 
 P value  <0.001 0.001 0.003 0.005 0.001 <0.001 
         
c.103G>C GG 628 17.19 ± 0.07 4.05 ± 0.11 21.56 ± 0.05 14.61 ± 0.04 16.88 ± 0.04 53.05 ± 0.11 
(p.G35R) CG 78 16.56 ± 0.17 4.89 ± 0.26 21.16 ± 0.13 14.35 ± 0.09 16.57 ± 0.09 52.07 ± 0.26 
 P value  <0.001 0.001 0.003 0.005 0.001 <0.001 
 
  
      
c.174+132A>G AA 628 17.19 ± 0.07 4.05 ± 0.11 21.56 ± 0.05 14.61 ± 0.04 16.88 ± 0.04 53.05 ± 0.11 
 AG 78 16.56 ± 0.17 4.89 ± 0.26 21.16 ± 0.13 14.35 ± 0.09 16.57 ± 0.09 52.07 ± 0.26 
  P value   <0.001 0.001 0.003 0.005 0.001 <0.001 
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The homozygous CC, GG, GG and AA genotypes of c.51C>T, c.79G>A, c.103G>C and 
c.174+132A>G respectively, showed association with an increase in hot carcass weight 
(0.63 kg), a 1.8% increase in leg, loin, shoulder and total lean meat yields; as well as a 
decrease in the fat depth (0.84 mm) (Table 5.8).  
With the c.59C>T substitution, when two copies of the T nucleotide were present (TT), 
there was a decrease in hot carcass weight (0.44 kg), leg yield (1.6%), loin yield (1.5%), 
shoulder yield (1.2%) and total yield (1.4%). 
5.3.7 Association of variant genotypes with carcass traits 
 
The genotype combinations of the variants were assessed for their effects on growth and 
carcass traits in Romney lambs (Table 5.9). The variant genotypes assessed were A3A3, A3B3 
and A3F3. A3C3 was not investigated as its frequency of 4% is lower than the 5% threshold 
required for analysis. 
 
Table 5.9 Association of variant genotypes in ovine GH with growth and carcass traits 
in NZ Romney sheep 
Growth traits A3A3 (n = 482) A3B3 (n = 169) A3F3 (n = 85) P-value 
Birth weight (kg) 5.05 ± 0.20a 5.21 ± 0.21ab 4.98 ± 0.22b 0.007 
Tailing weight (kg) 11.89 ± 0.55a 12.33 ± 0.56a 11.39 ± 0.59b 0.008 
Weaning weight (kg) 29.05 ± 0.94a 30.61 ± 0.97a 27.21 ± 1.01b <0.001 
Growth rate to weaning 
(g/day) 
259.13 ± 10.34a 274.59 ± 10.56a 242.10 ± 10.62b <0.001 
     
Carcass Traits A3A3 (n = 445) A3B3 (n = 155) A3F3 (n = 78) P-value 
HCW1 (kg) 17.09 ± 0.08a 17.45 ± 0.12a 16.55 ± 0.17b <0.001 
V-GR1 Fat Depth (mm) 4.21 ± 0.12a 3.75 ± 0.18ab 4.91 ± 0.25b <0.001 
Leg Yield (%) 21.47 ± 0.06a 21.75 ± 0.09ab 21.15 ± 0.13a <0.001 
Loin Yield (%) 14.55 ± 0.04a 14.72 ± 0.06ab 14.34 ± 0.09a 0.001 
Shoulder Yield (%) 16.84 ± 0.04a 17.00 ± 0.07a 16.56 ± 0.09b 0.001 
Total Yield (%) 52.86 ± 0.12a 53.47 ± 0.19ab 52.05 ± 0.26a <0.001 
a, b Mean values in the same row with different superscripts differ at P < 0.05 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
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In Serra de Estrela sheep, GH1/GH2-N and GH2-Z gene regions were found to be 
associated with milk yield traits, but animals with GH2/GH2 genotype produced more milk 
when compared to GH1/GH1 animals (Marques et al., 2006). The variants exhibited copy-
specific variation despite being duplicates, and higher milk yield was also observed with a 
GH2-N and GH2-Z ‘joined-effect’ genotype (Marques et al., 2006). 
The A3A3 genotype was the only one found in all NZ sheep breeds examined. Some GH 
genotypes were exclusive to certain breeds, which might indicate some possible breed-
specific benefit besides growth and carcass traits. The B3B3, B3D3 and C3C3 genotypes 
observed solely in the Merino breeds might have an effect on wool traits and production. 
By the same token, the A3D3 and C3E3 genotypes unique to the Perendale breed, and the 
A3G3 genotype unique to the White Dorper breed, might influence hardiness and carcass 
quality traits which are sought after in these breeds, respectively. 
It is interesting that although the A3B3 genotype is the second most abundant after A3A3, 
lambs exhibiting this genotype had the highest growth rates and lean meat yields, as well 
as the highest weights at tailing, weaning, and slaughter, when compared to lambs 
possessing other genotypes. Lambs possessing the A3B3 genotype also had the lowest 
intermuscular fat depth. The reverse was observed for the A3F3 genotype which exhibited 
the lowest growth traits and carcass traits, except for having the highest intermuscular fat 
depth. This agrees with previous findings in Russian Salsk sheep, where the AB genotype 
of GH had the highest carcass and slaughter weight, when compared to AA and AC 
genotypes (Gorlov et al., 2017). It is likely that the AB sequence reported in that study 
differs from that in this study; the similarities refer to the association of the IGF1R 
genotypes with ovine carcass traits in both studies. 
The B3 variant of GH was associated with higher weights at tailing and weaning, and faster 
growth rate. In contrast, the F3 variant was associated with lower tailing and weaning 
weights, and slower growth rates. These findings are in agreement with other reports on 
ovine GH. A nucleotide transition from T to C in the exon 4 of ovine GH, was found to be 
associated with growth traits such as body length, weight, and height in Chinese Tibetan 
sheep (Jia et al., 2014).  
The B3 variant was associated with a decrease in fat thickness and higher lean meat yield, 
while the F3 variant was associated with an increase in fat thickness and lower lean meat 
yield in the leg, loin and shoulder regions. This is consistent with the findings of Bahrami 
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et al. (2015), where nucleotide sequence variations in the exon 5 of ovine GH were 
associated with back fat thickness, body length, carcass weight and abdominal fat yield.  
A c.59C>T transition in exon 2 of GH brings about a putative substitution of proline for 
leucine at position 20. Proline is a polar residue with an uncharged sidechain, whereas its 
substitute leucine, is a non-polar residue. Proline is unique, in that its side-chain connects 
directly to the residue’s amino group to form a ring, hence giving it a compact and rigid 
structure (von Heijne, 1990). Proline, therefore, has the ability to ‘kink’ a protein, thus 
affecting the secondary and tertiary structures. The substitution to leucine, a larger amino 
acid, could result in bumps within the protein and disruption in the rigidity within the 
polypeptide backbone.  
Signal peptides are short starter sequences, 15 to 30 amino acids long, at the N-terminal of 
a nascent polypeptide that is cleaved off by specialised signal peptidases to yield a mature 
protein. Given its crucial position within the signal peptide, the p.Pro20Leu variant could 
alter GH processing and function.  
The substitution of alanine, a non-polar residue for threonine, a polar uncharged residue at 
position 27 is caused by a c.79G>A transition in the exon 2 of GH. This variation falls 
within the conserved boundary region of GH signal peptide. Around the signal peptide, a “-
3, -1” rule applies, which states that in order for proteolytic cleavage to take place 
correctly, residues occupying the -3  and -1 amino acid positions, relative to the cleavage 
site, must be small and uncharged (Jain et al., 1994). These residues include alanine, 
glycine and serine. Alanine is conserved across various proteins and species as the most 
common residue found at the -3 and -1 positions relative the signal peptide cleavage sites 
(von Heijne, 1990; Nielsen et al., 1997). The substitution of any amino acid in the place of 
alanine could impair signal peptide cleavage and hence protein activity.  
Although threonine satisfies the requirement of being small and uncharged, like serine and 
glycine, protein activity and stability prediction in this study revealed that the putative 
p.Ala27Thr variation is disruptive, and could decrease protein stability and alter normal 
functioning. This disruption could be explained by the loss of hydrophobicity in that 
region, as alanine is a hydrophobic non-polar residue, whereas threonine is polar and larger 
than alanine. Electrostatic interactions resulting from the threonine substitute could also be 
a contributing factor to the disruption. Several studies have established that the 
hydrophobicity of a signal peptide is crucial to its function (Fikes et al., 1990; von Heijne, 
1990; Jain et al., 1994). The importance of Ala27 to GH function was illustrated by GH 
Chapter 5: Variation in ovine GH and its association with growth and carcass traits in NZ sheep 
 
 111 
protein alignment analyses across species, which revealed that the Ala27 residue is 
conserved across humans, cattle, goats, pigs, dogs, rats, mice, and other sheep breeds. 
Threonine 27 was unique only to the F3 variant in this study, and not found in the other 
variants or mammalian species. This might explain why the F3 variant was associated with 
less desirable traits such as slower-growing animals, decreased total lean meat yield and 
higher intermuscular fat deposition. The F3 variant had the lowest frequency of all variants 
in NZ Romney sheep, thus suggesting that this variant was likely selected against. 
The findings in this study are in agreement with an in vivo investigation by Fikes et al. 
(1990), which reported inefficient signal peptide processing and diminished protein 
function when threonine substitutes alanine at the -1 position of the maltose-binding 
protein. Due to this substitution, the normal cleavage site was obstructed, and processing 
was moved to a different site within the signal peptide (Fikes et al., 1990; Jain et al., 1994). 
Crystallographic analyses have demonstrated that alanine residues at the cleavage sites 
serve a crucial function in interacting with unique binding pockets within the active sites of 
signal peptidase enzymes, thus facilitating the fine-tuned positioning and correct cleavage 
of the signalling peptide (Paetzel et al., 1998; Chen et al., 1999). 
The putative p.Pro20Leu and p.Ala27Thr missense variations both affect the GH signal 
peptide. Both variations may alter the function of the polypeptide product. While 
p.Pro20Leu occurs within the signal peptide sequence, p.Ala27Thr resides at the conserved 
cleavage site (von Heijne, 1990). Recognition of the signal peptide, and its subsequent 
cleavage by signal peptidases within the endoplasmic reticulum and Golgi apparatus is 
imperative to the processing of the polypeptide precursor into a mature GH protein. The 
threonine residue is less favourable and might bring about a blockage at the normal 
cleavage site, necessitating a redirection to an alternate site elsewhere within the signal 
peptide. This could potentially lead to the ineffective cleavage and processing of the signal 
peptide. By resulting in incorrect signal peptide processing, both p.Pro20Leu and 
p.Ala27Thr variants could bring about diminished or even loss of GH function and 
stability. Intracellular transport of the GH protein via endoplasmic reticulum to its final 
destination is also disrupted (Jain et al., 1994). This could explain findings from protein 
activity and stability analyses, which reveal both variations to be deleterious, and leading 
to decreased protein function and stability. 
Within the alpha helices of GH, a glycine residue at position 35 of the polypeptide was 
exchanged for an arginine residue. This p.Gly35Arg substitution was the result of a 
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c.103G>C transversion in the exon 2 of GH. Being the smallest amino acid due to its lack 
of a carbon sidechain, glycine is able to reside in areas within the protein that are forbidden 
to other residues due to steric hindrance and rotation. Glycine also confers upon a protein 
some conformational flexibility due to its large torsional space that can accommodate 
unusual torsion angles, especially in areas of tight turns within the protein (Dong et al., 
2012). Glycine is able to pack well against residues with both bulky and simple sidechains.  
In helical proteins such as GH, glycine plays an essential role in the intimate packing of α-
helices by permitting close proximity between the backbones (Javadpour et al., 1999). 
When performing their biological functions, some proteins undergo a certain degree of 
helix repacking and kinking, which is facilitated by the presence of glycine residues (Dong 
et al., 2012). By virtue of its larger torsional space, glycine, just like proline, can introduce 
kinks into tight spaces within a protein. Glycine also promotes helix-helix interactions, and 
can serve as a helix-breaker at the beginning or end of helices (O'Neil and DeGrado, 1990). 
Cumulative in effect, these characteristics of glycine promote stability in the crucial 
secondary and tertiary structures of a protein.  
There are stark differences functionally and structurally between glycine and arginine 
residues. Arginine is both polar and charged. This means it is able to form salt bridges with 
negatively-charged residues, as well as intra-helical and inter-helical hydrogen bonds with 
other polar amino acids. These unsolicited interactions could disrupt the protein’s 
secondary structure and natural conformation. In the glycophorin transmembrane receptor, 
an amino acid change from glycine to a larger amino acid in the α-helix region was 
reported to disrupt receptor dimerisation (Lemmon et al., 1994; Javadpour et al., 1999) 
Consistent with this study, there have been other reports of substitutions of glycine amino 
acids in the GH protein sequence. A glycine to serine substitution resulting from a 
c.265A>G transition (p.Gly89Ser), not observed in this study, was reported for the Serra de 
Estrela sheep breed (Marques et al., 2006).  
Past the signal peptide region into the alpha helices, another substitution occurred at a 
conserved position. An arginine residue was putatively replaced with a histidine residue at 
amino acid position 60. This was brought about by a guanine to adenine transition at DNA 
position 179 (c.179G>A) of exon 3. Although this position is conserved across most 
mammalian species explored, multiple alignment analyses revealed a precedence for a 
substitution at this site, with arginine-60 being replaced with a glutamic acid residue 
(p.Arg60His) in humans. The sheep finding is also similar to the findings of Gupta et al. 
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(2007) in Black Bengal goats, where an amino acid substitution of arginine with histidine, 
encoded for by a substitution in exon 4 of caprine GH was reported. 
The p.Arg60His variant, was only observed for the D3 variant of ovine GH. Although 
arginine and histidine are both basic amino acids with positively charged sidechains, 
arginine is aliphatic whereas the sidechain of histidine is cyclic in nature. Protein structure 
prediction using online prediction software, postulated disruption in the ionic interactions 
between the wild-type arginine-60, and two other residues - aspartic acid at position 53, 
and glutamic acid at position 59. 
Growth hormone is pleiotropic in its function, in that it is capable of stimulating both 
anabolic (growth-promoting) and catabolic (growth-antagonising) processes. Catabolically, 
GH promotes lipolysis, while also promoting anabolic growth (Bergan-Roller and 
Sheridan, 2018). Whether growth or lipolysis is induced, is dependent upon the signalling 
pathways activated upon GH binding to its receptor. GH has been reported to induce 
chondrogenesis in cartilage and longitudinal bone growth. 
The only synonymous variant found in this study was c.51C>T (p.Leu17Leu) in exon 2, 
while intron 2 presented with six non-coding variations. These variations were found to 
show associations with growth and carcass traits in NZ Romney sheep. The variations 
could have impacted sheep phenotypic traits by influencing GH protein folding or stability, 
rate of transcription and translation, or by impacting mRNA stability and the rate and 
efficiency of transcription and translation (Cartegni et al., 2002; Le Hir et al., 2003).  
From a commercial perspective, the findings of this study show potential profitability. 
Farmers and producers in NZ are paid on average $6 per kg of lamb carcass, and about 27 
million carcasses were exported in the 2018 – 2019 period to yield an estimated revenue of 
$3.23 billion (Ministry of Primary Industries, 2019). The B3 variant of ovine GH was 
associated with a 0.41 kg increase in hot carcass weight, which would putatively generate 
an extra $2.5 per carcass. This means that if the B3 variant were incorporated into all flock, 
assuming all lambs responded in a similar fashion to this study, the small genetic gain 
could translate to a $67.5 million increase in sheep meat revenue. 
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The POU1F1 protein belongs to the POU-domain family of transcription factors which 
share a common N-terminal transactivation domain (TAD), and a C-terminal POU-specific 
domain (POUSD) and POU-homeodomain (POUHD). The TAD domain is crucial for the 
transactivation of target genes – GH, TSH and PRL, while high-affinity DNA binding is 
ensured by the POUSD and POUHD regions (Bastos et al., 2006a).  
 
 
 
Figure 6.1 Diagrammatic alignment of POU1F1 gene and protein sequences showing 
peptide domains 
The POU1F1 gene and the corresponding protein sequence with amino acid position 
numbers marking functional domain regions. TAD = Transactivation domain; SD = POU-
specific domain; HD = POU-homeodomain. The TAD domain is located between amino 
acids 1 - 80, the specific domain between amino acids 128 - 198, and the homeodomain 
between amino acids 214 - 273.  
 
The POU class of homeobox genes has been documented for its role in transcription and 
gene expression. The acronym POU (Pit-Oct-Unc) is derived from three mammalian genes 
whose products, the pituitary-specific factor 1 (Pit-1), octamer transcription factor (Oct-1 
and Oct-2), and Caenorhabditi elegans factor (Unc-86), were found to share a common 
homologous region, later named the POU domain (Herr et al., 1988). The POU domain is a 
bipartite DNA-binding domain consisting of two subdomains, namely the N-terminal 75-
amino acid POU-specific domain (POUSD) and the 60-amino acid C-terminal POU-
homeodomain (POUHD), which are separated by a short linker region (Sturm and Herr, 
1988) (Figure 6.1). Both subdomains are required for the high-affinity sequence-specific 
DNA binding of POU domain-containing transcription factors (Skowronska-Krawczyk et 
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al., 2016). Basic amino acid residues found in clusters in both POUSD and POUHD are 
essential to the function of the transcription factor.   
Structural domains are an integral part of many proteins. A protein domain is an 
independent evolutionary unit of a given protein sequence, which can exist and function 
independently of the remaining sequence; and each domain can often be independently 
stable and folded into a compact 3D structure (Kissinger et al., 1990; Wegner et al., 1993). 
Some proteins have one protein domain, while others have multiple domains. The same 
domain may appear in a variety of proteins with distinct functions. Recombination of 
domains in different arrangements can produce functionally-different proteins and allow 
for molecular evolution (Banerjee-Basu and Baxevanis, 2001). By virtue of their 
independent stability, genetic engineering can be employed to swap domains between 
proteins to yield chimeric proteins. 
The homeobox gene domain is a conserved DNA motif of about 180 bp in length, which 
was first described in Drosophila in the early 1980s (McGinnis and Krumlauf, 1992). The 
homeobox domain encodes the homeodomain protein, which has been reported to play a 
crucial role in the anatomical development of multicellular organisms. The homeodomain 
folds into a characteristic helix-turn-helix (HTH) structure, which can be a di-helical or tri-
helical bundle consisting of alpha helices connected by a short loop turn that interact to 
create a DNA-protein interface (Sturm and Herr, 1988). For a tri-helical HTH motif, the 
third helix, which is the C-terminal recognition helix, aligns with and binds to the major 
groove of target DNA via a number of hydrogen bonds and hydrophobic interactions 
between specific amino acid sidechains and exposed bases in the DNA; whereas, the first 
two N-terminal helices stabilise the DNA-protein structure (Kissinger et al., 1990). The 
HTH motif in the homeobox shares some similarities in sequence and structure to various 
DNA-binding proteins, such as the cro repressor family of proteins.  
During the later stages of pituitary development, around embryonic day 13, POU1F1 is 
specifically expressed by the thyrotrope, somatotrope and lactotrope cell types of the 
anterior pituitary (Bodner et al., 1988; Kelberman et al., 2009a). POU1F1 promotes the 
proliferation and terminal differentiation of these cell populations. By means of its POU-
homeodomain and POU-specific domain, POU1F1 binds with high affinity to regulatory 
regions on DNA sequences within these cells (Skowronska-Krawczyk et al., 2016). 
POU1F1 positively regulates the gene expression and synthesis of endocrine hormones, 
namely GH (somatotrope), TSH (thyrotrope) and PRL (lactotrope), within these anterior 
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pituitary cell populations (Pfäffle et al., 1992). Although, POU1F1 expression climaxes 
around embryonic day 16, it is still maintained within these pituitary cell lineages, well 
into adulthood (Bodner et al., 1988).  
6.1.2 POU1F1 variations 
Sequence variations in POU1F1 were first described in dwarf mice. In this respect, the 
Snell dwarf and Jackson dwarf mice have been studied extensively. The Snell dwarf mouse 
is characterised by an amino acid substitution of tryptophan for cysteine at position 261 
(p.Try261Cys) in the POU-homeodomain, resulting from a guanine to thymine mutation in 
murine POU1F1 sequence (Li et al., 1990; Hendriks-Stegeman et al., 2001). This variation 
abolishes the ability of POU1F1 to bind to target genes, and ultimately results in a lack of 
somatotropes, lactotropes and thyrotropes.  
On the other hand, the Jackson dwarf mouse is characterised by a complicated 
rearrangement of POU1F1, leading to a dysfunctional protein with a complete loss in its 
DNA-binding capacity (Li et al., 1990; Parks et al., 1999). 
In humans, a substitution of arginine for tryptophan at position 271 (p.Arg271Trp), in the 
conserved POU-homeodomain acts as a dominant inhibitor of POU1F1 function, and 
presents with deficiencies in the endocrine hormones, GH, PRL and TSH (Kishimoto et al., 
2003; Turton et al., 2005). Furthermore, an amino acid replacement of phenylalanine for 
cysteine at position 135 (p.Phe135Cys) in the POU-specific domain has been shown to 
decrease the transactivation of target genes by POU1F1, in cultured HeLa cell-lines 
(Vallette-Kasic et al., 2001b). Subsequent structural modelling revealed that the loss of 
function could have been due to the disruption of crucial intermolecular interactions 
between the wild-type phenylalanine residue and other proteins in the transcriptional 
machinery. Several polymorphisms have been described in the POU1F1, with some 
associated with production traits in mammals (Di Stasio et al., 2002; Huang et al., 2008). 
Bastos et al. (2006b) described the first POU1F1 polymorphisms in sheep. These included 
four sequence variations in the Churra da Terra Quente Portuguese sheep breed: a G to A 
transition in exon 2 that leads to a cysteine to tyrosine amino acid change at codon 58 
(p.Cys58Tyr), two G to A transitions in exon 3 that resulted in the replacement of glycine 
with asparagine at position 89 (p.Gly89Asn), and the substitution of alanine for threonine 
at position 105 (p.Ala105Thr), and an A to G transversion in intron 4 (Bastos et al., 2006b). 
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ideal PCR and SSCP conditions for each primer set were established empirically following 
multiple optimisation experiments.  
For a start, PCR optimisations entailed low stringency PCR with standard temperatures and 
reagent concentrations. The annealing temperature was subsequently raised in stepwise 
increments of 1 ºC until a single band was observed on agarose gel electrophoresis. This 
was done to curb non-specific amplification. Similar increments in a stepwise fashion were 
employed to the reagents used until the best results were obtained. The POU1F1 primer 
details and PCR-SSCP running conditions are stipulated in Table 6.1.  
Table 6.1 POU1F1 primers and PCR-SSCP conditions 
Gene  
Region 
Forward/reverse primers 
Oligonucleotide (5’ to 3’) 
Amplicon 
size 
Annealing 
temp (ºC) 
SSCP 
conditions 
Exon 1 
F: TGAGATCTGAAACGGCCCTT 
R: ACAAGATTCAAAGCACCCATCC 
301 bp 58 ºC 
12%, 280 V,  
20 ºC, 18 h 
Exon 3 
F: ACTGGCCTTCACAGAACAATC 
R: GACTTTGCAGATGGGGTTGT 
365 bp 58 ºC 
12%, 280 V,  
20 ºC, 18h 
Exon 6 
F: CATCTCCCTTCTTCTTTCCTGC 
R: AGAAAAGCTCGCTGTTACACA 
281 bp 58 ºC 
12%, 280 V,  
20 ºC, 18 h 
 
PCR amplifications were performed in 15 µL reactions containing the purified genomic 
DNA on a 1.2 mm diameter disc of FTA, 0.25 µM of each primer, 150 µM of each dNTP 
(Eppendorf, Hamburg, Germany), 1.5 mM Mg2+, 0.5 U Taq DNA polymerase (Qiagen, 
Hilden, Germany), and 1 × the reaction buffer supplied with the enzyme. Amplifications 
were undertaken in Bio-Rad S1000 thermal cyclers (Bio-Rad, Hercules, CA, USA). The 
thermal profile entailed an initial denaturation at 94 ºC for 2 mins, followed by 34 cycles of 
94 ºC for 30 s, annealing at 58 ºC for 30 s, and extension at 72 ºC for 30 s, and a final 
extension step at 72 ºC for 5 min.  
Subsequent visualisation of the amplicons from the PCR reaction were carried out by 
means of agarose gel electrophoresis using 1% agarose (Quantum Scientific, Queensland, 
Australia) gels containing 1 × TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM 
Na2EDTA), 200 ng/mL ethidium bromide. 2 µL aliquots of the PCR products were mixed 
with 2 µL of loading dye (0.2% bromophenol blue, 0.2% xylene cyanol, 40% (w/v) 
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sucrose), and loaded into the gels that were run at a constant 5 V/cm for 2 hours. After 
electrophoresis, the gels were visualised using ultraviolet transillumination at 254 nm. 
6.2.3 Single-stranded conformational polymorphism (SSCP) analyses 
Optimisations for SSCP involved running amplicons at various conditions and using 
different gel compositions until consistently clear banding patterns were obtained.  
Following PCR, 0.7 µL of each PCR product was mixed with 7µL of loading dye (98% 
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol). The 
samples were denatured at 105 ºC for 5 min, snap-chilled on ice, and 10 µL of each sample 
was loaded into 16 x 18 cm, 10% acrylamide:bisacrylamide (37.5:1, Bio-Rad) gels in 
Protean II xi cells (Bio-Rad). The samples were run at a voltage of 280 V at 12 ºC for 18 
hours.  
Silver-staining of the gels was performed according to the method described by Byun et al. 
(2009). Briefly, the gels were silver-stained with silver nitrate, washed with distilled water, 
and subsequently developed using a solution containing sodium hydroxide and 40% 
formaldehyde. Nucleotide sequencing was not performed due to insufficient variation 
detected. 
In order to ensure the integrity of the experiments and to obtain reproducible banding 
patterns, freshly prepared PCR and SSCP products were always used. A negative control 
well containing no DNA was also run with each series of amplifications. 
6.2.4 Statistical analyses 
Variant and genotypic frequencies were calculated using the PopGene 3.2 software. The 
variant frequencies were then tested for deviation from Hardy-Weinberg equilibrium using 
a Chi-square test available on the Online Encyclopedia for Genetic Epidemiology Studies 
(OEGE) (Rodriguez et al., 2009).  
Association studies were not performed due to insufficient variation, and phenotypic data 
was not available for the samples used.   
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findings are unsurprising, as previous studies point to the strong conservation of ovine 
POU1F1 evidenced by the similarity with its bovine (98.2%), human (91.2%) and murine 
(86.2%) counterparts (Bastos et al., 2006b). 
The POU1F1 gene belongs to a family of homeobox genes involved in early embryonic 
development of pituitary cell types. The homeobox is a 180 bp DNA sequence that 
encodes a homeodomain that consists of 60 amino acid residues that are arranged into three 
alpha helices. By means of its helices, the homeodomain is able to bind to specific 
sequences in target DNA, altering its function or expression. Homeodomains, therefore, 
confer upon transcription factors their unique role in regulating gene expression.  
By means of its POU-homeodomain, encoded in the exon 6 of the gene, POU1F1 is able to 
bind to regulatory and enhancer elements within the promoter and 3’ UTR of target genes, 
including GH, PRL and TSH (Skowronska-Krawczyk et al., 2016). Genetic variations that 
alter the homeodomain can, therefore, be detrimental. It is therefore logical that there will 
be strong selection pressure against nucleotide sequence variations in the exon 6 of ovine 
POU1F1, which might explain the findings of this study.  
In a similar fashion, the POU-specific domain assists the POU-homeodomain to bind to 
target DNA with high affinity and with the correct orientation. The POU-specific domain 
also interacts with the transcriptional machinery including co-activators and repressors, to 
ensure successful gene regulation; hence, this domain is crucial to POU1F1 function 
(Skowronska-Krawczyk et al., 2016). The POU-specific domain is encoded in the exon 3 
of ovine POU1F1, within which no variation was observed in this study. 
Given its function in the proliferation and differentiation of pituitary somatotropes, 
lactotropes and thyrotropes, sequence variations in POU1F1 would not only affect its 
protein, but would exert a cascading downstream effect on the production of vital 
endocrine hormones including GH, PRL and TSH. Impaired pituitary function (Radovick 
et al., 1992; Salemi et al., 2003), inhibited cognitive function (Snabboon et al., 2008), and 
postnatal growth failure (Turton et al., 2005), have been reported as pathological 
phenotypes in humans with POU1F1 mutations.  
The findings of this study of no variation in exons 3 and 6 of ovine POU1F1 are opposed 
to some reports in other sheep breeds. Bastos et al. (2006b) reported two G to A nucleotide 
variation in the exon 3 of POU1F1 resulting in the amino acid changes, p.Gly89Asn and 
p.Ala105Thr, in Portuguese sheep breeds. Ozmen et al. (2014) reported a T to C 
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binding to specific regulatory regions of the DNA, such as enhancers and promoters. The 
homeodomain comprises of a helix-turn-helix (HTH) structure, with which it binds to 
target DNA and brings about gene activation or repression (Bobola and Merabet, 2017). 
The HTH motif is formed by two alpha helices (helices 2 and 3) connected by a short 
amino acid loop. DNA binding by the second helix is mediated by hydrogen bonds and 
hydrophobic interactions between exposed bases on the target DNA and specific side-
chains on the helix (Wolberger, 1996). Another helix, helix 1, stabilises the binding 
structure.  
Homeodomains can often have dual functionality by binding DNA and also facilitating 
protein-protein interactions (Berger et al., 2008; Inukai et al., 2017). PROP1 possesses a 
paired-like homeodomain, and homeodomains within transcription factors regulate the 
activities of other genes by binding to DNA. To exert their gene expression function, the 
transcription factors (trans-elements) must interact with regulatory sequences such as 
promoters and enhancers (cis-elements). Some of the more common homeodomain classes 
include paired/Pax, POU, HOX and LIM, and these homeodomains have often been found 
to interact with one another (Bobola and Merabet, 2017). 
 
(a) 
SHEEP_PROP1 MDTEGRSEQAKQAKEQVCSSLWPEGYPAAETVTSSVDMNTQPYRNLSGVR     50 
HUMAN_PROP1 -ea-r-rqae-pk-gr-g---l--rh--tg-p-tt--ssap-c-r-p-ag     50 
MOUSE_PROP1 -eaqr--h-e--t-gha-grsl--prv-sg-li-t--rssea--r---te     50 
  RAT_PROP1 -eaqr--q-e--t-gp--grsl--sqa-sg-li-t--rspetskr---tg     50 
  PIG_PROP1 -ea---r--g-pr-gr-------------g-l-ar--is-r--------g     50 
  DOG_PROP1 -ea-----rg--k-grl-g----ds----g-l--t--vsp--sk-----g     50 
  COW_PROP1 -----s---g--t-------------------------------------     50 
 GOAT_PROP1 --------------------------------------------------     50 
 
SHEEP_PROP1 VGRPKLSLQGGQRGRPHSRRRHRTTFSPAQLEQLESAFGKNQYPDIWARE    100 
HUMAN_PROP1 g--srf-p--------------------v----------r----------    100 
MOUSE_PROP1 l-----cp-...--------------n------------r----------     97 
  RAT_PROP1 l-----cp-...--------------n----g-------r-------v--     97 
  PIG_PROP1 a---r--p-------------------------------r----------    100 
  DOG_PROP1 -r--r--p-------l----------n-g------t---r----------    100 
  COW_PROP1 ----------v----------------------------r----------    100 
 GOAT_PROP1 a-------------------------------------------------    100 
 
SHEEP_PROP1 SLAQDTGLSEARIQVWFQNRRAKQRKQERSLLQPLAHLSPATFSGFLPEP    150 
HUMAN_PROP1 ---r-------------------------------------a--s----s    150 
MOUSE_PROP1 g---------------------------------i----t---------s    147 
  RAT_PROP1 g---------------------------------t------------s-s    147 
  PIG_PROP1 g--r----------------------------------------------    150 
  DOG_PROP1 g--r---------------------------------------------s    150 
  COW_PROP1 --------------------------------------------------    150 
 GOAT_PROP1 --------------------------h-----------------------    150 
 
SHEEP_PROP1 PSCPYPYPTPPPPMTCFPHPYNHALPSQPSTGSSFARPYQSEDWYPNLHP    200 
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HUMAN_PROP1 ta---s-aa----v-------s----------ga--lsh-------t---    200 
MOUSE_PROP1 say--t-g-----ap------s-s-------aa-l-l-p-p-----t---    197 
  RAT_PROP1 spy--t-t-----vp--------------c--a-ltl-a-p-----t---    197 
  PIG_PROP1 -a---s--------------------------g----hp-------t---    200 
  DOG_PROP1 -a---s--------------------------g-----h-------t---    200 
  COW_PROP1 -----s--------------------------------------------    200 
 GOAT_PROP1 --------------------------------------------------    200 
 
SHEEP_PROP1 TPAGHLPCPPPPPMLPLSLEPPKSWN                            226 
HUMAN_PROP1 a--------------------s----                            226 
MOUSE_PROP1 a-t-----------f-----t-----                            223 
  RAT_PROP1 -ht---a-------fs----t-----                            223 
  PIG_PROP1 --t-------a--v------------                            226 
  DOG_PROP1 p-t---------t-------------                            226 
  COW_PROP1 ------a-------------------                            226 
 GOAT_PROP1 -----------------g--------                            226 
 
(b) 
 
 
 
 
 
 
  
Figure 7.2 Multiple sequence alignment and homology tree of PROP1 protein 
sequences from different species 
(a) Multiple sequence alignment of PROP1 protein sequences from different species 
using the MEGA Align software. Dashes (-) denote nucleotides identical to the 
Sheep_PROP1 sequence, while dots (.) denote missing nucleotides. The homeodomain is 
highlighted (amino acids 69 – 128).  
(b) Homology tree of PROP1 protein sequences from various species. The dendogram 
depicts the relationships between mammalian PROP1 proteins, and was constructed using 
the multiple alignment algorithm in the DNAMAN package (DNAMAN 5.2.10, Lynnon 
Biosoft), and. Numbers represent the percentage of identities between the indicated pairs. 
The amino acid sequences were extracted from Genbank with the following accession 
numbers: Human, Homo sapiens (AF076215); Sheep, Ovis aries (AY533709); Goat, 
Capra hircus (XM_005682787); Cow, Bos taurus (XM_015472155); Pig, Sus scrofa 
(XM_013987527); Dog, Canis familiaris (NM_001020807); Rat, Rattus norvegicus 
(XM_008767664) and Mouse, Mus musculus (U77946). 
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PROP1 homeodomain binds DNA via its helix motifs (Figure 7.3). Being sequence-
specific, PROP1 is also capable of recognising and binding to various palindromic TAAT 
motif sequences (two motifs separated by three nucleotides) with a varying range of 
binding affinities (Wilson et al., 1993; Kato et al., 2010). However, the PROP1 
homeodomain preferentially and conventionally binds to its consensus binding sequence 
5’-TAATTGAATTA-3’, termed PRDQ9, located in the promoter or enhancer regions of the 
DNA targets (Nakayama et al., 2009). PROP1, like most homeodomain proteins, bind 
DNA as a cooperative dimer formed with itself (homodimer) or other transcription factors 
(heterodimer). PROP1 mostly binds DNA as a dimer formed by intermolecular interactions 
between the Ile-96 in one PROP homeodomain and the Arg-71 in the other partner 
homeodomain, as well as hydrophobic interaction between the Ala-111 residues on both 
dimer proteins (Wilson et al., 1995; Nakayama et al., 2009) (Figure 7.3).  
 
 
Figure 7.3 Diagrammatic representation of helices in PROP1 homeodomain 
PROP1 homeodomain is divided into segments of three helices, with numbering in 
reference to the homeodomain position (bottom row) or the PROP1 amino acid position 
(top row). Letters in red represent residues in the DNA binding sites of the major and 
minor groove.  
 
Electrophoretic mobility assays have demonstrated that the PROP1 homodimer binds 
preferentially to an inverted TAAT motif possessing a T nucleotide immediately 3’ to the 
motif (Nakayama et al., 2009; Kato et al., 2010). X-ray crystallography studies revealed 
that certain conserved residues within the homeodomain are required for binding to the 
major and minor grooves of target DNA (Table 7.1) (Wilson et al., 1995; Nakayama et al., 
2009). The paired homeodomain typically lodges its third α-helix into the major groove of 
the DNA, while the adjoining minor groove binds to its N-terminal arm (Wolberger, 1996). 
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Table 7.1 PROP1 homeodomain DNA-binding residues 
DNA major groove-binding residues  DNA minor groove-binding residues 
HD1 location PROP1 location  HD location PROP1 location 
Arg-44 Arg-112  Arg-2 Arg-70 
Val-47 Val-115  Arg-3 Arg-71 
Trp-48 Trp-116  Arg-5 Arg-73 
Gln-50 Gln-118  Thr-6 Thr-74 
Asn-51 Asn-119  Tyr-25 Tyr-93 
Arg-57 Arg-125  Arg-31 Arg-99 
   Glu-42 Glu-110 
   Arg-53 Arg-121 
1 HD: Homeodomain 
 
Since the eukaryotic binding consensus sequence is typically short (4-8 nucleotides), most 
transcription factors have the intrinsic ability to bind to a diverse range of DNA sequences 
(Table 7.1). To address this issue, homeodomain sequence recognition and function are 
dictated in a dynamic fashion by a variety of factors such as the shape of the DNA, 
chromatin accessibility and landscape, methylation status of the DNA, motif-flanking 
regions, intermolecular interactions with transcriptional partners (dimerisation), 
interactions with non-DNA-binding cofactors, and combinatorial binding (Wilson et al., 
1995; Todeschini et al., 2014; Inukai et al., 2017). Unique features in DNA shape such as 
the width of the minor groove, and parameters of rotation and twist, can enable a 
transcription factor differentiate between motifs and decide whether or not to bind 
(Todeschini et al., 2014; Bobola and Merabet, 2017).  
Chromatin accessibility further fine-tunes transcriptional regulation, as transcription 
factors would favour consensus sequences with open and accessible chromatin 
arrangement (free of hindering nucleosomes), over tight and compact ones (Todeschini et 
al., 2014; Bobola and Merabet, 2017). This limits the number of motifs available for 
binding, as unnecessary binding sites are buried within condensed chromatin arrangement. 
Homeodomain binding to a consensus sequence is, thus, ‘condition-specific’.  
Transient transfection assays showed that the dimeric binding of PROP1 to a TAAT motif 
could bring about transcriptional activation, whereas a PROP1 monomer cannot trigger 
activation despite recognising and binding to a single TAAT core sequence (Nakayama et 
al., 2009). Dimeric PROP1 binding is more successful than monomeric binding because 
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the binding of the first homeodomain has been found to bend the DNA and provide an 
interaction surface, which in turn facilitates the binding of the second homeodomain 
(Wilson et al., 1995; Berger et al., 2008). These conformational changes and distortion in 
the DNA are vital for transcriptional activation (Wilson et al., 1993; Berger et al., 2008). 
Following successful binding to target DNA consensus sequence, the PROP1-dimer then 
recruits transcriptional machinery that brings about gene expression.  
Given the highly specific nature of DNA binding, the three-dimensional conformation of 
the PROP1 polypeptide plays a crucial role in successful activation. Nucleotide variations 
in PROP1 can alter the three-dimensional shape of the protein, and hence impair or 
improve binding and activation. Differing hydrophobicity and length of side chains of 
substituted amino acids can alter the distance between residues, and hence modify the 
strength of homeodomain dimerisation and binding magnitude.  
7.1.2 Organogenesis and development of the pituitary gland  
The pituitary gland is an organ of dual origin, as the adenohypophysis and 
neurohypophysis arise from two different embryonic tissues (Sheng et al., 1997). The 
anterior and intermediate lobes derive from the oral ectoderm while the posterior lobe 
originates from the neural ectoderm. Pituitary organogenesis occurs in three successive 
events.   
In mouse embryogenesis, at E8.5 – E9.0, the oral ectoderm thickens, with a simultaneous 
invagination or pouching of the oral epithelium to form Rathke’s pouch (Dasen and 
Rosenfeld, 1999; Sloop et al., 1999). The creation of this rudimentary epithelial pouch (or 
placode) is considered to be the first step of organogenesis. During the second phase, 
between E10.5 and E12.5, the ventral region of the pouch epithelial cells continues to 
proliferate and extend upwards, separating off from the underlying oral ectoderm to form a 
definitive detached pouch (Sornson et al., 1996; Treier et al., 1998). Close physical contact 
is maintained between Rathke’s pouch and the neural ectoderm of the ventral diencephalon 
(called infundibulum), prior to commitment to the pituitary lineage (Dasen and Rosenfeld, 
1999; Davis et al., 2010). This direct interaction between Rathke’s pouch and the 
infundibulum is essential to facilitate the pouch’s further development and the terminal 
proliferation of the primordium (Takuma et al., 1998).  
By E15, as Rathke’s pouch continues to grow and divide, epithelial cells in the ventral 
portion of Rathke’s pouch proliferate to yield primordial endocrine cell types that occupy 
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the anterior pituitary lobe (Treier et al., 1998). In the final phase by E17.5, progenitor cell 
types differentiate to produce a spectrum of hormone-secreting cell types arranged in a 
spatially and temporally specific manner (Sheng et al., 1996; Sloop et al., 1999). The 
infundibulum ultimately becomes the posterior lobe the pituitary gland.  
7.1.3 PROP1 signalling pathways during pituitary organogenesis 
A wide array of transcription factors function together in a delicate network to bring about 
pituitary ontogenesis. The spatial and temporal control of gene expression during pituitary 
organogenesis is a highly orchestrated process. Proper pituitary development requires both 
gene activation and gene repression at suitable and precise times. During the initial stage of 
pituitary development, several signalling factors are secreted by the neuroepithelium of the 
ventral diencephalon, including bone morphogenetic proteins (BMP) 2 and 4, fibroblast 
growth factor 8 (FGF8), sonic hedgehog (Shh) and Wnt5a which play a crucial role in the 
formation of Rathke’s pouch (Voss and Rosenfeld, 1992; Sheng et al., 1996; Takuma et al., 
1998). Other growth factors, mainly homeobox proteins, released in the oral ectoderm that 
derive from Rathke’s pouch include Pitx2/RIEG, Hesx1 (or Rpx), Lhx4/Gsh4, Lhx3/P-
Lim, and Pitx1/P-OTX (Watkins-Chow and Camper, 1998; Kioussi et al., 1999; Sloop et 
al., 1999).  
PROP1 has a short period of expression, appearing at E10, peaking out at E12.5, and 
decreasing by E14.5 (Sornson et al., 1996). PROP1 is found solely in the developing 
pituitary, with no evidence of expression at or beyond birth. PROP1 expression is needed 
for the extinction of Hesx1 expression and the activation of POU1F1. PROP1 expression 
peaks one day before POU1F1, and is necessary for POU1F1expression. In turn, POU1F1 
expression is needed for the silencing of PROP1 (Watkins-Chow and Camper, 1998). 
PROP1 is also a downstream target of Notch signalling (Zhu et al., 2007). Silencing of the 
Notch signalling is required for the terminal differentiation of POU1F1-dependent cell 
lineages (Zhu et al., 2006).  
PROP1 plays a vital role in the intermediate stages of pituitary development in promoting 
the proliferation, specification and cellular differentiation of four hormone-secreting cell 
lineages of the anterior pituitary. Three of these cell types are POU1F1-dependent, namely 
somatotropes (secreting growth hormone, GH), lactotropes (secreting prolactin, PRL), and 
thyrotropes (producing thyroid stimulating hormone, TSH), while gonadotropes (producing 
luteinizing hormone, LH, and follicle stimulating hormone, FSH) do not require POU1F1 
for their emergence.  
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In vitro studies also show that PROP1 forms a complex with β-catenin which can act as 
both a transcriptional activator or repressor, depending on the context (Olson et al., 2003). 
The PROP1/β-catenin complex enhances the expression of POU1F1, while down-
regulating the expression of Hesx1 (or Rpx). The combined action of PROP1 and Wnt/β-
catenin has been found to upregulate POU1F1 expression (Gage et al., 1996; Zhu et al., 
2006).  
Though the expression of PROP1 in the developing pituitary is transient, its function is by 
no means limited. The timely activation and repression of PROP1 is necessary, since 
premature expression can impair anterior pituitary development, and prolonged expression 
impedes terminal differentiation and can result in pituitary tumours (Bartke, 1965; Sornson 
et al., 1996). 
7.1.4 PROP1 knock-out mouse models 
The effects of PROP1 mutations were first described in spontaneous mouse mutants, the 
Ames dwarf mice (df) (Sornson et al., 1996). A similar phenomenon is described in the 
Snell dwarf mice (dw and dwJ), where defects are the result of mutation in Pou1f1 (Bartke, 
1965). In accordance with traditional nomenclature, lower case letters are used for the 
murine species (Prop1), while upper case letters are applied to the human species (PROP1) 
Knock-out mice models comparing cell populations in the anterior pituitary, demonstrated 
that proliferating cells which typically migrate from the pouch to the developing anterior 
pituitary were present in PROP1 wild-type mice, but severely impaired in their mutant 
counterparts (Ward et al., 2005). Additionally, PROP1df/df mice showed a reduction in 
pouch growth and size when compared to PROP1wt/wt mice (Sornson et al., 1996).  
Sornson et al. (1996) were the first to describe a naturally occurring Prop1 mutation – a T 
to C transition resulting in a p.Ser83Pro substitution in the Ames dwarf mouse. This serine 
to proline mutation occurs at the conserved residue 83, located in the first α-helix of the 
homeodomain of PROP1df/df, thus leading to a failure to activate Pou1f1. This in turn 
significantly impairs the Pou1f1-dependent somatotropes, lactotropes and thyrotropes, with 
less than one percent of the regular number of cell types found in circulation (Sornson et 
al., 1996). The resulting phenomenon of low circulating levels of GH, PRL and TSH is 
thereby characteristic of Ames dwarf mice (PROP1df/df) and the Snell dwarf mice 
(Pou1f1dw/dw), although more pronounced in the former (Sornson et al., 1996). Supporting 
this notion, a 43% decrease in transcriptional activation by the S83P-mutant has been 
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demonstrated using transient transfection and luciferase assays (Osorio et al., 2000). The 
Ames dwarf mice also present with decreased levels of gonadotrope products, LH and 
FSH, which is exhibited phenotypically in the form of hypothyroidism, growth retardation 
and infertility.  
7.1.5 PROP1 mutations in humans 
Mutations in PROP1 are the major genetic cause of combined pituitary hormone 
deficiency (CPHD) in humans, accounting for about 50% of familial cases and 12% of 
sporadic cases (Cogan et al., 1998; Wu et al., 1998). The human PROP1 gene is situated on 
chromosome 5q35, comprising of three exons and two introns and encodes a 226-amino 
acid protein (Duquesnoy et al., 1998). Till date, about 22 recessive PROP1 mutations have 
been identified in humans (Table 7.2). The classic phenotype of CPHD involves 
deficiencies in GH, PRL, TSH, LH and FSH. 
Frameshift and nonsense mutations 
Some of the earliest and most commonly reported PROP1 mutations in humans include a 
p.R120C substitution, a p.F117I substitution, and a c.301-302delAG deletion (Cogan et al., 
1998; Wu et al., 1998). The c.301-302delAG (also called c.296delGA) mutation accounts 
for about 50-72% of all familial CPHD-related PROP1 mutations identified by several 
distinct pedigrees in various countries, thus making it the most commonly occurring 
PROP1 mutation (Cogan et al., 1998; Wu et al., 1998). All of the deletion and nonsense 
mutations result in a premature stop codon that truncates the protein transcript. 
The two most frequent mutations are two dinucleotide deletions: c.301-302delAG and 
c.149-150delGA. Both of these lead to a premature stop codon, and ultimately the 
truncation of the predicted protein product at serine 109 residue (p.S109X) (Cogan et al., 
1998; Fofanova et al., 1998; Wu et al., 1998). The truncated PROP1 products were unable 
to bind to DNA target sites, and hence failed at the transactivation of genes (Cogan et al., 
1998; Wu et al., 1998). This is expected as the deletions occur in the second α-helix of the 
homeodomain, thus eliminating completely the third α-helix and the carboxyl-terminus 
which are required for homeodomain DNA binding and transcriptional activation 
respectively. Patients with the deletion mutations failed to produce LH and FSH in 
response to gonadotropin releasing hormone (GnRH) stimulation (Wu et al., 1998). These 
mutations were also linked with CPHD in Russian children, as all patients possessing them 
exhibited deficiencies in GH, PRL and TSH (Fofanova et al., 1998). A noteworthy finding 
is the unique compound heterozygosity of the two distinct deletions (c.149-
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150delGA/c.301-302delGA), which was identified in 36% of the cases (Fofanova et al., 
1998). The Streisinger slippage-repair model postulates that the misalignment of DNA 
strands during reannealing can result in insertion and deletion mutations in repeat 
sequences, which is a leading cause of human diseases (Streisinger et al., 1966) Based on 
this theory, the AG repeat sequences in  exon 2 (295-GAGAGAG-302) are potential 
mutational hotspots for deletions and insertions. Consistent with this notion, other deletion 
mutations have been found within the exon 2 vicinity of the AG tandem repeat. 
Other frameshift mutations caused by deletions in the exon 2 of human PROP1 include: 
c.112-124del-13bp, c.150delA and c.157delA (Fofanova et al., 1998; Agarwal et al., 2000; 
Tatsumi et al., 2004). The 13 bp deletion spanning nucleotides 112-124 and located 
upstream of the homeodomain, is the largest ever reported for PROP1 (Table 7.2). The 
truncated transcript is predicted to have only 37 out of the 226 amino acids in a normal 
PROP1 protein (Agarwal et al., 2000). The mutant protein would only possess the N-
terminal region with a complete loss of the homeodomain and C-terminal regions. The 
150delA and 157delA mutations lead to an untimely stop codon that disrupts the 
homeodomain, thus impairing its abilities to bind to target DNA and activate transcription 
(Riepe et al., 2001; Tatsumi et al., 2004). 
A nonsense mutation, caused by a c.247C>T transition, resulted in a truncation of the 
PROP1 transcript at the glutamine-83 residue (Voutetakis et al., 2004). Due to its location 
in the highly conserved first α-helix, the p.Q83X mutation led to the loss of two functional 
domains, the homeodomain and the transactivation C-terminal domain. The nonsense 
mutation predicts a product with only 82 out of the 226 amino acids in a wild-type PROP1 
protein. Truncated mRNA transcripts often undergo degradation by the cell via nonsense-
mediated pathways, before they can even undergo translation. Individuals possessing the 
p.Q83X mutation showed a lack of growth acceleration in response to GH therapy. 
Neonates with the mutation also presented with prolonged jaundice, which is common with 
GH deficiency and hypothyroidism (Voutetakis et al., 2004).  
Pituitary morphology differs across patients with PROP1 mutations. In most frameshift 
deletion cases, the pituitary is hypoplastic and reduced in size (Duquesnoy et al., 1998; 
Rosenbloom et al., 1999; Osorio et al., 2000; Vallette-Kasic et al., 2001a).  
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Table 7.2 PROP1 mutations in humans 
Location Nucleotide 
change 
Amino acid 
change 
Type of 
mutation 
References 
Exon 1 c.2T>C No 
translation 
Nonsense (Lemos et al., 2006) 
Intron 1 c.109+1G>T - Splice site (Böttner et al., 2004) 
Exon 2 c.112-124del-
13bp 
S480X Frameshift (Duquesnoy et al., 1998; Agarwal et al., 
2000) 
Exon 2 c.149-150delGA S109X Frameshift (Fofanova et al., 1998; Deladoëy et al., 
1999; Kelberman et al., 2009b) 
Exon 2 c.150delA V164X Frameshift (Riepe et al., 2001; Kelberman et al., 
2009b) 
Exon 2 c.157delA V164X Frameshift (Tatsumi et al., 2004) 
Exon 2 c.211C>T R71C Missense (Paracchini et al., 2003) 
Exon 2 c.212G>A R71H Missense (Paracchini et al., 2003) 
Exon 2 c.217C>T R73C Missense (Deladoëy et al., 1999; Paracchini et al., 
2003; Voutetakis et al., 2004) 
Exon 2 c.218G>A R73H Missense (Vallette-Kasic et al., 2001a; Paracchini et 
al., 2003; Voutetakis et al., 2004) 
Exon 2 c.247C>T Q83X Nonsense (Voutetakis et al., 2004) 
Exon 2 c.263T>C F88S Missense (Osorio et al., 2000) 
Exon 2 c.295C>T R99X Nonsense (Vallette-Kasic et al., 2001a) 
Exon 2 c.296G>A R99Q Missense (Vieira et al., 2003) 
Exon 2 c.301-302delAG 
(OR c.296delGA) 
S109X Frameshift (Cogan et al., 1998; Fofanova et al., 1998; 
Wu et al., 1998) 
Exon 2 c.310delC R103X Frameshift (Kelberman et al., 2009b) 
Intron 2 c.343-2A>T - Splice site (Duquesnoy et al., 1998) 
Intron 2 c.343-11C>G - Splice site (Kelberman et al., 2009b) 
Exon 3 c.349T>A F117I Missense (Wu et al., 1998) 
Exon 3 c.358C>T R120C Missense (Flück et al., 1998; Wu et al., 1998; 
Deladoëy et al., 1999) 
Exon 3 c.373C>T R125W Missense (Kelberman et al., 2009b) 
Exon 3 c.467insT 191X Frameshift (Nose et al., 2006) 
Exon 3 c.582G>A W194X Nonsense (Reynaud et al., 2005) 
Exon 3 c.629delC  Frameshift (Reynaud et al., 2006) 
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Missense mutations 
An arginine to cysteine substitution at residue 120 (p.R120C) was brought about by a C to 
T transition; while a T to A transversion resulted in the replacement of phenylalanine by 
isoleucine (p.F117I) at amino acid position 117 (Wu et al., 1998) (Table 7.2). In addition to 
causing an impairment of transactivation activities in both cases, the p.R120C-mutant and 
p.F117I-mutant led to the decrease in DNA binding affinity by eight-fold and twenty-fold 
respectively, when compared to the wild-type PROP1 protein (Wu et al., 1998). Wu et al. 
(1998) reported that affected individuals homozygous for the p.R120C mutation exhibited 
lower circulating levels of the GH, PRL, TSH, FSH and LH hormones, while their 
adrenocorticotropic hormone (ACTH) levels were normal. They also failed to respond to 
external stimulations using LH-releasing hormone, GH-releasing hormone, and TSH-
releasing hormone.  
Of noteworthy attention, is the finding by Flück et al. (1998) in a different study where 
phenotypic variability in pituitary size and symptoms was reported amongst patients with 
the same p.R120C mutation (Flück et al., 1998). The patients presented with severe 
retardation in growth and an inability to thrive, as well as spontaneous commencement of 
puberty, attributable to TSH and/or GH deficiencies. The results indicated a deterioration 
in anterior pituitary function indicated by a gradual decline in peak levels of pituitary 
hormones (GH, TSH, PRL, LH and FSH) with age, the magnitude of which varied between 
patients (Flück et al., 1998; Böttner et al., 2004). 
The impairment brought about by PROP1 mutations in humans was comparatively more 
severe than that previously observed in the Ames dwarf mice (PROP1df/df). Supporting this 
notion, is the complete loss of gonadotropin hormones (LH and FSH) in humans, which 
was not observed in their murine counterparts (Tang et al., 1993; Wu et al., 1998). 
Two other mutations were reported in the same study: a c.310delC single nucleotide 
deletion resulting in a frameshift mutation that yielded a non-functional transcript, and a 
non-synonymous p.R125W substitution caused by a c.373C>T transition mutation in exon 
3, which impaired the transcriptional activation of genetic targets, although the mutant 
protein retained its DNA-binding capacity (Kelberman et al., 2009b) (Table 7.2). 
Compared to wild-type PROP1, the p.R125W mutant had a 40% decrease in gene 
transactivation activity, while the c.310delC mutant showed no activity at all (Kelberman 
et al., 2009b). The p.R125W mutation was located within a highly conserved basic region 
of the homeodomain. Interestingly, Guy et al. (2004) previously described two highly 
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conserved basic regions, named B1 and B2, at the N-terminal (residues 69 - 73) and C-
terminal (residues 120 - 126) ends of the homeodomain, found to contain nuclear 
localisation signals that are essential for the proper PROP1 protein transport into the 
nucleus. EMSA revealed faster migration by the p.R125W mutant-DNA complex 
compared to the wild-type, implying a change in protein conformation which possibly 
impacted the nuclear localisation signals, hence altering PROP1 nuclear transport and 
transactivation (Kelberman et al., 2009b).  
A T to C transition at nucleotide 263 resulted in the substitution of phenylalanine for serine 
at residue 88 (Osorio et al., 2000). Phenylalanine is a non-polar residue which lies in a 
highly conserved region of the homeodomain consisting of the hydrophobic core of the 
first α-helix, which is required for stabilising the PROP1 dimer-DNA complex. Hence, the 
substitution by serine, which is a polar amino acid, was expected to modify the protein 
conformation and disrupt DNA binding. The p.F88S-mutant had a 34% decrease in 
transactivation activity and impaired DNA binding to the PRDQ9 consensus, compared to 
the wild-type PROP1 (Osorio et al., 2000). The human p.F88S mutation corresponds with 
the p.F85S mutation in mice, which is two codons away from the critical p.S83P mutation 
in Ames dwarf mice (Sornson et al., 1996). In a transfection analysis, Osorio et al. (2000) 
showed that transactivation activity was reduced by 34% in the p.F85S-mutant mouse, 
compared to a decrease in activity by nearly half in the p.S83P-mutant mouse.   
Intronic mutations 
While many reports of PROP1 mutations in humans focus on the coding regions, 
interesting findings have been reported in the non-coding regions. Within affected 
individuals of three different pedigrees, Kelberman et al. (2009b) described a CPHD-
associated c.343-11C>G mutation located in the intron 2 of human PROP1. When present 
in its homozygous form, this intronic mutation interferes with accurate splicing and 
ultimately results in a PROP1 transcript lacking an exon 3 region. Individuals carrying the 
c.343-11C>G intronic mutation exhibited a deficiency in ACTH.  
7.1.6 PROP1 mutations in livestock 
Zeng et al. (2011) examined variations in exons 1 - 3 of ovine PROP1 and their association 
with commercial wool traits such as fibre diameter, natural staple length, and stretch staple 
length in Chinese Merino Sheep. The study revealed one SNP in exon 1, four SNPs in exon 
2, and one SNP in exon 3. For the non-coding regions, one SNP was described in intron 1 
and four SNPs in intron 2.  
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A synonymous p.Glu15Glu substitution resulting from a g.45A>G SNP was described in 
exon 1 (P1 fragment); and for exon 2 a combination of synonymous and non-synonymous 
variations including g.1341G>C (Arg63Ser), g.1389G>A (Ala79Ala), g.1402C>T 
(Leu84Leu) and g.1424A>G (Asn91Ser) were found (Zeng et al., 2011). In intron 1, a 
g.1198A>G was also detected. However, these variations in intron 1 and exon 2 (P2 
fragment) showed no significant association with wool traits.   
None of the four SNPs found in intron 2 (P3 fragment) were associated with phenotypic 
traits, including g.1522C>T, g.1556A>T, g.1574T>C and g.2430C>G (Zeng et al., 2011). 
A final g.2647A>G variation resulting in a p.Thr181Ala substitution was found in exon 3 
(P4 fragment). All three genotypes of this variant were found to be significantly associated 
with wool fibre diameter. Liu et al. (2015) reported a C330T variation in the intron 1 of 
PROP1 in Chinese Small Tail Han sheep. The TT and CT genotypes were associated with 
an increase in litter size, compared to the CC genotype.  
Showalter et al. (2002) investigated the molecular basis of PROP1 function by cloning the 
encoding gene in cattle and performing a comparative analysis on its protein activity and 
conservation. In that study, an amino acid change from histidine to arginine at position 173 
in the exon 3 of bovine PROP1 resulting from an A to G transition, was described. 
Although the location of this substitution was reasonably distant from the homeodomain 
(69 - 128 aa), it still had striking effects on PROP1 function. Two distinct protein products 
with varying DNA binding and activation capabilities were encoded by the two alleles 
(Arg-173 and His-173). In vitro analyses of transcription and translation using 
radiolabelled PROP1 protein isoforms demonstrated that a protein possessing the arginine 
isoform (G allele) in its carboxyl domain, had a 5-fold decrease in DNA binding and 
reduced gene activation capacity, compared to that possessing the histidine isoform (A 
allele) (Showalter et al., 2002).  
The bovine PROP1 differs markedly from that of other species due to the presence of a 
fourth exon and a corresponding third intron within its 3’ UTR. The fourth exon is 
evidently non-coding, and intron 3 is thought to contain a SinA repetitive element 
(Showalter et al., 2002).  
In the US Holstein cattle breed, the same p.His173Arg amino acid change, brought about 
by an A to G SNP in exon 3 of bovine PROP1, was found to be associated with production 
traits (Lan et al., 2013b). The arginine isoform (G allele) has a significant association with 
an increase in protein yield, total index and productive life, as well as a decrease in sire 
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Although the search for variation was performed on all sheep samples, lambs lacking 
phenotypic data for growth and carcass traits were subsequently excluded from the 
statistical analyses, leaving 720 Romney lambs for which these data were available. The 
lambs examined in this study were obtained from 40 unrelated sire-lines belonging to the 
top 20% of Romney sheep in the Sheep Improvement Limited (SIL) dual-purpose index 
ranking. 
The genomic DNA from the FTA blood samples was purified using a two-step procedure. 
This involved a cell and protein denaturation with 20 mM NaOH at 60 ºC heat for 30 min, 
and subsequent washing with 1 × TE buffer for 5 min, as outlined by Zhou et al. (2006).   
7.2.2 Primer design and PCR-SSCP protocol  
The primer pair 5’-AAGGGAGAAGTGAACAGGCT-3’ forward, and 5’- 
AGTGAGGAGACAGATTTCAGCT -3’ reverse, were used to amplify a 336 bp fragment 
of PROP1 spanning the partial exon 1 and intron 1 regions. While a 385 bp fragment of 
PROP1 spanning the exon 2 region, with flanking intron 1 and intron 2 regions, was 
amplified using the primer pair 5’-AGTCTGGGATGGATGGATGG-3’ forward, and 5’-
GCCCTGAGAATTTATGCCCC-3’ reverse. The primers were designed based on the 
sheep PROP1 sequence on the NCBI database (GenBank accession number AY533708), 
and synthesised by Integrated DNA Technologies (Coralville, IA, USA).   
The ideal PCR and SSCP conditions for each primer set were established empirically 
following multiple optimisation experiments. For a start, PCR optimisations entailed low 
stringency PCR with standard temperatures and reagent concentrations. The annealing 
temperature was subsequently raised in stepwise increments of 1 ºC until a single band was 
observed on agarose gel electrophoresis. This was done to curb non-specific amplification. 
Similar increments in a stepwise fashion were employed to the reagents used until the best 
results were obtained. Table 7.3 outlines the primer details and PCR-SSCP running 
conditions for the investigated regions of ovine PROP1.  
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Table 7.3 PROP1 primers and PCR-SSCP conditions 
 
The following protocol description is based on the conditions optimal for PROP1 exon 1. 
The protocol was similar for exon 2, except for the different conditions listed in Table 7.3. 
PCR amplifications were carried out in 15 µl reaction consisting of 1.2 mm punch of the 
sample FTA card, 0.25 µM of each primer, 3.0 mM Mg2+, 150 µM of each 
deoxyribonucleoside triphosphate (dNTP) (Bioline, London, UK), 0.5 U of Taq DNA 
polymerase (Qiagen, Hilden, Germany), 1 × reaction buffer supplied with the enzyme, and 
double-distilled water (d.H2O) to make up the volume. Amplifications took place in Bio-
rad S1000 thermal cyclers (Bio-Rad, Hercules, CA, USA). The thermal profile was as 
follows: initial denaturation at 94 ºC for 2 min, followed by 34 cycles of 94 ºC for 30 s 
(denaturation), 61 ºC for 30 s (annealing), 72 ºC for 30 s (elongation), with a final 
extension step at 72 ºC for 5 min. PCR products were visualised by agarose gel 
electrophoresis, where 2 µl of PCR products were run in 1% agarose (Quantum Scientific, 
Queensland, Australia) gels containing 200 ng/mL of ethidium bromide, using 1 × TBE 
buffer (89 mM Tris, 89 mM Boric acid, 2 mM Na2EDTA) at a voltage of 5 V/cm for 2 
hours, and visualised by ultraviolet transillumination. 
7.2.3 Single-stranded conformational polymorphism (SSCP) analyses 
Optimisations for SSCP involved running amplicons at various conditions and using 
different gel compositions until consistently clear banding patterns were obtained. 
For SSCP analysis, a 0.7 µl aliquot of the amplicon was mixed with 7 µl of loading dye 
(98% formamide, 10mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol). The 
samples were denatured at 95 ºC for 5 min and cooled rapidly on wet ice before being 
loaded on 16 x 18 cm, 14% acrylamide:bisacrylamide (37.5:1) (Bio-Rad) gels. 
PROP1  
Region 
Forward/reverse primers  
Oligonucleotide (5’ to 3’) 
Amplicon 
size 
Annealing 
temp (ºC) 
SSCP 
conditions 
Exon 1 (partial) 
Intron 1 (partial) 
F: AAGGGAGAAGTGAACAGGCT 
R: AGTGAGGAGACAGATTTCAGCT 
336 61 
14%, 300 V, 
30 ºC, 13 h 
Exon 2 
(flanking intron 
1 and 2) 
F: AGTCTGGGATGGATGGATGG 
R: GCCCTGAGAATTTATGCCCC 
385 60 
14%, 300 V, 
17 ºC, 19 h 
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Electrophoresis was carried out at 300 V at 30 ºC for 13 h in 0.5 X TBE using Protean II xi 
cells (Bio-Rad). The gels were silver-stained using a method described by (Byun et al., 
2009). Briefly, the gels were silver-stained with silver nitrate, washed with distilled water, 
and subsequently developed using a solution containing sodium hydroxide and 40% 
formaldehyde.  
In order to ensure the integrity of the experiments and to obtain reproducible banding 
patterns, freshly prepared PCR and SSCP products were always used. A negative control 
well containing no DNA was also run with each series of amplifications. 
7.2.4 Nucleotide sequencing and genotyping  
Following PCR-SSCP analysis, the banding patterns in the gels were observed. Amplicons 
deemed to be homozygous were sequenced in the forward and reverse directions using 
capillary sequencing at the Lincoln University DNA Sequencing Facility. For patterns that 
appeared to be heterozygous, single bands of non-homozygous samples were excised from 
the SSCP gel, washed repeatedly, and genomic DNA extracted. The resulting homozygous 
DNA was re-amplified, and then sequenced. Reactions were replicated to ensure accuracy 
and prevent PCR and sequencing errors. 
Sequence alignments, translations and comparisons were carried out using DNAMAN 
version 5.2.10 (Lynnon BioSoft, Vaudreuil, Canada). The BLAST algorithm 
(http://blast.ncbi.nlm.nih.gov/) was used to search the NCBI GenBank and Ensembl 
databases for homologous sequences in various species.   
7.2.5 Statistical analysis  
IBM SPSS Statistics (Version 23, IBM, NY, USA) was used to perform all analyses. Trait 
data normality was tested using the Shapiro-Wilk test and Normal Q-Q plots. Variant and 
genotypic frequencies were calculated using the PopGene 3.2 software. The variant 
frequencies were then tested for deviation from Hardy-Weinberg equilibrium using a Chi-
square test available on the Online Encyclopedia for Genetic Epidemiology Studies 
(OEGE) (Rodriguez et al., 2009). The same software was used to test for measures of 
linkage disequilibrium.  
Prediction of the effect of nucleotide variations on protein stability and function was 
performed using a variety of online software to ensure reliability, including SIFT (Ng and 
Henikoff, 2003), PROVEAN (Choi et al., 2012), HOPE (Venselaar et al., 2010), MuPro 
(Cheng et al., 2006), and iMutant 2.0 (Capriotti et al., 2005). Changes in protein stability 
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were predicted using delta delta G (ΔΔG) in Kcal/mol, which refers to a change in the 
Gibbs free energy between folded and unfolded states of the wild-type and variant protein 
sequences. The analyses were carried out on the assumptions that temperature was 25 °C 
and pH was 7.0.  
The strength of relationships between the different traits was assessed using Pearson 
correlation coefficients. A Bonferroni correction was applied to the analyses. The growth 
traits investigated were birth weight, tailing weight, weaning weight, and growth rate-to-
weaning. The carcass traits investigated were hot carcass weight (HCW), fat depth at the 
12th rib (V-GR), hind-leg lean meat yield, loin lean meat yield, shoulder lean meat yield, 
and total carcass lean meat yield. 
Two sets of general linear mixed-effect models (GLMMs) were carried out. The first 
model was used to investigate the effect of the presence and absence (coded as 1 and 0 
respectively) of a specific variant on growth and carcass traits, while the second model 
assessed associations between the genotypes for each nucleotide substitution and growth 
and carcass traits.  
The statistical model used was:  
      Yijkl = µ + Si + Gj + Bk + Vl + eijkl     
where: 
Yijkl is the trait measured on each animal (birth, tailing and weaning weights,  
                 growth-rate, HCW, V-GR, and leg, loin, shoulder, and total lean meat yields) 
µ is the mean for the trait 
Si is the random effect of sire 
Gj is the fixed effect of gender 
Bj is the fixed effect of birth rank 
Vl  is the fixed effect of variant (presence or absence) or genotype 
eijkl is the random residual error 
 
Gender was fitted as a fixed factor, and sire as a random factor in all growth trait models. 
For the growth trait models assessing the relationship between nucleotide genotype (or the 
presence/absence of a sequence variant) and tailing and weaning weights, the age at tailing 
and weaning were fitted as covariates respectively, as variation in age at measurement 
could potentially influence these traits.  
&KDSWHU&KDUDFWHULVDWLRQRIRYLQH3523YDULDWLRQDQGLWVDVVRFLDWLRQZLWKJURZWKDQGFDUFDVVWUDLWV

 146 
,QRUGHUWRDFFRXQWIRUWKHHIIHFWRISUHQDWDOJURZWKDQGGHYHORSPHQWELUWKZHLJKWZKLFK
KDGDELJJHUHIIHFWWKDQELUWKUDQNZDVILWWHGDVDFRYDULDWHLQPRGHOVDVVHVVLQJWKH
UHODWLRQVKLSEHWZHHQQXFOHRWLGHYDULDQWJHQRW\SHRUWKHSUHVHQFHDEVHQFHRIDVHTXHQFH
YDULDQWDQGJURZWKUDWHWRZHDQLQJ5HDULQJUDQNZKLFKLVUHIOHFWLYHRIPDWHUQDO
LQIOXHQFHZDVVKRZQWRKDYHDQHIIHFWDQGKHQFHZDVFRUUHFWHGIRULQJURZWKUDWHPRGHOV
)RUDOOFDUFDVVWUDLWPRGHOVJHQRW\SHZDVILWWHGDVDIL[HGIDFWRUDQGVLUHDVDUDQGRP
IDFWRUZKLOHELUWKZHLJKWDQGVODXJKWHUDJHLQGD\VZHUHILWWHGDVFRYDULDWHVVRDVWR
FRUUHFWIRUWKHHIIHFWRISUHQDWDOPXVFOHGHYHORSPHQWDQGWKHYDULDWLRQLQWKHDJHRIWKH
ODPEVDWVODXJKWHUUHVSHFWLYHO\*HQGHUZDVQRWFRUUHFWHGIRULQDQ\RIWKHFDUFDVVWUDLW
PRGHOVDVRQO\UDPODPEVZHUHVHQWIRUVODXJKWHU
7KHYDULDQWPRGHOZDVUXQLQWZRSKDVHV)LUVWO\DVLQJOHYDULDQWPRGHODVVHVVLQJWKH
XQLODWHUDOHIIHFWRIYDULDQWSUHVHQFHDEVHQFHRQLQGLYLGXDOWUDLWVZDVUXQ,IDVLJQLILFDQW
WUHQGZDVREVHUYHG3WKHWKUHVKROGIRULQFOXVLRQWKHQDVXEVHTXHQWPXOWLYDULDQW
PRGHOLQYHVWLJDWLQJWKHHIIHFWRIWKHSUHVHQFHDEVHQFHRIDYDULDQWZLWKLQWKHFRQWH[WRI
WKHHIIHFWRIWKHRWKHUYDULDQWVZDVSHUIRUPHG
9DOXHVIURPWKH*/00SDLUZLVHFRPSDULVRQZDVSUHVHQWHGDVHVWLPDWHGPDUJLQDOPHDQV
VWDQGDUGHUURUPHDQ6(8QOHVVRWKHUZLVHVSHFLILHGVWDWLVWLFDOVLJQLILFDQFHZDV
GHFODUHGDW3DQGWUHQGVZHUHREVHUYHGDW3

 5HVXOWV
 9DULDWLRQVLQRYLQH3523
$ESIUDJPHQWVSDQQLQJWKHSDUWLDOH[RQDQGLQWURQUHJLRQRI3523ZDV
DPSOLILHGLQWHQ1=VKHHSEUHHGV)LJXUH7KH3&566&3DQDO\VLVDQGQXFOHRWLGH
VHTXHQFLQJUHYHDOHGWKUHH613VRUJDQLVHGLQWRWKUHHYDULDQWSDWWHUQV$%DQG&2QH
RIWKH613VF$!*ZDVORFDWHGLQH[RQDQGZRXOGSXWDWLYHO\UHVXOWLQDV\QRQ\PRXV
S*OX*OXVXEVWLWXWLRQ/RFDWHGLQLQWURQZHUHWKHRWKHUWZR613VF7!&DQG
F&!77KHXQLTXHDUUDQJHPHQWRIWKH613VDWORFLF$!*F7!&DQG
F&!7UHVSHFWLYHO\WRIRUPYDULDQWVDUHDVIROORZV$*&&%$7&DQG
&*&77KHYDULDQWVHTXHQFHVZHUHVXEPLWWHGWR*HQ%DQNZLWKWKHDFFHVVLRQ
QXPEHUV0)0)
Chapter 7: Characterisation of ovine PROP1 variation and its association with growth and carcass traits 
 
 147 
 
Figure 7.4 Amplified regions of PROP1 and variants detected 
(a) Stylistic map showing the exon and intron regions of PROP1, and the 336 bp and 385 
bp regions amplified. (b) The resulting gel patterns from polymerase chain reaction single-
stranded conformational polymorphism (PCR-SSCP) indicating exon 1 (on the left) 
homozygous variants A1 (well 1), B1 (well 2) and C1 (well 3), and exon 2 (on the right) 
homozygous variants A2 (well 1), B2 (well 2) and C2 (well 3). The subscript ‘1’ denotes the 
exon ‘1’, while subscript ‘2’ denotes the exon ‘2’; (c) Single nucleotide polymorphisms 
(SNPs) detected in the amplified regions of PROP1 respectively. 
 
On the other hand, three unique banding patterns (A2, B2 and C2) corresponding to three 
unique DNA sequences were revealed in the 385 bp fragment of PROP1 (Figure 7.4). 
Alignment of these sequences revealed three SNPs: c.189G>C and c.237G>A in exon 2, 
and c.342+62A>T in intron 2. These SNPs have been reported previously (Zeng et al., 
2011). The variant sequences were deposited into GenBank with accession numbers 
MH469232 - MH469234. The c.237G>A SNP was synonymous (p.Ala79Ala).  
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The c.189G>C variation was found exclusively in the C2 allele. If translated, this variation 
would lead to a non-synonymous amino acid substitution from arginine to serine at 
position 63 (p.Arg63Ser) in the PROP1 homeobox domain. Prediction analyses revealed 
the non-synonymous c.189G>C (p.Arg63Ser) to yield a ΔΔG value of -0.84 Kcal/mol, thus 
indicating that the putative amino acid change would result in a less stable PROP1 protein. 
7.3.2 Variant, SNP and genotype frequencies of ovine PROP1 
Table 7.4 summarises the frequencies for PROP1 variant genotypes in exons 1 and 2 
across ten NZ sheep breeds.  
Table 7.4 Breed frequencies of ovine PROP1 
Breed 
 PROP1 Exon 1 Variant Genotypes (%) 
n A1A1 A1B1 A1C1 B1B1 B1C1 C1C1 
Romney 720 47.8 17.9 14.2 5.1 12.1 2.9 
Coopworth 30 40.0 23.3 23.3 6.7 6.7 _ 
Corriedale 30 33.3 30.0 33.3 _ 3.4 _ 
Dorset Down 31 29.0 12.9 51.7 3.2 _ 3.2 
Merino 32 50.0 18.7 12.5 6.3 12.5 _ 
Perendale 30 46.7 26.7 13.3 3.3 10.0 _ 
Poll Dorset 33 36.4 15.1 36.4 _ 9.0 3.1 
Suffolk 31 32.2 22.6 35.5 6.4 _ 3.3 
Texel 40 35.0 15.0 40.0 _ 5.0 5.0 
White Dorper 41 48.8 14.6 24.4 9.8 2.4 _ 
        
Total 1018       
        
Breed 
 PROP1 Exon 2 Variant Genotypes (%) 
n A2A2 A2B2 A2C2 B2B2 B2C2 C2C2 
Romney 720 25.7 51.1 8.0 9.6 4.9 0.7 
Coopworth 30 20.0 50.0 10.0 20.0 _ _ 
Corriedale 30 16.7 33.3 6.7 20.0 23.3 _ 
Dorset Down 31 29.0 51.6 3.3 16.1 _ _ 
Merino 32 18.7 25.0 12.6 18.7 25.0 _ 
Perendale 30 16.7 50.0 10.0 16.7 6.6 _ 
Poll Dorset 33 30.3 48.5 _ 18.1 3.1 _ 
Suffolk 31 29.0 51.6 3.2 16.2 _ _ 
Texel 40 10.0 60.0 _ 25.0 5.0 _ 
White Dorper 41 19.5 24.4 21.9 _ 31.7 2.5 
        
Total 1018       
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The most abundant genotypes across most breeds were A1A1 for exon 1, and A2B2 for exon 
2. The C2C2 genotype was the rarest, presenting only in the Romney and White Dorper 
breeds at 0.7% and 2.5% respectively, compared to C1C1 genotype which was present in 
five breeds (Table 7.4). The A1C1 was found in all sheep breeds examined, whereas the 
A2C2 genotype was not observed in the Poll Dorset and Texel breeds. The B2B2 genotype 
frequency was lowest in the Romney breed and highest in the Texel breed, and was 
observed in all but the White Dorper breed.   
The genotypic and variant frequencies for exon 1 SNPs are presented in Table 7.5. 
Table 7.5 Variant and genotype frequencies for exon 1 of ovine PROP1 in NZ 
Romney sheep 
SNP 
AA1 
change 
Vari
ant 
Variant 
frequency 
n Genotype 
Genotype 
frequency 
HWE2 
c.45A>G p.Glu15Glu A 0.2 34 AA 0.07 χ2 = 2.84 
(Exon 1)  G 0.8 201 AG 0.45 P = 0.092 
    435 GG 0.48  
        
c.109+40T>C - C 0.8 435 CC 0.48 χ2 = 2.84 
(Intron 1)  T 0.2 201 CT 0.45 P = 0.092 
    34 TT 0.07  
        
c.109+207C>T - C 0.84 474 CC 0.89 χ2 = 0.55 
(Intron 1)  T 0.16 176 CT 0.11 P = 0.474 
    20 TT 0.00  
1 AA – amino acid predicted,  2 HWE: Hardy-Weinberg Equilibrium 
None of the variants deviated from Hardy-Weinberg Equilibrium (P < 0.05). The c.45A>G 
and c.109+40 T>C exhibited the same pattern of allelic and genotypic frequencies, with the 
G and C as major alleles with frequencies of 80%, while the A and T minor alleles had 
frequencies of 20% (Table 7.5).  
On the genotypic end, the predominant homozygous genotypes (GG and CC) had 
frequencies of 48%, which was similar to the 45% frequencies observed for heterozygotes 
(AG and CT), while the AA and TT genotypes exhibited the lowest frequencies of 7%. 
More extreme values were observed for the c.109+207C>T with the major allele (C) 
frequency of 84%, and the minor allele (T) frequency of 16% (Table 7.5). Genotype 
analysis revealed the CC genotype to have the highest frequency (89%), followed by CT 
(11%), while TT was not observed (0%).  
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The genotypic and variant frequencies for exon 2 SNPs are presented in Table 7.6. 
Table 7.6 Variant and genotype frequencies for exon 2/intron 2 of ovine PROP1 in NZ 
Romney sheep 
SNP 
AA1 
change 
Variant 
Variant 
frequency 
n Genotype 
Genotype 
frequency 
HWE2 
c.189G>C p.Arg63Ser C 0.07 5 CC 0.01 χ2 = 0.73 
(Exon 2)  G 0.93 87 CG 0.13 P = 0.381 
    578 GG 0.86  
        
c.237G>A p.Gly79Gly A 0.55 172 AA 0.30 χ2 = 25.51 
(Exon 2)  G 0.45 396 AG 0.50 P < 0.001 
    102 GG 0.20  
         
c.342+62A>T - A 0.45 102 AA 0.20 χ2 = 25.51 
(Intron 2)  T 0.55 396 AT 0.50 P < 0.001 
       172 TT 0.30   
1 AA – amino acid predicted,  2 HWE: Hardy-Weinberg Equilibrium 
For c.189G>C, the guanine frequency (93%) was much higher than that of cytosine (7%). 
The c.237G>A SNP had nucleotides of similar frequencies – adenine (55%) and guanine 
(45%), and for the c.342+62A>T SNP, adenine was found at a frequency of 45%. In both 
cases, upon HWE analysis, the P-value was less than 0.001, suggesting that the observed 
frequencies differed from the expected population frequency (Table 7.6).  
The measures of LD (r2 and D′) between pairs of SNPs in exon 2 of ovine PROP1 were 
calculated using the OEGE software and the results are presented in Table 7.7.  
Table 7.7 Linkage disequilibrium measures between SNP pairs detected in exon 2 of 
ovine PROP1 
Locus 1 Locus 2 D' r2 
c.189G>C c.237G>A 1.0 0.096 
c.189G>C c.342+62A>T 1.0 0.096 
c.237G>A c.342+62A>T -1.0 1.0 
   D′: Lewontin's coefficient;  r2: squared correlation coefficient  
The D’ value for the three SNPs in exon 2 of ovine PROP1 is 1, meaning that the SNPs are 
in high linkage disequilibrium, and hence are likely co-inherited. 
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7.3.3 Association of growth traits with PROP1 exon 1 genetic variants  
The results for the association of PROP1 exon 1 variants with growth traits in NZ Romney 
lambs are given in Table 7.8.  
Table 7.8 Association of PROP1 exon 1 variants with growth traits in NZ Romney 
sheep 
 Trait 
(unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant 
absent (0) 
n 
Variant  
present (1) 
n P-value  
Birth  A1  5.48 ± 0.22 145 5.54 ± 0.21 575 0.406 
weight (kg) B1  5.56 ± 0.21 467 5.42 ± 0.22 253 0.025 
  C1  5.53 ± 0.21 510 5.57 ± 0.22 210 0.476 
Tailing  A1  11.09 ± 0.60 145 12.17 ± 0.58 575 <0.001 
weight (kg) B1  12.17 ± 0.58 467 11.51 ± 0.60 253 <0.001 
 C1  12.10 ± 0.59 510 11.74 ± 0.60 210 0.053 
 A1 B1, C1 11.14 ± 0.61 145 12.11 ± 0.59 575 0.001 
 B1 A1, C1 11.74 ± 0.59 467 11.51 ± 0.59 253 0.275 
  C1 A1, B1 11.59 ± 0.59 510 11.66 ± 0.60 210 0.737 
Weaning  A1  28.00 ± 1.00 145 30.88 ± 0.95 575 <0.001 
weight (kg) B1  30.90 ± 0.98 467 29.28 ± 1.00 253 <0.001 
 C1  30.75 ± 0.99 510 29.71 ± 1.02 210 0.001 
 A1 B1, C1 28.09 ± 1.01 145 30.78 ± 0.97 575 <0.001 
 B1 A1, C1 29.64 ± 0.97 467 29.23 ± 0.98 253 0.246 
  C1 A1, B1 29.37 ± 0.97 510 29.50 ± 0.98 210 0.719 
Growth rate  
to weaning  
A1  237.90 ± 10.38 145 270.11 ± 9.91 575 <0.001 
B1  273.62 ± 10.38 467 257.67 ± 10.41 253 <0.001 
(g/day) C1  268.10 ± 10.34 510 254.36 ± 10.69 210 <0.001 
 A1 B1, C1 238.89 ± 10.58 145 269.65 ± 10.05 575 <0.001 
 B1 A1, C1 255.13 ± 10.31 467 253.41 ± 10.07 253 0.638 
  C1 A1, B1 254.59 ± 10.12 510 253.95 ± 10.26 210 0.860 
 
Only the B1 variant showed significant association with birth weight – a decrease from 
5.56 kg to 5.42 kg. The A1 variant exhibited strong association with an increase in tailing 
weight by 1.08 kg, weaning weight by 2.88 kg and growth rate-to-weaning by 32.21 g/day, 
with significance persisting in the multi-variant analysis (Table 7.8). Both the B1 and C1 
variants, on the other hand, showed negative associations with tailing and weaning 
weights, and growth rate-to-weaning, which were no longer significant when other variants 
were accounted for. This suggests that only the A1 effect is independent of other variants.  
Association studies assessing the effect of individual SNPs in exon 1 with growth traits 
were carried out in NZ Romney breeds, and the results are summarised in Table 7.9. 
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Table 7.9 Association of PROP1 exon 1 SNP genotypes with growth traits in NZ 
Romney sheep 
                       SNP   
Trait    
c.45A>G (Glu15Glu) 
AA (n = 37) AG (n = 216) GG (n = 467) P-value 
Birth weight (kg) 5.33 ± 0.25 5.43 ± 0.22 5.56 ± 0.21 0.063 
Tailing weight (kg) 11.06 ± 0.69a 11.57 ± 0.60a 12.17 ± 0.58b <0.001 
Weaning weight (kg) 27.20 ± 1.15 29.59 ± 1.00 30.87 ± 0.97 <0.001 
Growth rate  234.60 ± 12.00 260.63 ± 10.34 272.90 ± 10.28 <0.001 
to weaning (g/day)     
 
 c.109+40T>C 
  TT (n = 37) CT (n = 216) CC (n = 467) P-value 
Birth weight (kg) 5.33 ± 0.25 5.43 ± 0.22 5.56 ± 0.21 0.063 
Tailing weight (kg) 11.06 ± 0.69a 11.57 ± 0.60a 12.17 ± 0.58b <0.001 
Weaning weight (kg) 27.20 ± 1.15 29.59 ± 1.00 30.87 ± 0.97 <0.001 
Growth rate  234.60 ± 12.00 260.63 ± 10.34 272.90 ± 10.28 <0.001 
to weaning (g/day)     
 
 c.109+207C>T 
CC (n = 510) CT (n = 189) TT (n = 21) P-value 
Birth weight (kg) 5.53 ± 0.21 5.55 ± 0.22 5.81 ± 0.27 0.281 
Tailing weight (kg) 12.09 ± 0.59 11.80 ± 0.60 11.12 ± 0.76 0.060 
Weaning weight (kg) 30.74 ± 0.99a 29.85 ± 1.02b 28.38 ± 1.28b 0.001 
Growth rate  268.41 ± 10.31a 256.45 ± 10.71b 237.85 ± 13.21b <0.001 
to weaning (g/day)     
 a, b Mean values in the same row with different superscripts differ at P < 0.05. 
 
The GG and CC homozygotes at the c.45A>G and c.109+40T>C loci respectively, showed 
significant association with an increase in several growth traits when compared to the 
AA/AG and TT/TC genotypes (Table 7.9). An increase in tailing weight by 1.11 kg, 
weaning weight by 3.67 kg, and growth rate-to-weaning by 38.3 g/day was observed for 
both the GG and CC variant genotypes when compared to the AA and TT genotypes.  
In contrast, individuals with the TT variant genotypes at the c.109+207C>T locus exhibited 
a trend (P = 0.060) toward a decrease in tailing weight by 0.97 kg. When compared to their 
CC counterparts, lambs possessing the TT genotype showed a decrease in weaning weight 
by 7.7% and growth rate by 11.4%. Although none of the genotypes demonstrated 
significant association with birth weight in NZ Romney sheep, a strong increasing trend 
was observed (P = 0.063) with the variant genotypes of c.45A>G and c.109+40T>C.   
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7.3.4 Association of growth traits with PROP1 exon 2 genetic variants  
The results for the association of PROP1 exon 2 variants with growth traits in NZ Romney 
lambs are given in Table 7.10.  
Table 7.10 Association of PROP1 exon 2 variants with growth traits in NZ Romney 
sheep 
 
Lambs possessing the A2 variant grew faster by 27.5 g/day, and had higher weights at 
tailing (0.75 kg) and weaning (2.75 kg); while lambs possessing the C2 variant had grew 
slower by 22.3 g/day, and had lower tailing (0.87 kg) and weaning (2.27 kg) weights 
(Table 7.10). The B2 variant showed no association with ovine growth traits. The C2 was 
the only variant to show a significant association with a decrease in birth weight by 0.19 
kg. 
Association studies assessing the effect of individual SNPs in exon 2 with growth traits 
were carried out in NZ Romney breeds, and the results are summarised in Table 7.11.  
  
Trait (unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant absent 
(0) 
n 
Variant  
present (1) 
n P-value  
Birth  A2  5.51 ± 0.22 110 5.54 ± 0.21 610 0.787 
weight (kg) B2  5.47 ± 0.22  248 5.56 ± 0.21 472 0.186 
 C2  5.55 ± 0.21 622 5.36 ± 0.23 98 0.031 
 B2 C2 5.42 ± 0.22 248 5.47 ± 0.22 472 0.409 
  C2 B2 5.53 ± 0.21 622 5.36 ± 0.23 98 0.058 
Tailing  A2  11.35 ± 0.62 110 12.10 ± 0.58 610 0.001 
weight (kg) B2  11.92 ± 0.60 248 12.07 ± 0.59 472 0.390 
 C2  12.10 ± 0.58 622 11.23 ± 0.62 98 <0.001 
 A2 C2 11.23 ± 0.62 110 11.78 ± 0.59 610 0.022 
  C2 A2 11.86 ± 0.59 622 11.15 ± 0.62 98 0.005 
Weaning  A2  28.28 ± 1.03 110 30.85 ± 0.97 610 <0.001 
weight (kg) B2  30.38 ± 1.02 248 30.65 ± 1.00 472 0.382 
 C2  30.74 ± 0.98 622 28.47 ± 1.05 98 <0.001 
 A2 C2 27.98 ± 1.02 110 30.10 ± 0.98 610 <0.001 
  C2 A2 29.86 ± 0.97 622 28.22 ± 1.03 98 <0.001 
Growth rate  
to weaning  
A2  247.91 ± 10.48 110 275.45 ± 10.23 610 <0.001 
B2  265.04 ± 10.70 248 266.52 ± 10.49 472 0.630 
(g/day) C2  268.45 ± 10.27 622 246.12 ± 10.94 98 <0.001 
 A2 C2 244.62 ± 10.43 248 267.93 ± 10.36 472 <0.001 
  C2 A2 263.97 ± 10.09 622 248.58 ± 10.72 98 <0.001 
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Table 7.11 Association of PROP1 exon 2 SNP genotypes with growth traits in NZ 
Romney sheep 
                        SNP                              
Trait    
c.189G>C (Arg63Ser) 
GG (n = 622) CG (n = 93) CC (n = 5) P-value 
Birth weight (kg) 5.54 ± 0.21a 5.40 ± 0.23b 4.34 ± 0.42b 0.001 
Tailing weight (kg) 12.09 ± 0.58a 11.30 ± 0.62a 9.83 ± 1.14b 0.007 
Weaning weight (kg) 30.69 ± 0.97 28.67 ± 1.04 24.08 ± 1.92 <0.001 
Growth rate  268.30 ± 10.23a 248.33 ± 10.93a 203.73 ± 20.00b <0.001 
to weaning (g/day)     
 
 c.237G>A (Ala79Ala) 
  GG (n = 109) AG (n = 426) AA (n = 185) P-value 
Birth weight (kg) 5.52 ± 0.22 5.55 ± 0.21 5.51 ± 0.22 0.849 
Tailing weight (kg) 11.29 ± 0.62a 12.15 ± 0.58b 12.00 ± 0.60b 0.002 
Weaning weight (kg) 28.31 ± 1.03a 30.92 ± 0.97b 30.65 ± 1.00b <0.001 
Growth rate  248.11 ± 10.48a 276.05 ± 10.28b 273.87 ± 10.49b <0.001 
to weaning (g/day)     
 
 c.342+62A>T 
AA (n = 109) AT (n = 426) TT (n = 185) P-value 
Birth weight (kg) 5.52 ± 0.22 5.55 ± 0.21 5.51 ± 0.22 0.849 
Tailing weight (kg) 11.29 ± 0.62a 12.15 ± 0.58b 12.00 ± 0.60b 0.002 
Weaning weight (kg) 28.31 ± 1.03a 30.92 ± 0.97b 30.65 ± 1.00b <0.001 
Growth rate  248.11 ± 10.48a 276.05 ± 10.28b 273.87 ± 10.49b <0.001 
to weaning (g/day)     
a, b Mean values in the same row with different superscripts differ at P < 0.05. 
 
At the c.237G>A and c.342+62A>T variant loci, the heterozygous genotypes, AG and AT 
respectively, had the highest tailing weight, weaning weight and growth rate when 
compared to the homozygous genotypes (Table 7.11). When compared to lambs having the 
GG genotype, lambs possessing the AG genotype of c.237G>A weighed 7.6% and 9.2% 
more at tailing and weaning respectively, and grew 11.3% faster. 
The rare CC variant of c.189G>C had the lowest weights at birth, tailing and weaning, and 
growth rate, compared to the CG and GG genotypes. Only five individuals expressed the 
CC genotype, hence the results presented with regards to this genotype might not be 
representative of the population. 
 
  
Chapter 7: Characterisation of ovine PROP1 variation and its association with growth and carcass traits 
 
 155 
7.3.5 Association of carcass traits with PROP1 exon 1 genetic variants  
The association of PROP1 exon 1 variants with carcass traits in NZ Romney lambs are 
given in Table 7.12. 
Table 7.12 Association of PROP1 exon 1 variants with carcass traits in NZ Romney 
sheep 
Trait (unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant 
absent (0) 
n 
Variant  
present (1) 
n 
P-
value  
HCW1 (kg) A1  16.62 ± 0.15 135 17.21 ± 0.09 535 <0.001 
 B1  17.19 ± 0.10 435 17.00 ± 0.11 235 0.132 
 C1  17.17 ± 0.09 474 16.93 ± 0.13 196 0.061 
 A1 B1, C1 16.57 ± 0.16 135 17.24 ± 0.11 535 0.001 
 B1 A1, C1 16.85 ± 0.13 435 16.96 ± 0.12 235 0.474 
  C1 A1, B1 16.90 ± 0.12 474 16.92 ± 0.13 196 0.905 
V-GR2 Fat  A1  4.73 ± 0.22 135 4.18 ± 0.13 535 0.010 
Depth (mm) B1  4.10 ± 0.14 435 4.55 ± 0.16 235 0.013 
 C1  4.22 ± 0.13 474 4.42 ± 0.19 196 0.274 
 A1 B1 4.62 ± 0.23 135 4.24 ± 0.13 535 0.135 
  B1 A1 4.29 ± 0.19 474 4.57 ± 0.17 196 0.184 
Leg  A1  21.21 ± 0.11 135 21.55 ± 0.06 535 0.002 
Yield (%) B1  21.56 ± 0.07 435 21.39 ± 0.08 235 0.061 
 C1  21.55 ± 0.06 474 21.31 ± 0.09 196 0.012 
 A1 B1, C1 21.26 ± 0.12 135 21.48 ± 0.08 535 0.122 
 B1 A1, C1 21.40 ± 0.09 435 21.34 ± 0.08 235 0.584 
  C1 A1, B1 21.44 ± 0.08 474 21.30 ± 0.09 196 0.193 
Loin  A1  14.33 ± 0.08 135 14.59 ± 0.04 535 0.001 
Yield (%) B1  14.60 ± 0.05 435 14.47 ± 0.06 235 0.043 
 C1  14.59 ± 0.04 474 14.40 ± 0.06 196 0.005 
 A1 B1, C1 14.37 ± 0.08 135 14.54 ± 0.06 535 0.115 
 B1 A1, C1 14.48 ± 0.07 435 14.43 ± 0.06 235 0.526 
  C1 A1, B1 14.51 ± 0.06 474 14.40 ± 0.07 196 0.120 
Shoulder  A1  16.54 ± 0.08 135 16.84 ± 0.05 535 <0.001 
Yield (%) B1  16.88 ± 0.05 435 16.64 ± 0.06 235 0.001 
 C1  16.82 ± 0.05 474 16.70 ± 0.07 196 0.109 
 A1 B1, C1 16.60 ± 0.09 135 16.80 ± 0.06 535 0.077 
 B1 A1, C1 16.77 ± 0.07 435 16.62 ± 0.06 235 0.074 
  C1 A1, B1 16.71 ± 0.06 474 16.69 ± 0.07 196 0.767 
Total  A1  52.09 ± 0.22 135 52.98 ± 0.13 535 <0.001 
Yield (%)   B1  53.03 ± 0.14 435 52.50 ± 0.17  235 0.004 
 C1  52.95 ± 0.13 474 52.42 ± 0.19 196 0.006 
 A1 B1, C1 52.24 ± 0.25 135 52.82 ± 0.16 535 0.053 
 B1 A1, C1 52.66 ± 0.19 435 52.40 ± 0.17 235 0.254 
  C1 A1, B1 52.67 ± 0.17 474 52.39 ± 0.19 196 0.203 
1 HCW = Hot carcass weight,  2 V-GR = Viascan fat depth around the 12th rib 
  
Chapter 7: Characterisation of ovine PROP1 variation and its association with growth and carcass traits 
 
 156 
The A1 variant was associated with an increase in carcass weight by 0.59 kg, and a 
decrease in fat depth by 0.55 mm, while the B1 variant was associated with an increase in 
fat depth by 0.45 mm (Table 7.12).  
The A1 variant showed association with an increase in leg, loin, shoulder, and total lean 
meat yields by 1.6%, 1.8%, 1.8% and 1.7% respectively. The B1 variant was associated 
with a decrease in loin, shoulder and total lean meat yields by 0.89%, 1.4% and 1% 
respectively. The C1 variant was also associated with a decrease in leg, loin and total meat 
yields by 1.1%, 1.3% and 1% respectively. 
Association studies assessing the effect of individual SNPs in exon 1 with carcass traits 
were carried out in NZ Romney breeds, and the results are summarised in Table 7.13. 
Table 7.13 Association of PROP1 exon 1 SNP genotypes with carcass traits in NZ 
Romney sheep 
                         SNP                              
Trait    
c.45A>G (Glu15Glu) 
AA (n = 34) AG (n = 201) GG (n = 435) P-value 
HCW1 (kg) 16.50 ± 0.27a 17.07 ± 0.12b 17.18 ± 0.10b 0.038 
V-GR2 Fat Depth (mm) 4.82 ± 0.39a 4.50 ± 0.17ab 4.10 ± 0.14b 0.033 
Leg Yield (%) 21.09 ± 0.19a 21.43 ± 0.09ab 21.55 ± 0.07a 0.039 
Loin Yield (%) 14.34 ± 0.13 14.49 ± 0.06 14.60 ± 0.05 0.076 
Shoulder Yield (%) 16.34 ± 0.14 16.69 ± 0.06 16.88 ± 0.05 <0.001 
Total Yield (%) 51.78 ± 0.40 52.61 ± 0.18 53.03 ± 0.14 0.002 
 
 c.109+40T>C 
  TT (n = 34) CT (n = 201) CC (n = 435) P-value 
HCW1 (kg) 16.50 ± 0.27a 17.07 ± 0.12b 17.18 ± 0.10b 0.038 
V-GR2 Fat Depth (mm) 4.82 ± 0.39a 4.50 ± 0.17ab 4.10 ± 0.14b 0.033 
Leg Yield (%) 21.09 ± 0.19a 21.43 ± 0.09b 21.55 ± 0.07a 0.039 
Loin Yield (%) 14.34 ± 0.13 14.49 ± 0.06 14.60 ± 0.05 0.076 
Shoulder Yield (%) 16.34 ± 0.14 16.69 ± 0.06 16.88 ± 0.05 <0.001 
Total Yield (%) 51.78 ± 0.40 52.61 ± 0.18 53.03 ± 0.14 0.002 
 
 c.109+207C>T 
CC (n = 474) CT (n = 176) TT (n = 20) P-value 
HCW1 (kg) 17.17 ± 0.09 16.98 ± 0.13 16.44 ± 0.34 0.050 
V-GR2 Fat Depth (mm) 4.22 ± 0.13a 4.28 ± 0.19a 5.77 ± 0.49b 0.006 
Leg Yield (%) 21.55 ± 0.06a 21.37 ± 0.10a 20.75 ± 0.24b 0.002 
Loin Yield (%) 14.59 ± 0.04 14.44 ± 0.07 14.03 ± 0.17 0.001 
Shoulder Yield (%) 16.82 ± 0.05a 16.74 ± 0.07ab 16.39 ± 0.18a 0.054 
Total Yield (%) 52.96 ± 0.13a 52.55 ± 0.20a 51.18 ± 0.50b 0.001 
a, b Mean values in the same row with different superscripts differ at P < 0.05 
1 HCW = Hot carcass weight, 2 V-GR = Viascan fat depth around the 12th rib 
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The predominant GG and CC genotypes of c.45A>G and c.109+40T>C respectively, had 
the highest carcass weight (17.18 ± 0.10), leg yield (21.55 ± 0.07), shoulder yield (16.88 ± 
0.05), and total lean meat yield (53.03 ± 0.14), as well as the lowest fat depth (4.10 ± 0.14), 
compared to the heterozygous AG/CT and homozygous AA/TT (Table 7.13).  
In contrast, the less abundant TT genotype of c.109+207C>T had the lowest leg yield 
(20.75 ± 0.24), loin yield (14.03 ± 0.17) and total yield (51.18 ± 0.5), but the highest fat 
depth (5.77 ± 0.49).  
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7.3.6 Association of carcass traits with PROP1 exon 2 genetic variants  
The results for the association of PROP1 exon 2 variants with carcass traits in NZ Romney 
lambs are given in Table 7.14. 
Table 7.14 Association of PROP1 exon 2 variants with carcass traits in NZ Romney 
sheep 
Trait (unit) 
Variant 
assessed 
Other 
variants 
Mean ±  SE  
Variant absent 
(0) 
n 
Variant  
present (1) 
n P-value  
HCW1 (kg)  A2  16.14 ± 0.16 103 17.30 ± 0.08 567 <0.001 
 B2  17.20 ± 0.11 231 17.07 ± 0.09 439 0.269 
 C2  17.17 ± 0.09 578 16.75 ± 0.17 92 0.013 
 A2 C2 16.12 ± 0.16 103 17.25 ± 0.11 567 <0.001 
  C2 A2 16.74 ± 0.10 578 16.64 ± 0.16 92 0.548 
V-GR2 Fat  
Depth (mm)  
A2  3.93 ± 0.23 103 4.33 ± 0.13 567 0.093 
B2  4.47 ± 0.16 231 4.16 ± 0.14 439 0.075 
 C2  4.25 ± 0.13 578 4.35 ± 0.25 92 0.716 
 A2 B2 4.04 ± 0.25 103 4.35 ± 0.13 567 0.208 
  B2 A2 4.32 ± 0.20 231 4.07 ± 0.15 439 0.165 
Leg  A2  21.36 ± 0.12 103 21.52 ± 0.06 567 0.195 
Yield (%) B2  21.47 ± 0.08 231 21.51 ± 0.07 439 0.647 
 C2  21.52 ± 0.06 578 21.31 ± 0.12 92 0.090 
 A2 C2 21.34 ± 0.12 103 21.44 ± 0.08 567 0.384 
  C2 A2 21.48 ± 0.08 578 21.30 ± 0.12 92 0.163 
Loin  A2  14.21 ± 0.08 103 14.61 ± 0.04 567 <0.001 
Yield (%) B2  14.57 ± 0.06 231 14.53 ± 0.05 439 0.480 
 C2  14.57 ± 0.04 578 14.37 ± 0.09 92 0.016 
 A2 C2 14.19 ± 0.08 103 14.57 ± 0.06 567 <0.001 
  C2 A2 14.43 ± 0.05 578 14.33 ± 0.08 92 0.257 
Shoulder  
Yield (%) 
A2  16.58 ± 0.09 103 16.83 ± 0.05 567 0.005 
B2  16.76 ± 0.06 231 16.81 ± 0.05 439 0.511 
 C2  16.81 ± 0.05 578 16.66 ± 0.09 92 0.097 
 A2 C2 16.56 ± 0.09 103 16.79 ± 0.06 567 0.014 
  C2 A2 16.72 ± 0.06 578 16.63 ± 0.09 92 0.349 
Total  A2  52.15 ± 0.24 103 52.96 ± 0.13 567 0.001 
Yield (%)    B2  52.81 ± 0.17 231 52.85 ± 0.14 439 0.824 
 C2  52.90 ± 0.13 578 52.33 ± 0.25 92 0.025 
 A2 C2 52.09 ± 0.24 103 52.81 ± 0.17 567 0.005 
  C2 A2 52.63 ± 0.16 578 52.26 ± 0.25 92 0.159 
1 HCW = Hot carcass weight, 2 V-GR = Viascan fat depth around the 12th rib 
For the variant model, GLMM revealed that the presence (and absence) of PROP1 
variants, A2 and C2, were associated with carcass traits. In the single-variant model, the 
presence of A2 was associated with an increase in hot carcass weight by 1.16 kg, loin yield 
by 2.8%, shoulder yield by 1.5%, and total yield by 1.5% (Table 7.14).  
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In contrast, the C2 variant was associated with a decrease in hot carcass weight by 0.42 kg, 
loin yield by 1.4%, and total yield by 1.1%. The associations observed for the A2 variant 
persisted, while those observed for C2 were lost in the multi-variant analyses. This means 
that the A2 variant effect is not weakened by the presence of other variants.  
In the multi-variant model, the effect of A2 in increasing leg, loin, shoulder and total yields 
persisted. There was a trend for association (P = 0.075) between intermuscular fat depth 
trait and presence/absence of B2. This trend was lost in the multi-variant model, suggesting 
the effect was probably driven by variant A2 in the large number of A2B2 lambs. 
Association studies assessing the effect of individual SNPs in exon 2 with carcass traits 
were carried out in NZ Romney breeds, and the results are summarised in Table 7.15. 
Table 7.15 Association of PROP1 exon 2 SNP genotypes with carcass traits in NZ 
Romney sheep 
                            SNP 
Trait    
c.189G>C (Arg63Ser) 
GG (n = 578) CG (n = 87) CC (n = 5) P-value 
HCW1 (kg) 17.17 ± 0.09a 16.77 ± 0.17b 16.45 ± 0.67b 0.042 
V-GR2 Fat Depth (mm) 4.26 ± 0.12a 4.13 ± 0.25b 8.06 ± 0.96b <0.001 
Leg Yield (%)  21.52 ± 0.06 21.35 ± 0.13 20.58 ± 0.48 0.072 
Loin Yield (%)  14.57 ± 0.04a 14.41 ± 0.09ab 13.58 ± 0.34b 0.003 
Shoulder Yield (%)  16.81 ± 0.05a 16.72 ± 0.09b 15.49 ± 0.36b 0.001 
Total Yield (%)  52.90 ± 0.13a 52.49 ± 0.26ab 49.65 ± 0.99b 0.002 
  
c.237G>A (Ala79Ala)  
GG (n = 102) AG (n = 396) AA (n = 172) P-value 
HCW1 (kg) 16.13 ± 0.16a 17.29 ± 0.09b 17.28 ± 0.12b <0.001 
V-GR2 Fat Depth (mm) 3.93 ± 0.24 4.29 ± 0.14 4.41 ± 0.18 0.198 
Leg Yield (%) 21.36 ± 0.12 21.52 ± 0.07 21.51 ± 0.09 0.430 
Loin Yield (%) 14.20 ± 0.08a 14.60 ± 0.05b 14.63 ± 0.06b <0.001 
Shoulder Yield (%) 16.57 ± 0.09a 16.83 ± 0.05ab 16.82 ± 0.07b 0.018 
Total Yield (%) 52.14 ± 0.24a 52.95 ± 0.14ab 52.96 ± 0.19b 0.004 
  
c.342+62A>T 
AA (n = 102) AT (n = 396) TT (n = 172) P-value 
HCW1 (kg) 16.13 ± 0.16a 17.29 ± 0.09b 17.29 ± 0.12b <0.001 
V-GR2 Fat Depth (mm) 3.93 ± 0.24 4.29 ± 0.14 4.41 ± 0.18 0.198 
Leg Yield (%) 21.36 ± 0.12 21.52 ± 0.07 21.51 ± 0.09 0.430 
Loin Yield (%) 14.20 ± 0.08a 14.60 ± 0.05b 14.63 ± 0.06b <0.001 
Shoulder Yield (%) 16.57 ± 0.09a 16.83 ± 0.05ab 16.82 ± 0.07b 0.018 
Total Yield (%) 52.14 ± 0.24a 52.95 ± 0.14ab 52.96 ± 0.19b 0.004 
a, b Mean values in the same row with different superscripts differ at P < 0.05 
1 HCW = Hot carcass weight, 2 V-GR = Viascan fat depth around the 12th rib 
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The variant CC genotype at the c.189G>C locus was strongly associated with lower 
carcass yields when compared to its GG counterpart (Table 7.15). The trait values for the 
CG heterozygotes dwelled in a middle range between the GG and CC genotype values. 
The CC genotype exhibited a decrease in hot carcass weight by 4.2%, loin yield by 6.8%, 
shoulder yield by 7.8%, and total yield by 6.1%, when compared to GG.  
While leg yield followed a similar trend to the other yields, its association was not 
significant (P = 0.072). Interestingly, the CC genotype was associated with a remarkable 
89% increase in the fat depth around the 12th rib when compared to the GG genotype. It is 
worth noting that only a small number of animals (n = 5) carried the CC genotype, as 
compared to 578 GG-possessing animals. This enormous disparity in genotype distribution 
could justify some of the findings. 
In contrast, the variant genotypes, AA and TT, at the c.237G>A and c.342+62A>T loci 
respectively, were both associated with a marked increase in hot carcass weight from 16.13 
kg to 17.29 kg, loin yield from 14.20% to 14.63%, shoulder yield from 16.57% to 16.82%, 
and total yield from 52.14% to 52.96% (Table 7.15). Unlike the c.189 G>C SNP, the 
heterozygotes of c.237G>A and c.342+62A>T had very similar trait values to their variant 
homozygotes (AA and TT respectively), which were higher than those for the original 
homozygotes (GG and AA respectively).  
For hot carcass weight, the heterozygotes (AG/AT) and variant homozygotes both weighed 
17.29 kg; and heterozygotes and variant homozygotes only differed in total yield by 
0.01%. It would appear that the variant allele, A and T for c.237G>A and c.342+62A>T 
respectively, has stronger trait influence that dominates over the original allele when both 
are present. No association was observed for leg yield and fat depth with genotypes at both 
loci. 
7.3.7 Protein Alignment and Stability Assessment  
Figure 7.5 compares the amino acid sequences of PROP1 in sheep to other species: human, 
goat, cow, pig, dog, mouse and rat. The region compared encompasses the fragment 
sequenced in this study, ranging from amino acid residues 38 to 114. The arginine amino 
acid at the 63rd position was found to be conserved across various species, differing only in 
the C2 variant reported in this study, where it was putatively substituted for a serine. On the 
other hand, the alanine residue at position 79 was replaced by a valine in humans, and 
glycine in dogs. Online analysis performed in this study using a predictor software of 
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protein stability revealed that the substitution of arginine for serine at position 63 in exon 2 
decreased the stability of the PROP1 protein. 
 
Sheep_PROP1 MNTQPYRNLSGVRVGRPKLSLQGGQRGRPHSRRRHRTTFSPAQLEQLESA     38-87 
Human_PROP1 ssap-c-r-p-agg--srf-p--------------------v--------     38-87 
 Goat_PROP1 -------------a------------------------------------     38-87 
  Cow_PROP1 -----------------------v--------------------------     38-87 
  Pig_PROP1 is-r--------ga---r--p-----------------------------     38-87 
  Dog_PROP1 vsp--sk-----g-r--r--p-------l----------n-g------t-     38-87 
Mouse_PROP1 rssea--r---tel-----cp-...--------------n----------     38-84 
  Rat_PROP1 rspetskr---tgl-----cp-...--------------n----g-----     38-84 
   A2 _PROP1 --------------------------------------------------     38-87 
   B2 _PROP1 --------------------------------------------------     38-87 
   C2 _PROP1 -------------------------s------------------------     38-87 
 
Sheep_PROP1 FGKNQYPDIWARESLAQDTGLSEARIQ                            88-114 
Human_PROP1 --r-------------r----------                            88-114 
 Goat_PROP1 ---------------------------                            88-114 
  Cow_PROP1 --r------------------------                            88-114 
  Pig_PROP1 --r----------g--r----------                            88-114 
  Dog_PROP1 --r----------g--r----------                            88-114 
Mouse_PROP1 --r----------g-------------                            85-111 
  Rat_PROP1 --r-------v--g-------------                            85-111 
   A2 _PROP1 ---------------------------                            88-114 
   B2 _PROP1 ---------------------------                            88-114 
   C2 _PROP1 ---------------------------                            88-114 
 
Figure 7.5 Alignment of PROP1 exon 2 protein sequence across different species 
Multiple sequence alignment of PROP1 exon 2 protein sequence across different species starting 
from amino acid p.38 to p.114, using the DNAMAN software. Bars (-) denote nucleotides identical 
to the ‘Sheep_PROP1’ sequence, while dots (.) denote missing nucleotides. The homeodomain is 
emboldened (residues 69 - 128), and two regions of nucleotide variation found in this study, 
p.Arg63Ser and p.Ala79Ala, are highlighted. The amino acid sequences were extracted from 
Genbank with the following accession numbers: Human, Homo sapiens (AF076215); Sheep, Ovis 
aries (AY533709); Goat, Capra hircus (XM_005682787); Cow, Bos taurus (XM_015472155); 
Pig, Sus scrofa (XM_013987527); Dog, Canis familiaris (NM_001020807); Rat, Rattus norvegicus 
(XM_008767664) and Mouse, Mus musculus (U77946). A2, B2, and C2 are based on amino acid 
sequences predicted from the DNA sequences reported in this study for the respective variants.   
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Exon 1 
Similar to the present study, Zeng et al. (2011) described an A to G variation in the exon 1 
of ovine PROP1, potentially resulting in a synonymous substitution of the glutamic acid 
residue at position 15 of the polypeptide. The genotype frequencies noted for the Chinese 
Merino sheep examined were comparable to this study, with the major genotypes found in 
the population being AG and GG, whilst the AA genotype was not observed in the Chinese 
Merino sheep. This study did observe the occurrence of the AA, albeit at a low frequency, 
thus reflecting either breed differences and/or the larger sheep population examined. Zeng 
et al. (2011) found no association with wool traits, in contrast, results from this study 
demonstrated a strong association between the GG genotype of the c.45A>G variation and 
an increase in weaning weight, growth rate, hot carcass weight and total lean meat yield, as 
well as a decrease in intermuscular fat depth. 
Emerging evidence suggests that synonymous and non-coding intronic variations, although 
not yielding any amino acid changes, can affect the phenotypic characteristics of the 
protein product in diverse ways, such as altering the mRNA stability, structure and codon 
usage during translation, changing the rate of translation, altering protein expression, 
stability and three-dimensional folding, and modifying the electrical charge of the resulting 
polypeptide (Le Hir et al., 2003; Sauna and Kimchi-Sarfaty, 2011; Hunt et al., 2014).  
Within the non-coding region of ovine PROP1, Liu et al. (2015) examined small tail Han 
sheep and reported that sheep with the TT and CT genotypes of a C330T variation in intron 
1 had a higher litter size compared to sheep with the CC genotype. However, this 
difference was not significant. A g.1198 A>G variation reported by Zeng et al. (2011) was 
also not found to have any significant association with wool traits, such as fibre diameter. 
Neither of those previously reported variations were observed in the present study. In 
contrast, this study described strong positive associations, with individuals possessing the 
variant CC genotype of c.109+40 T>C weighing more at tailing and slaughter, were faster-
growing, and had higher leg and total lean meat yields. On the other hand, negative 
associations with sheep growth and carcass traits were observed with the TT homozygous 
genotypes of c.109+207C>T.  
The first intron of PROP1 plays an interesting role in the unique relationship between 
Notch and PROP1 signalling during embryonic pituitary development. Electrophoretic 
mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) analyses have 
revealed that Rbp-J, a DNA-binding protein that mediates Notch signalling, can regulate 
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the activity of PROP1 by binding to an evolutionarily conserved consensus sequence 
within the intron 1 of PROP1 (Zhu et al., 2006). Although Notch signalling via Rbp-J does 
not initiate PROP1 expression, it is required for the upregulation and sustained expression 
of PROP1 at embryonic day E12.5 of murine embryos (Sornson et al., 1996; Zhu et al., 
2006). This suggests that the first intron of PROP1 is a direct target of Rbp-J-mediated 
Notch activity, which plays a vital mechanistic role in upregulating PROP1 expression, and 
hence is crucial to the early lineage commitment of cells in the anterior pituitary.  
Providing further credence to this view are studies into other genes that have demonstrated 
the regulatory effects of first introns in altering transcription efficiency and gene 
expression levels (Gaunitz et al., 2004; Chorev and Carmel, 2012). Gene modulation was 
achievable by means of regulatory elements, such as silencers and enhancers present in 
these 5’-proximal introns (Gaunitz et al., 2004; Chorev and Carmel, 2012). Supporting this 
notion and consistent with the findings of this study, variation in the intron 1 of the ovine 
myostatin gene showed association with meat production traits in NZ sheep breeds, 
including leg, loin, and total meat yields (Hickford et al., 2010).  
The results observed for the genotypes were consistent in the variant model. The A1 
variant, which comprised of the G-C-C alleles at the three polymorphic loci in that order, 
was associated with an increase in weaning and hot carcass weights, growth rate-to-
weaning, lean meat yields in the leg, loin and shoulder, and lower fat deposition. On the 
other hand, the B1 variant, which consisted of A-T-C alleles, had negative effects on growth 
traits and carcass traits including lower birth weight, weaning weight, growth rate, loin 
yield, total yield, and increased intermuscular fat depth.  
Exon 2 
The A2 variant was associated with higher weaning weight, growth rate, hot carcass weight, 
and loin, shoulder and total lean meat yields. Conversely, the C2 variant showed 
association with decreased birth rate, weaning weight, growth rate, hot carcass weight, loin 
yield and total yield. The C2 association with carcass traits was found to be diminished by 
the presence of other variants, unlike the persistent A2 association. 
The G allele of c.189G>C was more frequent than the C allele by thirteen-fold within the 
population. This stark difference could be due to the non-synonymous nature of the 
resulting putative p.Arg63Ser substitution, which was predicted by stability prediction 
software to yield a less stable PROP1 protein. Consistent with this notion is the finding that 
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the arginine residue at position 63 is highly conserved across various species. This 
evolutionary conservation, which is scarcely explored, points to the pronounced 
importance of Arg63 in the physiological function of PROP1. The two residues differ in 
chemical grouping, with arginine possessing a positively charged side chain, while serine 
contains an uncharged polar side chain (Wolfenden et al., 1981). The unique interactions 
between the side chains of specific amino acids which determine the three-dimensional 
shape of the polypeptide, could be distorted by substitution such as that detected in this 
study. Amino acid residues in core positions within a protein are particularly vital to its 
folding, stability and biological function (Bowie et al., 1990).  
The p.Arg63Ser substitution lies in a central location in the vicinity of the homeobox 
domain of PROP1, and could potentially result in a significant change in the structure and 
conformation of the protein product, thus affecting its function. The homeobox domain 
carries out the primary function of PROP1 as a transcription factor, by interacting directly 
with target DNA through hydrogen bonding and hydrophobic interaction (Inukai et al., 
2017). A change in protein conformation as a consequence of the presence of Ser63, could 
impair its ability to activate the transcription of downstream targets such as POU1F1-
dependent somatotropes, lactotropes and thyrotropes. Subsequent reduction in the levels of 
GH, LH and FSH could then impede growth and muscle development, as has been 
documented for humans and mice possessing mutations in PROP1 (Nakamura et al., 1999; 
Kelberman et al., 2009b). Guy et al. (2004) reported that variations within the basic regions 
of the PROP1 homeodomain altered its DNA binding and transactivation activities in both 
humans and sheep. 
This would ultimately bring about a cascade effect manifesting as decreased yield of 
production traits in livestock breeds. This is supported by findings in this study that 
individuals possessing the CC genotype of c.189G>C had lower hot carcass and weaning 
weights, growth rate and lean meat yield. On the other hand, the GG genotype was linked 
with a marked increase in weights at weaning and slaughter, higher growth rate, increased 
loin, shoulder and total lean meat yields, and decrease in intermuscular fat thickness. While 
intramuscular fat is generally indicative of the juicy texture of meat, excessive visceral or 
intermuscular fat however, is commercially undesirable as many consumers view it as 
unhealthy and unappetising. The breeder could, therefore, potentially breed in favour of the 
GG genotype, and against its CC counterpart.  
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It is notable that exon 2 of PROP1, within which the homeodomain lies, has been an area 
of growing attention since it is considered a ‘hotspot’ that accounts for over half of all 
reported mutations associated with CPHD in humans (Wu et al., 1998; Kelberman and 
Dattani, 2006; Lemos et al., 2006). Arginine residues frequently occur within and around 
the homeodomain, indicating their importance to PROP1 function. In humans, a 
p.Arg71Cys substitution has been revealed to underpin structural change in PROP1 
associated with CPHD and the accompanying low circulating levels of GH, TSH and PRL 
hormones (Paracchini et al., 2003). This human substitution is sufficiently close to the 
ovine p.Arg63Ser described herein, to suggest a similar effect might occur in sheep. 
A reported g.1389G>A SNP that would result in a putative synonymous p.Ala79Ala 
substitution was found to have no association with wool traits in Chinese Merino Sheep 
(Zeng et al., 2011). In contrast, this study revealed that despite its synonymous nature, the 
c.237G>A (p.Ala79Ala) variation was associated with various growth and carcass traits. 
The AA genotype, although producing the same alanine residue, was associated with 
increased weaning and carcass weights, and higher growth rate and lean meat yields, when 
compared to its GG counterpart. The TT genotype of the c.342+62A>T SNP present in the 
non-coding region was also associated with superior growth and carcass traits.  
These associations could be due to the linkage of c.237G>A (Ala79Ala) and c.342+62A>T 
to other trait-influencing SNPs in its vicinity; or alternatively that the change in the 
nucleotide sequence affects some aspect of the transcription or translation of PROP1. The 
alanine residue at the 79th position is also fairly conserved across mammalian species, 
except for humans and dogs. Interestingly, a non-synonymous p.Ala79Val substitution 
(AF453512: g.1795C>T) at an analogous caprine PROP1 region, has been described in 
Chinese goat breeds; however, it was found to have no significant associations with wool 
traits and milk yield (Lan et al., 2009).   
The disparity in association and significance between the current study and the previous 
research could be attributed to the differences in the breeds, number of animals or traits 
investigated. While most studies so far examine ovine PROP1 in relation to wool 
production, milk production or fertility (Zeng et al., 2011; Liu et al., 2015), this study 
explores a different direction of growth traits. Indeed, growth traits are considered to be 
some of the most important traits in animal production as they interest both breeders and 
consumers. However, some previous reports are consistent with the present study in 
describing the association between PROP1 variations in other regions of the gene and 
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Chapter 8 
General Summary and Future Direction  
In order to maintain viability, the multi-billion dollar NZ meat industry must aim for 
increased efficiency, by reducing production cost and increasing productivity. Using 
genetic markers, enhanced productivity in sheep production can be accomplished by 
selection and breeding for increased muscling and higher growth rates. The search for 
nucleotide sequence variations in specific loci influencing key production traits is a 
necessity for sheep genetic improvement approaches. 
This thesis focused on identifying genetic variation within four genes of the somatotropic 
axis in sheep – GH, IGF1R, POU1F1 and PROP1, and whether any variation found was 
associated with sheep production traits. These genes were selected because of their 
documented effects on growth and carcass traits in other mammals, including cattle, goats 
and sheep. The genes selected were involved in energy metabolism and protein turnover 
(IGF1R, Chapter 4), somatic growth and development (GH, Chapter 5), and regulation of 
the expression of other genes (POU1F1 and PROP1, Chapters 6 and 7).  
The IGF1 receptor, a potent effector of GH action, appeared to be more conserved through 
evolution. Of the three separate fragments amplified, only the fragment that spanned the 
exon 9 to intron 10 region had delectable nucleotide variation (Chapter 4). Being either 
synonymous or within introns, none of the nucleotide sequence variations were found to 
alter the amino acid sequence. Ten novel nucleotide variations were however revealed, and 
these defined five sequence variants (A9 to E9). Variant A9 was associated with increased 
postnatal growth rate and higher lean meat yield. Given its central role in vertebrates, these 
‘subtle’ IGF1R variations could be useful for developing genetic tools that select for faster-
growing, higher-yielding lambs, with lower fat deposition, as they might persist long 
enough in future generations to reliably be passed onto offspring. 
In Chapter 5, a fragment of ovine GH spanning exon 2 – exon 3 was revealed to be highly 
variable, with 11 nucleotide substitutions defining seven novel nucleotide sequences (A3 to 
G3). Four of the substitutions were non-synonymous, thereby putatively resulting in 
changes in the amino acid sequence. The B3 variant was associated with an increase in 
average daily weight gain and higher lean meat yield. These findings suggest that 
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nucleotide sequence variation in GH could be applied in the development of markers for 
breeding faster-growing lambs that produce leaner meat.  
The gene POU1F1 also appeared to be evolutionarily conserved, with two (exons 3 and 6) 
of the three explored regions showing no variation (Chapter 6). This might be due to the 
crucial domains encoded by these gene regions. The exon 1 region showed limited 
variation with only two variants (A and B) being observed. Further investigation into the 
non-coding regions of POU1F1 is required to determine if they have greater freedom to 
accumulate genetic variations.  
The gene PROP1 revealed greater variability (Chapter 7). Three nucleotide variants were 
identified for both the exon 1 (A1, B1 and C1) and exon 2 (A2, B2 and C2) regions; and three 
nucleotide substitutions were also described for each region. The A1 variant was associated 
with increased muscling and lower intermuscular fat levels, while the A2 variant was 
associated with higher lamb growth rates. These PROP1 variants could therefore possibly 
be useful in breeding lambs that grow more quickly and produce more meat.  
Strategies that use alterations in environmental factors such as farm management 
approaches, nutrition, and pre-slaughter handling, only provide short-lived or non-enduring 
improvements. Long-lasting solutions that can be passed down to future livestock 
generations would require breeding strategies utilising genetic technologies to bring about 
improved livestock performance.  
In this respect, breeding for faster-growing sheep with lean-carcasses by means of genetic 
technologies would benefit the sheep industry, enabling them to better meet consumer 
expectations and better financially reward farmers and breeders. High quality and premium 
meat products would also ensure that New Zealand retains its stake in the competitive 
global sheep meat market, bringing in important export revenue.  
Although the influence of genetics on animal growth and carcass traits is well established, 
there still exists a dearth of information on genetic control in small ruminant animals. 
Future work, therefore, needs to examine other key genes involved in growth and 
metabolic pathways, with the aim of developing a multi-gene breeding tool that improves 
the accuracy and speed of genetic selection.  
As promising as the early findings from this thesis are, further research is required to 
replicate and confirm the reported associations before they can be applied in breeding 
selection approaches. These studies could be undertaken using more advanced genetic 
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tools, such as clustered regularly interspaced short palindromic repeats (CRISPR), to drive 
greater genetic variation, by studying a wider range of sheep breeds and other livestock 
species such as cattle, goats and pigs. Information obtained from this research would 
ultimately improve the accuracy of choices made when a breeding stock is selected. 
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Appendix C 
GH 
GH protein sequence alignment across species 
 
SHEEP_GH2  MMAAGPRTSLLLAFTLLCLLWTQVVGAFPAMSLSRLFANAVLRAQHLHQL     50 
HUMAN_GH2  .----s--------g----s-l-egs---tip-----d--m---rr-y--     49 
GOAT_GH2   -------------------p--------------g---------------     50 
COW_GH2    --------------a----p--------------g---------------     50 
PIG_GH2    .--------v----a----p---e-------p--s---------------     49 
DOG_GH2    .---s--n-v----a----p-p-e-------p--s---------------     49 
RAT_GH2    .---dsq-pw--t-s------p-ea--l---p--s---------------     49 
MOUSE_GH   .--tds---w--tvs------p-eas-----p--s--s------------     49 
 
SHEEP_GH2  AADTFKEFERTYIPEGQRYS.IQNTQVAFCFSETIPAPTSKNEAQQKSDL     99 
HUMAN_GH2  -y--yq---ea--lke-k--fl--p-tsl----s--t-snrvkt----n-     99 
GOAT_GH2   --------------------.------------------g----------     99 
COW_GH2    --------------------.------------------g----------     99 
PIG_GH2    ----y-----a---------.---a-a------------g-d----r--v     98 
DOG_GH2    ----y-----a---------.---a-a------------g-d----r--v     98 
RAT_GH2    ----y-----a---------.---a-a------------g-e----rt-m     98 
MOUSE_GH   ----y-----a---------.---a-a------------g-e----rt-m     98 
 
SHEEP_GH2  ELLRISLLLIQSWLGPLQFLSRVFTNSLVFGTSDR.VYEKLKDLEEGILA    148 
HUMAN_GH2  --------------e-v-l-rs--a----y-a--sn--rh--------qt    149 
GOAT_GH2   -----------------------------------.--------------    148 
COW_GH2    -----------------------------------.--------------    148 
PIG_GH2    ----fp----------v------------------.------------q-    147 
DOG_GH2    ----f-----------v------------------.------------q-    147 
RAT_GH2    ----f-----------v-----i-----m------.------------q-    147 
MOUSE_GH   ----f-----------v-----i-----m------.------------q-    147 
 
SHEEP_GH2  LMRELEDVTPRAGQILKQTYDKFDTNMRSDDALLKNYGLLSCFRKDLHKT    198 
HUMAN_GH2  --wr---gs--t---fn-s-s----kshn-----------y-----md-v    199 
GOAT_GH2   --------------------------------------------------    198 
COW_GH2    -------g------------------------------------------    198 
PIG_GH2    -------gs-----------------l----------------k-----a    197 
DOG_GH2    -------gs-----------------l----------------k-----a    197 
RAT_GH2    --q----gs--i------------a------------------k-----a    197 
MOUSE_GH   --q----gs--v------------a------------------k-----a    197 
 
SHEEP_GH2  ETYLRVMKCRRFGEASCAF                                   217 
HUMAN_GH2  --f--ivq--.sv-g--g-                                   217 
GOAT_GH2   -------------------                                   217 
COW_GH2    -------------------                                   217 
PIG_GH2    ------------v-s----                                   216 
DOG_GH2    ------------v-s----                                   216 
RAT_GH2    ------------a-s----                                   216 
MOUSE_GH   ------------v-s----                                   216 
 
 
 
 
 
  203 
(a) 
 
A_allele GPRTSLLLAFTLLCLLWTQVVGAFPAMSLSGLFANAVLRAQHLHQLAADT     5-54 
B_allele ---------------p----------------------------------     5-54 
C_allele ---------------p----------------------------------     5-54 
D_allele ---------------p----------------------------------     5-54 
E_allele ---------------p--------------r-------------------     5-54 
F_allele ----------------------t-------r-------------------     5-54 
G_allele ---------------p----------------------------------     5-54 
 
A_allele FKEFERTYIPEGQRYSIQNTQVAFCFSETIPAPTGKNEAQQKS            55-97 
B_allele -------------------------------------------            55-97 
C_allele -------------------------------------------            55-97 
D_allele -----h-------------------------------------            55-97 
E_allele -------------------------------------------            55-97 
F_allele -------------------------------------------            55-97 
G_allele -------------------------------------------            55-97 
(b) 
SHEEP_GH2  MMAAGPRTSLLLAFTLLCLLWTQVVGAFPAMSLSRLFANAVLRAQHLHQL     50 
HUMAN_GH2  .----s--------g----s-l-egs---tip-----d--m---rr-y--     49 
GOAT_GH2   -------------------p--------------g---------------     50 
COW_GH2    --------------a----p--------------g---------------     50 
PIG_GH2    .--------v----a----p---e-------p--s---------------     49 
DOG_GH2    .---s--n-v----a----p-p-e-------p--s---------------     49 
RAT_GH2    .---dsq-pw--t-s------p-ea--l---p--s---------------     49 
MOUSE_GH   .--tds---w--tvs------p-eas-----p--s--s------------     49 
 
SHEEP_GH2  AADTFKEFERTYIPEGQRYS.IQNTQVAFCFSETIPAPTSKNEAQQKS       97 
HUMAN_GH2  -y--yq---ea--lke-k--fl--p-tsl----s--t-snrvkt----       97 
GOAT_GH2   --------------------.------------------g--------       97 
COW_GH2    --------------------.------------------g--------       97 
PIG_GH2    ----y-----a---------.---a-a------------g-d----r-       97 
DOG_GH2    ----y-----a---------.---a-a------------g-d----r-       97 
RAT_GH2    ----y-----a---------.---a-a------------g-e----rt       97 
MOUSE_GH   ----y-----a---------.---a-a------------g-e----rt       97 
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Coding of variables 
 
Present = 1,  Absent = 0 
 
Birth weight and GH2 variants 
Dependent variable: Birth weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
 
Continuous Variable Information 
 N Minimum Maximum Mean 
Std. 
Deviation 
Dependent Variable Birth Wt 766 3.00 8.50 5.6821 .93899 
Single-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 5.0886 .20324 4.6903 5.4870 
 
 
Estimated Marginal Means 2: B 
 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 5.0589 .20316 4.6608 5.4571 
1.0 5.2043 .21009 4.7925 5.6161 
 
 
Geno A3 B3 C3 F3 c.51C>T c.59C>T c.79G>A c.103G>C c.174+132A>G 
AA 1 0 0 0 CC TT GG GG AA 
AB 1 1 0 0 CC CT GG GG AA 
AC 1 0 1 0 CC CT GG GG AA 
AF 1 0 0 1 CT TT AG CG AG 
Overall Test Results 
Wald Chi-
Square df Sig. 
4.362 1 .037 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 5.0976 .20308 4.6996 5.4956 
1.0 4.9686 .22022 4.5370 5.4002 
 
 
 
Multi-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 5.0859 .20826 4.6777 5.4940 
 
 
 
Estimated Marginal Means 3: B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
1.975 1 .160 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 5.0200 .20644 4.6154 5.4246 
1.0 5.1518 .21594 4.7285 5.5750 
Overall Test Results 
Wald Chi-
Square df Sig. 
3.467 1 .063 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
 
 
 
 
 
 
 
 
 
SNP model 
 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CC 5.0976 .20308 4.6996 5.4956 
CT 4.9686 .22022 4.5370 5.4002 
 
 
 
 
Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 5.2424 .20825 4.8343 5.6506 
TT 5.0434 .20257 4.6463 5.4404 
 
 
 
 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
1.083 1 .298 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 5.1344 .20358 4.7354 5.5334 
1.0 5.0374 .22280 4.6007 5.4741 
Overall Test Results 
Wald Chi-
Square df Sig. 
1.975 1 .160 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
9.257 1 .002 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Estimated Marginal Means 2: c.79G>A 
 
 
 
Estimates 
c.79G&gt;A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
AG 4.9686 .22022 4.5370 5.4002 
GG 5.0976 .20308 4.6996 5.4956 
 
 
 
 
 
Estimated Marginal Means 2: c.103G>C 
 
Estimates 
c.103G&gt;
C Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CG 4.9686 .22022 4.5370 5.4002 
GG 5.0976 .20308 4.6996 5.4956 
 
 
 
 
 Estimated Marginal Means 2: c.174+132A>G 
 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
1.975 1 .160 
The Wald chi-square tests the 
effect of c.79G&gt;A. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
1.975 1 .160 
The Wald chi-square tests the 
effect of c.103G&gt;C. This test 
is based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Estimates 
c.174+132A&gt
;G Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
AA 5.0976 .20308 4.6996 5.4956 
AG 4.9686 .22022 4.5370 5.4002 
Overall Test Results 
Wald Chi-
Square df Sig. 
1.975 1 .160 
The Wald chi-square tests the 
effect of c.174+132A&gt;G. This 
test is based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Tailing weight and GH2 variants 
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
Covariate: Tailing Age 
 
Continuous Variable Information 
 N Minimum Maximum Mean 
Std. 
Deviation 
Dependent Variable Tailing Wt 766 5.5 26.0 12.872 3.0026 
Covariate T.Age 766 5.0 55.0 31.808 10.6432 
 
Single-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 11.961 .5500 10.883 13.039 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 11.860 .5489 10.784 12.935 
1.0 12.350 .5671 11.239 13.461 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.928 1 .008 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 11.994 .5479 10.920 13.068 
1.0 11.375 .5951 10.209 12.542 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
Multi-variant model 
 
Estimated Marginal Means 2: A 
 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 11.853 .5620 10.751 12.954 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 11.644 .5571 10.552 12.736 
1.0 12.062 .5823 10.920 13.203 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.334 1 .012 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
4.892 1 .027 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 12.111 .5487 11.036 13.186 
1.0 11.594 .6014 10.415 12.773 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
SNP model 
 
 Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;
T Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
CC 11.994 .5479 10.920 13.068 
CT 11.375 .5951 10.209 12.542 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
 
 Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;
T Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
CT 12.339 .5643 11.233 13.445 
TT 11.856 .5486 10.781 12.931 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.808 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
4.299 1 .038 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.334 1 .012 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
7.555 1 .006 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Weaning weight and GH2 variants 
Dependent variable: Weaning weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant  
Covariate: Weaning Age 
 
Continuous Variable Information 
 N Minimum Maximum Mean 
Std. 
Deviation 
Dependent Variable Weaning Wt 766 12.5 50.5 31.238 4.7419 
Covariate W.Age 766 63.0 106.0 88.625 5.9194 
 
Single-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 29.274 .9645 27.383 31.164 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 28.913 .9488 27.053 30.772 
1.0 30.677 .9811 28.754 32.600 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
29.481 1 .000 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 29.421 .9475 27.564 31.278 
1.0 27.133 1.0287 25.117 29.149 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
 
Multi-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 28.877 .9614 26.993 30.762 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 28.130 .9529 26.262 29.998 
1.0 29.625 .9968 27.671 31.579 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
28.425 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
20.978 1 .000 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 29.839 .9392 27.998 31.680 
1.0 27.916 1.0292 25.898 29.933 
Covariates appearing in the model are fixed at the 
following values: W.Age=88.625 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CC 29.421 .9475 27.564 31.278 
CT 27.133 1.0287 25.117 29.149 
Covariates appearing in the model are fixed at the following 
values: W.Age=88.625 
 
 
 
 Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 30.663 .9729 28.756 32.570 
TT 28.872 .9461 27.018 30.726 
Covariates appearing in the model are fixed at the following 
values: W.Age=88.625 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
19.933 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
28.425 1 .000 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
34.356 1 .000 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Growth rate and GH2 variants 
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Rearing rank, Variant 
Covariate: Birth weight 
 
Continuous Variable Information 
 N Minimum Maximum Mean 
Std. 
Deviation 
Dependent Variable Growth rate 766 92.0 444.7 288.516 47.5343 
Covariate Birth Wt 766 3.00 8.50 5.6821 .93899 
 
Single-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 257.375 10.4606 236.872 277.877 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 253.593 10.3143 233.377 273.809 
1.0 270.969 10.6276 250.139 291.799 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
25.984 1 .000 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 264.061 10.4131 243.652 284.471 
1.0 242.992 10.7634 221.896 264.087 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
 
Multi-variant model 
 
Estimated Marginal Means 2: A 
 
Estimates 
A Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
1.0 258.407 10.2818 238.255 278.559 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 250.915 10.2383 230.848 270.981 
1.0 265.900 10.6064 245.112 286.688 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
21.862 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
19.065 1 .000 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 267.164 10.3104 246.956 287.372 
1.0 249.651 10.7407 228.599 270.702 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.6821 
 
SNP model 
 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CC 264.061 10.4131 243.652 284.471 
CT 242.992 10.7634 221.896 264.087 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.6821 
 
 
 
Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 269.970 10.5573 249.278 290.662 
TT 253.121 10.3109 232.912 273.330 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.6821 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
14.978 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
21.862 1 .000 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
27.339 1 .000 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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HCW and GH2 variants 
Dependent variable: Hot carcass weight 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 17.035 .0760 16.886 17.184 
1.0 17.445 .1260 17.198 17.692 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 17.190 .0726 17.047 17.332 
1.0 16.562 .1732 16.223 16.902 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.831 .1001 16.634 17.027 
1.0 17.174 .1526 16.875 17.473 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
Overall Test Results 
Wald Chi-
Square df Sig. 
9.451 1 .002 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
12.570 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.532 1 .011 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 17.279 .0804 17.122 17.437 
1.0 16.725 .1838 16.365 17.085 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
Estimates 
c.51C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CC 17.190 .0726 17.047 17.332 
CT 16.562 .1732 16.223 16.902 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: c.59C>T 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 17.448 .1174 17.218 17.678 
TT 17.011 .0774 16.860 17.163 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
9.639 1 .002 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
12.570 1 .000 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
11.868 1 .001 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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V-GR and GH2 variants 
Dependent variable: V-GR 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 4.244 .1132 4.022 4.466 
1.0 3.758 .1876 3.391 4.126 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 4.050 .1080 3.838 4.262 
1.0 4.891 .2576 4.386 5.396 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 4.522 .1492 4.230 4.815 
1.0 4.129 .2274 3.683 4.574 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
Overall Test Results 
Wald Chi-
Square df Sig. 
5.975 1 .015 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.197 1 .001 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
3.878 1 .049 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 3.947 .1198 3.713 4.182 
1.0 4.704 .2739 4.167 5.241 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
Estimates 
c.51C&gt;
T Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
CC 4.050 .1080 3.838 4.262 
CT 4.891 .2576 4.386 5.396 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
 
 
 
Estimated Marginal Means 2: c.59C>T 
Estimates 
c.59C&gt;
T Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
CT 3.649 .1743 3.308 3.991 
TT 4.308 .1149 4.083 4.534 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
8.087 1 .004 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.197 1 .001 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
12.298 1 .000 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
  221 
Leg yield and GH2 variants 
Dependent variable: Leg yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 21.4528 .05708 21.3409 21.5646 
1.0 21.7496 .09459 21.5643 21.9350 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 21.5590 .05464 21.4519 21.6661 
1.0 21.1603 .13029 20.9049 21.4156 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 21.3260 .07534 21.1783 21.4736 
1.0 21.5813 .11481 21.3562 21.8063 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
Overall Test Results 
Wald Chi-
Square df Sig. 
8.792 1 .003 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
8.968 1 .003 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.392 1 .011 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 21.6257 .06046 21.5072 21.7442 
1.0 21.2815 .13829 21.0105 21.5526 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;
T Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
CC 21.559
0 
.05464 21.4519 21.6661 
CT 21.160
3 
.13029 20.9049 21.4156 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
 
 
 
Estimated Marginal Means 2: c.59C>T 
Estimates 
c.59C&gt;
T Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
CT 21.7856 .08792 21.6133 21.9580 
TT 21.4240 .05798 21.3103 21.5376 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
6.568 1 .010 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
8.968 1 .003 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
14.544 1 .000 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Loin yield and GH2 variants 
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 14.5422 .03976 14.4643 14.6201 
1.0 14.7170 .06589 14.5879 14.8462 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 14.6073 .03803 14.5328 14.6818 
1.0 14.3483 .09067 14.1706 14.5260 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 14.4584 .05250 14.3555 14.5613 
1.0 14.6057 .08001 14.4489 14.7625 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.285 1 .012 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
7.812 1 .005 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
4.385 1 .036 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 14.6458 .04213 14.5632 14.7284 
1.0 14.4183 .09637 14.2294 14.6072 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;
T Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
CC 14.6073 .03803 14.5328 14.6818 
CT 14.3483 .09067 14.1706 14.5260 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: c.59C>T 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 14.7451 .06127 14.6250 14.8652 
TT 14.5229 .04040 14.4437 14.6021 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
5.908 1 .015 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
7.812 1 .005 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
11.304 1 .001 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Shoulder yield and GH2 variants 
Dependent variable: Shoulder yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.8106 .04185 16.7286 16.8927 
1.0 16.9988 .06936 16.8628 17.1347 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: F 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.8847 .03996 16.8064 16.9630 
1.0 16.5680 .09528 16.3813 16.7548 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.7061 .05517 16.5979 16.8142 
1.0 16.8599 .08408 16.6951 17.0247 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.568 1 .010 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.579 1 .001 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
4.329 1 .037 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.9249 .04427 16.8381 17.0117 
1.0 16.6411 .10128 16.4426 16.8396 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; DraftAgedays=132.29 
 
SNP model 
 
Estimated Marginal Means 2: c.51C>T 
 
Estimates 
c.51C&gt;
T Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
CC 16.8847 .03996 16.8064 16.9630 
CT 16.5680 .09528 16.3813 16.7548 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7598; 
DraftAgedays=132.29 
 
 
 
Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 17.0018 .06464 16.8751 17.1285 
TT 16.7992 .04263 16.7157 16.8828 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
8.327 1 .004 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.579 1 .001 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
8.440 1 .004 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Total yield and GH2 variants 
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
Single-variant model 
 
Estimated Marginal Means 2: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 52.8057017
70000000 
.116148710
000000 
52.5780544
80000000 
53.0333490
60000000 
1.0 53.4663403
10000000 
.192483526
000000 
53.0890795
30000000 
53.8436010
80000000 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 2: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 53.0514845
90000000 
.111013534
000000 
52.8339020
60000000 
53.2690671
20000000 
1.0 52.0754139
40000004 
.264698391
000000 
51.5566146
20000000 
52.5942132
50000000 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
 
 
 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.515 1 .001 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
13.019 1 .000 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Multi-variant model 
 
Estimated Marginal Means 3: B 
 
Estimates 
B Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 52.4899885
90000000 
.152950491
000000 
52.1902111
30000000 
52.7897660
40000000 
1.0 53.0470720
30000000 
.233093111
000000 
52.5902179
20000000 
53.5039261
30000000 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
Estimated Marginal Means 4: F 
 
Estimates 
F Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 53.1970198
00000000 
.122736686
000000 
52.9564603
10000004 
53.4375792
80000000 
1.0 52.3400408
10000000 
.280752034
000000 
51.7897769
40000000 
52.8903046
90000000 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
7.385 1 .007 
The Wald chi-square tests the 
effect of B. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
9.879 1 .002 
The Wald chi-square tests the 
effect of F. This test is based on 
the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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SNP model 
 
Estimated Marginal Means 2: c.51C>T 
Estimates 
c.51C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CC 53.051484
590000000 
.11101353
4000000 
52.833902
060000000 
53.269067
120000000 
CT 52.075413
940000004 
.26469839
1000000 
51.556614
620000000 
52.594213
250000000 
Covariates appearing in the model are fixed at the following 
values: BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
 
Estimated Marginal Means 2: c.59C>T 
 
Estimates 
c.59C&gt;T Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
CT 53.5333488
60000004 
.178869937
000000 
53.1827702
30000000 
53.8839274
90000000 
TT 52.7461712
90000000 
.117948696
000000 
52.5149960
90000004 
52.9773464
80000000 
Covariates appearing in the model are fixed at the following values: 
BirthWt=5.7598; DraftAgedays=132.29 
 
 
 
 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
13.019 1 .000 
The Wald chi-square tests the 
effect of c.51C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
16.649 1 .000 
The Wald chi-square tests the 
effect of c.59C&gt;T. This test is 
based on the linearly 
independent pairwise 
comparisons among the 
estimated marginal means. 
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Appendix D 
IGF1R 
Coding of variables 
Present = 1,  Absent = 0  
Geno A9 B9 E9 c.2019C>T c.2037C>T c.2201+28A>C c.2201+114_118delCGCAG 
AA 1 0 0 CC CC AA CGCAG/CGCAG 
BB 0 1 0 TT TT AA del/del 
EE 0 0 1 CC CC CC del/del 
AB 1 1 0 CT CT AA CGCAG/del 
AE 1 0 1 CC CC AC CGCAG/del 
BE 0 1 1 CT CT AC del/del 
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Birth weight and IGF1R variants 
Dependent variable: Birth weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 5.0349150
68000000 
.20733732
9000000 
4.6285413
71000000 
5.4412887
66000000 
1 5.1306553
22000000 
.20588319
9000000 
4.7271316
66000000 
5.5341789
77000001 
 
 
 
Estimated Marginal Means: B9 
 
 
Estimates 
B9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 5.1297435
82000001 
.20892991
9000000 
4.7202484
64000000 
5.5392386
99000000 
1 5.0726328
44000000 
.20487301
6000000 
4.6710891
10000001 
5.4741765
78000001 
 
 
Estimated Marginal Means 2: E9 
 
 
Estimates 
E9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 5.1061943
30000000 
.20415738
7000000 
4.7060532
04000001 
5.5063354
56000000 
1 4.9979943
04000001 
.21282041
8000000 
4.5808739
49000000 
5.4151146
59000000 
 
Overall Test Results 
Wald Chi-Square df Sig. 
2.069 1 .150 
The Wald chi-square tests the effect of A9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
.810 1 .368 
The Wald chi-square tests the effect of B9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
2.228 1 .136 
The Wald chi-square tests the effect of 
E9. This test is based on the linearly 
independent pairwise comparisons 
among the estimated marginal means. 
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Tailing weight and IGF1R variants 
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
Covariate: Tailing Age 
 
 
Estimated Marginal Means: A9 
 
 
Estimates 
A9 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 11.752 .5615 10.652 12.853 
1 12.142 .5580 11.048 13.236 
Covariates appearing in the model are fixed at 
the following values: T.Age=31.915 
 
 
 
Estimated Marginal Means: B9 
 
Estimates 
B9 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 12.201 .5658 11.092 13.310 
1 11.875 .5551 10.787 12.963 
Covariates appearing in the model are fixed at the 
following values: T.Age=31.915 
 
 
 
Estimated Marginal Means: E9 
 
Estimates 
E9 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 12.035 .5533 10.951 13.119 
1 11.609 .5766 10.479 12.739 
Covariates appearing in the model are fixed 
at the following values: T.Age=31.915 
Overall Test Results 
Wald Chi-Square df Sig. 
4.756 1 .029 
The Wald chi-square tests the effect of A9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
3.675 1 .055 
The Wald chi-square tests the effect of B9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
4.791 1 .029 
The Wald chi-square tests the effect of E9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
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Weaning weight and IGF1R variants 
Dependent variable: Weaning weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant  
Covariate: Weaning Age 
 
Estimated Marginal Means: A9 
 
 
Estimates 
A9 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 28.625 .9691 26.726 30.524 
1 29.756 .9622 27.870 31.642 
Covariates appearing in the model are fixed at 
the following values: W.Age=88.665 
 
 
 
Estimated Marginal Means: B9 
 
 
 
 
 
 
 
 
 
 
 
Estimated Marginal Means: E9 
 
Estimates 
E9 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 29.450 .9550 27.578 31.322 
1 28.272 .9957 26.320 30.224 
Covariates appearing in the model are fixed at 
the following values: W.Age=88.665 
Overall Test Results 
Wald Chi-Square df Sig. 
13.234 1 .000 
The Wald chi-square tests the effect of A9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Estimates 
B9 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 29.926 .9780 28.009 31.843 
1 28.998 .9589 27.119 30.878 
Covariates appearing in the model are fixed at 
the following values: W.Age=88.665 
Overall Test Results 
Wald Chi-Square df Sig. 
9.773 1 .002 
The Wald chi-square tests the effect of B9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
12.071 1 .001 
The Wald chi-square tests the effect of E9. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
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Growth rate and IGF1R variants 
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Rearing rank, Variant 
Covariate: Birth weight 
 
Estimated Marginal Means: A9 
 
 
Estimates 
A9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 249.588158
699999980 
10.5708831
30000000 
228.869608
500000000 
270.306708
900000000 
1 260.348450
100000000 
10.3511972
10000000 
240.060476
299999980 
280.636423
800000000 
Covariates appearing in the model are fixed at the following 
values: Birth Wt=5.686406460296090 
 
 
Estimated Marginal Means: B9 
 
 
 
 
 
 
  
Overall Test Results 
Wald Chi-
Square df Sig. 
11.054 1 .001 
The Wald chi-square tests the effect 
of A9. This test is based on the 
linearly independent pairwise 
comparisons among the estimated 
marginal means. 
Estimates 
B9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 264.911507
400000000 
10.5654510
90000000 
244.203603
800000000 
285.619411
000000000 
1 254.778842
699999980 
10.3413829
70000000 
234.510104
499999980 
275.047580
800000000 
Covariates appearing in the model are fixed at the following 
values: Birth Wt=5.686406460296090 
Overall Test Results 
Wald Chi-
Square df Sig. 
10.884 1 .001 
The Wald chi-square tests the effect of 
B9. This test is based on the linearly 
independent pairwise comparisons 
among the estimated marginal means. 
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HCW and IGF1R variants 
Dependent variable: Hot carcass weight 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
.0 16.744 .1155 16.517 16.970 
1.0 17.266 .0776 17.114 17.419 
Covariates appearing in the model are fixed at 
the following values: BirthWt=5.7671; 
DraftAgedays=132.09 
 
 
 
V-GR and IGF1R variants 
Dependent variable: V-GR 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
.0 4.440 .1751 4.096 4.783 
1.0 4.046 .1176 3.816 4.277 
Covariates appearing in the model are fixed at 
the following values: BirthWt=5.7671; 
DraftAgedays=132.09 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
17.523 1 .000 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
4.314 1 .038 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
  236 
Leg yield and IGF1R variants 
Dependent variable: Leg yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
.0 21.3480 .08780 21.1759 21.5201 
1.0 21.5613 .05900 21.4457 21.6770 
Covariates appearing in the model are fixed at 
the following values: BirthWt=5.7671; 
DraftAgedays=132.09 
 
 
 
 
Loin yield and IGF1R variants 
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means: A9 
 
Estimates 
  
A9 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
.0 14.4531 .06115 14.3332 14.5729 
1.0 14.6210 .04109 14.5405 14.7016 
Covariates appearing in the model are fixed at 
the following values: BirthWt=5.7671; 
DraftAgedays=132.09 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
5.049 1 .025 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
6.456 1 .011 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Shoulder yield and IGF1R variants 
Dependent variable: Shoulder yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 16.6574 .06380 16.5323 16.7824 
1.0 16.9243 .04287 16.8402 17.0083 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7671; 
DraftAgedays=132.09 
 
 
 
Total yield and IGF1R variants 
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
 
Estimated Marginal Means: A9 
 
Estimates 
A9 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
.0 52.459216
98000000
0 
.17806195
6000000 
52.110221
96000000
4 
52.808212
00000000
5 
1.0 53.106618
01000000
0 
.11963922
8000000 
52.872129
43000000
0 
53.341106
59000000
0 
Covariates appearing in the model are fixed at the 
following values: BirthWt=5.7671; DraftAgedays=132.09 
Overall Test Results 
Wald Chi-
Square df Sig. 
14.972 1 .000 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
11.310 1 .001 
The Wald chi-square tests the 
effect of A9. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal means. 
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Appendix E 
PROP1  
Coding of variables 
 
Present = 1,  Absent = 0 
 
 
 
 
 
  
PROP1 Exon 1 A1 B1 C1 c.45A>G c.109+40T>C c.109+207C>T 
AA 1 0 0 GG CC CC 
AB 1 1 0 AG CT CC 
AC 1 0 1 GG CC CT 
BB 0 1 0 AA TT CC 
BC 0 1 1 AG CT CT 
CC 0 0 1 GG CC TT 
PROP1 Exon 2 A2 B2 C2 c.189G>C c.237G>A c.342+62A>T 
AA 1 0 0 GG AA TT 
AB 1 1 0 GG AG AT 
AC 1 0 1 CG AG AT 
BB 0 1 0 GG GG AA 
BC 0 1 1 CG GG AA 
CC 0 0 1 CC GG AA 
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PROP1 protein sequence alignment across species 
 
SHEEP_PROP1 MDTEGRSEQAKQAKEQVCSSLWPEGYPAAETVTSSVDMNTQPYRNLSGVR     50 
HUMAN_PROP1 -ea-r-rqae-pk-gr-g---l--rh--tg-p-tt--ssap-c-r-p-ag     50 
MOUSE_PROP1 -eaqr--h-e--t-gha-grsl--prv-sg-li-t--rssea--r---te     50 
RAT_PROP1   -eaqr--q-e--t-gp--grsl--sqa-sg-li-t--rspetskr---tg     50 
PIG_PROP1   -ea---r--g-pr-gr-------------g-l-ar--is-r--------g     50 
DOG_PROP1   -ea-----rg--k-grl-g----ds----g-l--t--vsp--sk-----g     50 
COW_PROP1   -----s---g--t-------------------------------------     50 
GOAT_PROP1  --------------------------------------------------     50 
 
SHEEP_PROP1 VGRPKLSLQGGQRGRPHSRRRHRTTFSPAQLEQLESAFGKNQYPDIWARE    100 
HUMAN_PROP1 g--srf-p--------------------v----------r----------    100 
MOUSE_PROP1 l-----cp-...--------------n------------r----------     97 
RAT_PROP1   l-----cp-...--------------n----g-------r-------v--     97 
PIG_PROP1   a---r--p-------------------------------r----------    100 
DOG_PROP1   -r--r--p-------l----------n-g------t---r----------    100 
COW_PROP1   ----------v----------------------------r----------    100 
GOAT_PROP1  a-------------------------------------------------    100 
 
SHEEP_PROP1 SLAQDTGLSEARIQVWFQNRRAKQRKQERSLLQPLAHLSPATFSGFLPEP    150 
HUMAN_PROP1 ---r-------------------------------------a--s----s    150 
MOUSE_PROP1 g---------------------------------i----t---------s    147 
RAT_PROP1   g---------------------------------t------------s-s    147 
PIG_PROP1   g--r----------------------------------------------    150 
DOG_PROP1   g--r---------------------------------------------s    150 
COW_PROP1   --------------------------------------------------    150 
GOAT_PROP1  --------------------------h-----------------------    150 
 
SHEEP_PROP1 PSCPYPYPTPPPPMTCFPHPYNHALPSQPSTGSSFARPYQSEDWYPNLHP    200 
HUMAN_PROP1 ta---s-aa----v-------s----------ga--lsh-------t---    200 
MOUSE_PROP1 say--t-g-----ap------s-s-------aa-l-l-p-p-----t---    197 
RAT_PROP1   spy--t-t-----vp--------------c--a-ltl-a-p-----t---    197 
PIG_PROP1   -a---s--------------------------g----hp-------t---    200 
DOG_PROP1   -a---s--------------------------g-----h-------t---    200 
COW_PROP1   -----s--------------------------------------------    200 
GOAT_PROP1  --------------------------------------------------    200 
 
SHEEP_PROP1 TPAGHLPCPPPPPMLPLSLEPPKSWN                            226 
HUMAN_PROP1 a--------------------s----                            226 
MOUSE_PROP1 a-t-----------f-----t-----                            223 
RAT_PROP1   -ht---a-------fs----t-----                            223 
PIG_PROP1   --t-------a--v------------                            226 
DOG_PROP1   p-t---------t-------------                            226 
COW_PROP1   ------a-------------------                            226 
GOAT_PROP1  -----------------g--------                            226 
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Figure E1. Phylogenetic tree of PROP1 protein sequences from various species. The tree 
depicts the phylogenetic relationships between mammalian PROP1 proteins, and was constructed 
using the maximum-likelihood algorithm based on the JTT-matrix model in the Mega7 package 
(Kumar et al., 2016) Branch lengths represent the number of substitutions per site. The amino acid 
sequences were extracted from Genbank with the following accession numbers: Human, Homo 
sapiens (AF076215); Sheep, Ovis aries (AY533709); Goat, Capra hircus (XM_005682787); Cow, 
Bos taurus (XM_015472155); Pig, Sus scrofa (XM_013987527); Dog, Canis familiaris 
(NM_001020807); Rat, Rattus norvegicus (XM_008767664) and Mouse, Mus musculus (U77946). 
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Chromatogram of PROP1 Sequence 
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Birth weight and PROP1 variants 
Dependent variable: Birth weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
 
Estimated Marginal Means 2: A1 
 
 
Estimates 
A1 Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 5.476534
88800000
1 
.2230998
2900000
0 
5.039267
2590000
01 
5.913802
51700000
1 
1 5.540537
25100000
0 
.2122621
4400000
0 
5.124511
0940000
01 
5.956563
40700000
0 
 
 
 
 
Tailing weight and PROP1 variants  
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant 
Covariate: Tailing Age 
 
Estimated Marginal Means 2: A1 
 
 
Estimates 
A1 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 11.086 .6047 9.901 12.271 
1 12.167 .5773 11.036 13.299 
Covariates appearing in the model are fixed at the 
following values: Tailing Age=30.446 
 
 
Overall Test Results 
Wald Chi-Square df Sig. 
.692 1 .406 
The Wald chi-square tests the effect of A1. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
27.152 1 .000 
The Wald chi-square tests the effect of A1. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
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Weaning weight and PROP1 variants  
Dependent variable: Weaning weight 
Model: (Intercept), RamID, Sex, Birth rank, Variant  
Covariate: Weaning Age 
 
Estimated Marginal Means 2: A2 
 
 
Estimates 
A2 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 28.284 1.0285 26.268 30.300 
1 30.849 .9686 28.950 32.747 
Covariates appearing in the model are fixed at 
the following values: Weaning Age=88.356 
 
Growth rate and PROP1 variants  
Dependent variable: Tailing weight 
Model: (Intercept), RamID, Sex, Rearing rank, Variant 
Covariate: Birth weight 
 
Estimated Marginal Means 2: A2 
 
Estimates 
A2 Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 247.9125
1620000
0000 
10.47903
3000000
000 
227.3739
8900000
0000 
268.4510
4349999
9970 
1 275.4492
1610000
0000 
10.22751
2700000
000 
255.4036
5949999
9970 
295.4947
7260000
0000 
Covariates appearing in the model are fixed at the 
following values: Birth Wt=5.806111111111114 
 
 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
43.341 1 .000 
The Wald chi-square tests the effect of 
A2. This test is based on the linearly 
independent pairwise comparisons 
among the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
46.886 1 .000 
The Wald chi-square tests the effect of A2. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
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HCW and PROP1 variants  
Dependent variable: Hot carcass weight 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A1 
 
Estimates 
A1 Mean 
Std. 
Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 16.618 .1493 16.325 16.911 
1 17.212 .0869 17.042 17.382 
Covariates appearing in the model are fixed at the 
following values: Draft Age (days)=130.93; Birth 
Wt=5.793507462686569 
 
 
V-GR and PROP1 variants  
Dependent variable: V-GR 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A1 
 
Estimates 
A1 Mean 
Std. 
Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 4.734399
8480000
01 
.2180509
6200000
0 
4.307027
8150000
01 
5.161771
8810000
00 
1 4.176791
9350000
01 
.1269025
1400000
0 
3.928067
5780000
00 
4.425516
2930000
00 
Covariates appearing in the model are fixed at 
the following values: Draft Age (days)=130.93; 
Birth Wt=5.793507462686569 
 
Overall Test Results 
Wald Chi-Square df Sig. 
16.141 1 .000 
The Wald chi-square tests the effect of A1. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
6.665 1 .010 
The Wald chi-square tests the effect of A1. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
  245 
Leg yield and PROP1 variants  
Dependent variable: Leg yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A1 
 
Estimates 
A1 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 21.2097507
70000000 
.109124412
000000 
20.9958708
50000000 
21.4236306
90000000 
1 21.5487900
80000000 
.063508833
300000 
21.4243150
60000000 
21.6732651
10000000 
Covariates appearing in the model are fixed at the following 
values: Draft Age (days)=130.93; Birth 
Wt=5.793507462686569 
 
Loin yield and PROP1 variants  
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A2 
 
 
Estimates 
  A2 Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 14.20617
48400000
01 
.0810557
2160000
0 
14.04730
8540000
000 
14.36504
11300000
00 
1 14.61091
25600000
01 
.0440437
5900000
0 
14.52458
8380000
000 
14.69723
67400000
01 
Covariates appearing in the model are fixed at the 
following values: Birth Wt=5.793507462686569; 
Draft Age (days)=130.93 
Overall Test Results 
Wald Chi-
Square df Sig. 
9.838 1 .002 
The Wald chi-square tests the 
effect of A1. This test is based 
on the linearly independent 
pairwise comparisons among 
the estimated marginal 
means. 
Overall Test Results 
Wald Chi-
Square df Sig. 
24.332 1 .000 
The Wald chi-square tests the 
effect of A2. This test is based on 
the linearly independent pairwise 
comparisons among the 
estimated marginal means. 
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Shoulder yield and PROP1 variants  
Dependent variable: Shoulder yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A2 
 
Estimates 
A2 Mean Std. Error 
95% Wald 
Confidence Interval 
Lower Upper 
0 16.57879
05200000
02 
.0885466
5040000
0 
16.40524
2280000
000 
16.75233
87700000
00 
1 16.83056
42400000
00 
.0481141
5220000
0 
16.73626
2240000
002 
16.92486
62500000
00 
Covariates appearing in the model are fixed at the 
following values: Birth Wt=5.793507462686569; 
Draft Age (days)=130.93 
 
Total yield and PROP1 variants  
Dependent variable: Loin yield 
Model: (Intercept), RamID, Variant 
Covariate: Birth weight, Draft Age 
 
Estimated Marginal Means 2: A2 
 
Estimates 
A2 Mean Std. Error 
95% Wald Confidence 
Interval 
Lower Upper 
0 52.1471857
30000004 
.241259159
000000 
51.6743264
70000004 
52.62004500
0000005 
1 52.9595711
90000000 
.131094512
000000 
52.7026306
60000004 
53.21651171
0000000 
Covariates appearing in the model are fixed at the following 
values: Birth Wt=5.793507462686569; Draft Age (days)=130.93 
 
Overall Test Results 
Wald Chi-
Square df Sig. 
7.890 1 .005 
The Wald chi-square tests the 
effect of A2. This test is based on 
the linearly independent pairwise 
comparisons among the estimated 
marginal means. 
Overall Test Results 
Wald Chi-Square df Sig. 
11.065 1 .001 
The Wald chi-square tests the effect of A2. 
This test is based on the linearly 
independent pairwise comparisons among 
the estimated marginal means. 
